Genetic basis for the virulence of enterohemorrhagic Escherichia coli strain TW14359 by Morgan, Jason Kyle
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
5-2-2014
Genetic basis for the virulence of
enterohemorrhagic Escherichia coli strain
TW14359
Jason Kyle Morgan
University of South Florida, jkmorgan@mail.usf.edu
Follow this and additional works at: https://scholarcommons.usf.edu/etd
Part of the Microbiology Commons, and the Molecular Biology Commons
This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in
Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.
Scholar Commons Citation
Morgan, Jason Kyle, "Genetic basis for the virulence of enterohemorrhagic Escherichia coli strain TW14359" (2014). Graduate Theses
and Dissertations.
https://scholarcommons.usf.edu/etd/5277
  
 
 
 
Genetic basis for the virulence of enterohemorrhagic Escherichia coli strain TW14359 
 
 
 
by 
  
 
 
Jason K. Morgan 
 
 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
Department of Cell Biology, Microbiology & Molecular Biology 
College of Arts and Sciences 
University of South Florida 
 
 
 
Major Professor: James Riordan, Ph.D. 
Lindsey Shaw, Ph.D. 
Burt Anderson, Ph.D. 
Stanley Stevens, Ph.D. 
 
 
Date of Approval: 
May 2, 2014 
 
 
 
Keywords: Bacterial Pathogenesis, Gene Regulation, Bicarbonate, EHEC, RcsB 
 
Copyright © 2014, Jason K. Morgan 
i 
 
 
 
               Table of Contents 
 
List of Tables ................................................................................................................................. iv 
 
List of Figures ................................................................................................................................. v 
 
Abstract…… ................................................................................................................................. vii 
 
Chapter 1: Introduction ................................................................................................................... 1 
1.1 Enterohemorrhagic Escherichia coli (EHEC) ...............................................................1 
1.2 Virulence determinants of EHEC and the mechanisms by which they 
cause disease ..................................................................................................................3 
1.2.1 Shiga Toxin.......... .......................................................................................... 3 
1.2.2 The Locus of Enterocyte Effacement (LEE) ................................................. 4 
1.2.3 Regulation of type III secretion in EHEC ...................................................... 8 
1.2.4 The E. coli common pilus (ECP) ................................................................. 13 
1.3 Variation in virulence among EHEC O157:H7 strains ................................................14 
1.4 The RcsCDB phosphorelay system .............................................................................14 
1.5 The G. mellonella virulence model ..............................................................................27 
1.6 Project aim ...................................................................................................................28 
 
Chapter 2: RcsB determines the locus of enterocyte effacement (LEE) expression 
and adherence phenotype of Escherichia coli O157:H7 spinach outbreak 
strain TW14359 and coordinates bicarbonate-dependent LEE activation with 
repression of motility .............................................................................................................. 30 
2.1 Background ..................................................................................................................30 
2.2 Methods…....................................................................................................................32 
2.2.1 Bacterial strains and culture conditions ....................................................... 32 
2.2.2 Genetic manipulations and chromosomal FLAG-fusion 
construction ..................................................................................................... 32 
2.2.3 Protein extraction, SDS-PAGE and western blots ....................................... 33 
2.2.4 Proteomic analysis ....................................................................................... 34 
2.2.5 RNA purification and quantitative real-time PCR (qRT-PCR) ................... 35 
2.2.6 Construction of lacZ transcriptional promoter fusions and β-
galactosidase assays ........................................................................................ 35 
2.2.7 Adherence assays ......................................................................................... 36 
2.2.8 Motility assays ..........................................................................................................37 
2.3 Results...... ....................................................................................................................37 
2.3.1 The LEE expression phenotype of strain TW14359 .................................... 37 
2.3.2 Role for RcsB in the LEE expression and adherence 
phenotype of strain TW14359 ........................................................................ 38 
ii 
 
2.3.3 Control of rcsB by the LEE-encoded regulator GrlA, and 
GrlA-RcsB dependent repression of motility...... ........................................... 48 
2.3.4 Role for Rcs phosphorelay and grvA in bicarbonate-
dependent activation of the LEE ..................................................................... 51 
2.4 Discussion ....................................................................................................................54 
2.5 Acknowledgments........................................................................................................58 
 
Chapter 3: Function and regulation of the RcsB-GrvA pathway controlling 
virulence and fitness factors in enterohemorrhagic Escherichia coli ..................................... 64 
3.1 Background ..................................................................................................................64 
3.2 Methods……..……......................................................................................................67 
3.2.1 Bacterial strains and culture conditions ....................................................... 67 
3.2.2 Genetic manipulations and complementation .............................................. 68 
3.2.3 Protein extraction, SDS-PAGE and western immunoblots.......................... 69 
3.2.4 RNA purification and quantitative real-time PCR (qRT-PCR) ................... 70 
3.2.5 Construction of single copy luxE operon fusions ........................................ 70 
3.2.6 Luciferase plate assays ................................................................................. 71 
3.2.7 Electrophoretic mobility shift assay (EMSA) .............................................. 72 
3.2.8 Construction of lacZ transcriptional promoter fusions and β-
galactosidase assays ........................................................................................ 73 
3.2.9 RNA-seq and data analysis .......................................................................... 74 
3.2.10 Adherence assays ....................................................................................... 74 
3.2.11 Acid resistance assays ................................................................................ 75 
3.3 Results……. .................................................................................................................76 
3.3.1 Expression profiles of the rcsDB and grvAB operons, and 
molecular basis for grvA activation by RcsB .................................................. 76 
3.3.2 The GrvA regulon of EHEC ........................................................................ 80 
3.3.3 GrvA/GadE control of ler and adherence to HT-29 colonic 
epithelial cells ................................................................................................. 90 
3.3.4 Effect of grvA mutation on gadE promoter activity .................................... 92 
3.3.5 Acid Resistance experiments in TW14359 and grvA mutant 
strains .............................................................................................................. 96 
3.4 Discussion ....................................................................................................................98 
 
Chapter 4: A novel promoter drives transcription of the Escherichia coli common 
pilus in the 2006 EHEC O157:H7 spinach outbreak strain TW14359 ................................. 111 
4.1 Background ................................................................................................................111 
4.2 Methods……..............................................................................................................113 
4.2.1 Bacterial and mammalian tissue culture .................................................... 113 
4.2.2 Mutagenesis and vector construction ......................................................... 114 
4.2.3 RNA purification and quantitative real-time PCR (qRT-PCR) ................. 115 
4.2.4 β-galactosidase assays ................................................................................ 116 
4.2.5 Protein extraction and western blotting ..................................................... 117 
4.2.6 Flow cytometry .......................................................................................... 117 
4.3 Results….. ..................................................................................................................118 
iii 
 
4.3.1 Promoter analysis of the ecpR and ecpA upstream regions in 
TW14359 identified a novel promotable element within the 
ecpR open reading frame .............................................................................. 118 
4.3.2 Basal EcpA production independent of the ecpR promoter ....................... 119 
4.3.3 A single nucleotide polymorphism within the TW14359 ecpR 
open reading frame is required for maximal ecpA promoter 
activity........................................................................................................... 122 
4.3.4 Adherence to epithelial cells mediated by ECP in the absence 
of the ecpR promoter ..................................................................................... 125 
4.3.5 Overproduction of EcpR increases cytosolic RcsB and Tir 
protein levels ................................................................................................. 129 
4.4 Discussion ..................................................................................................................133 
 
Chapter 5: Conclusions and Future Directions ........................................................................... 144 
 
References........ ........................................................................................................................... 160 
 
Appendices....... ........................................................................................................................... 187 
Appendix A: Copyright Permissions ...............................................................................187 
Appendix B: Manuscripts ................................................................................................189 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
 
 
                
List of Tables 
 
Table 1 - Select list of proteins identified by iTRAQ proteomics .................................... 42 
 
Table 2 - Strains and plasmids used in Chapter 2 ............................................................. 59 
 
Table 3 - Primers used in Chapter 2.................................................................................. 61 
 
Table 4 - RNA-seq transcriptome data ............................................................................. 82 
 
Table 5 - qRT-PCR validation of RNA-seq data .............................................................. 89 
 
Table 6 - Strains and plasmids used in Chapter 3 ........................................................... 106 
 
Table 7 - Primers used in Chapter 3................................................................................ 108 
 
Table 8 - Strains and plasmids used in Chapter 4 ........................................................... 140 
 
Table 9 - Primers used in Chapter 4................................................................................ 142 
 
 
 
 
 
 
 
 
 
 
v 
 
 
                                        
List of Figures 
Figure 1 - Model depicting the pathway for enterohemorrhagic E. coli host 
colonization .........................................................................................................2 
 
Figure 2 - Model for type III secretion in hemorrhagic Escherichia coli (EHEC) ............. 7 
 
Figure 3 - Model for LEE gene regulation in EHEC ........................................................ 10 
 
Figure 4 - The RcsCDB phosphorelay and regulation of type III secretion in 
EHEC ................................................................................................................ 16 
 
Figure 5 - Homo- and hetero-dimerization of RcsB in E. coli .......................................... 18 
 
Figure 6 - Functional domains of the Rcs components in E. coli ..................................... 20 
 
Figure 7 - RcsF and DjiA activation of the Rcs phosphorelay ......................................... 24 
 
Figure 8 - The LEE expression phenotype of strain TW14359 ........................................ 39 
 
Figure 9 - qRT-PCR for ler mRNA stability in TW14359 and Sakai. ............................. 40 
 
Figure 10 - rcsB expression in Sakai and TW14359. ....................................................... 45 
 
Figure 11 - rcsB, grvA and the LEE expression and adherence phenotype of 
TW14359. ....................................................................................................... 47 
 
Figure 12 - qRT-PCR for ler and grlA mRNA in TW14359 and 
TW14359grlR::kan. ........................................................................................ 49 
 
Figure 13 - GrlA-RcsB dependent repression of motility. ................................................ 50 
 
Figure 14 - Effect of bicarbonate on RcsB, and rcsB-dependent LEE activation. ........... 52 
 
Figure 15 - Temporal expression of rcsDB and grvAB operons in TW14359 .................. 77 
 
Figure 16 - Direct transcriptional regulation of grvA by RcsB ......................................... 79 
vi 
 
 
Figure 17 - Circular plot of RNA-Seq in EHEC strain TW14359 and mutant 
derivatives ..................................................................................................... 81 
 
Figure 18 - Analysis of the gadE dependent GrvA regulation of ler and 
competitive adherence to HT-29 colonic epithelial cells .............................. 91 
 
Figure 19 - Investigating the individual contribution of gadE promoters using 
promoter lacZ fusions .................................................................................... 93 
 
Figure 20 - Investigating the contribution of GadX and GadW to increased gadE 
promoter activity ........................................................................................... 95 
 
Figure 21 - GrvA dependent exponential phase acid resistance phenotype ..................... 97 
 
Figure 22 – The transcriptional regulation of ecpR and ecpA ........................................ 120 
 
Figure 23 - Western blot analysis of EcpA-FLAG in TW14359 .................................... 121 
 
Figure 24 - Alignment of the ecpA upstream region from select E. coli strains ............. 123 
 
Figure 25 - Characterizing the TW14359 ecpA specific promoter polymorphism ......... 124 
 
Figure 26 - Regulation of the TW14359 ecpA promoter by H-NS ................................. 126 
 
Figure 27 - ECP directed adherence and production of ECP by the ecpR and ecpA 
promoters ..................................................................................................... 127 
 
Figure 28 - qRT-PCR and Western blot analysis of rcsB, ecp, and LEE gene 
targets .......................................................................................................... 130 
 
Figure 29 - qRT-PCR and western blot analysis of rcsB, ecp, and LEE gene 
targets with pecpABCDE ............................................................................. 132 
 
Figure 30 - Schematic model for TolQRA and the Rcs phosphorelay ........................... 149 
 
Figure 31 - Model for ECP biogenesis and predicted stimulation of the Rcs 
phosphorelay ............................................................................................... 154 
 
Figure 32 - Schematic model for RcsB-GrvA regulation of the LEE............................. 157 
vii 
 
 
 
Abstract…… 
 Enterohemorrhagic Escherichia coli (EHEC) is a virulent pathotype of E. coli that is 
associated with major outbreaks of hemorrhagic colitis and the life-threatening kidney disease 
hemolytic uremic syndrome. For successful host colonization and attachment to the intestinal 
mucosa, EHEC requires the locus of enterocyte effacement (LEE) pathogenicity island, which 
encodes a type III secretion system (TTSS) responsible for secreting and translocating effector 
proteins into host colonocytes. Regulation of the LEE is primarily directed through the first 
operon, LEE1, encoding the locus encoded regulator (Ler), and occurs through the direct and 
indirect action of several regulators. The 2006 U.S. spinach outbreak of E. coli O157:H7, 
characterized by unusually severe disease, has been attributed to a strain (TW14359) with 
enhanced pathogenic potential including elevated virulence gene expression, robust adherence, 
and the presence of novel virulence factors.   
 Aim 1 of this dissertation proposes a mechanism for the unique virulence expression and 
adherence phenotype of this strain, and further expands the role for regulator RcsB in control of 
the E. coli locus of enterocyte effacement (LEE) pathogenicity island. Proteomic analysis of 
TW14359 revealed a virulence proteome consistent with previous transcriptome studies that 
included elevated levels of the LEE regulatory protein Ler and type III secretion system (T3SS) 
proteins, secreted T3SS effectors, and Shiga toxin 2. Basal levels of the LEE activator and Rcs 
phosphorelay response regulator, RcsB, were increased in strain TW14359 relative to O157:H7 
strain Sakai. Deletion of rcsB eliminated inherent differences between these strains in ler 
expression, and in T3SS-dependent adherence. A reciprocating regulatory pathway involving 
RcsB and LEE-encoded activator GrlA was identified and predicted to coordinate LEE activation 
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with repression of the flhDC flagellar regulator and motility. Overexpression of grlA was shown 
to increase RcsB levels, but did not alter expression from promoters driving rcsB transcription.  
Expression of rcsDB and RcsB was determined to increase in response to physiologic levels of 
bicarbonate, and bicarbonate-dependent stimulation of the LEE was shown to be dependent on 
an intact Rcs system and ler activator grvA. The results of this aim significantly broaden the role 
for RcsB in EHEC virulence regulation. 
 The bicarbonate ion (HCO3
-
) has been shown to stimulate LEE gene transcription through 
the LEE1 promoter, and is predicted to serve as a physiologic signal for EHEC colonization.  
Results from the previous aim demonstrated that bicarbonate induction of the LEE is mediated 
through the Rcs phosphorelay, and is dependent upon an intact global regulator of virulence grvA 
gene. However, the direct mechanism through which RcsB-GrvA regulates ler, and the 
contribution of GrvA to the virulence of EHEC is unknown. In Aim 2, the RcsB-GrvA regulon 
of EHEC was determined by RNA sequencing, and the contributions of each to virulence and 
stress fitness was explored. A significant increase in transcription of the gad genes for extreme 
acid resistance was observed for both EHEC strains TW14359∆grvA and TW14359∆rcsB∆grvA 
compared to TW14359, and corresponded with a significant increase in acid survival for 
TW14359∆grvA during exponential growth. Therefore, a model by which RcsB-GrvA 
coordinate LEE expression with acid resistance through GadE was proposed.  Finally, the 
temporal regulation of both rcsDB and grvAB operons in response to bicarbonate was defined 
using single copy luxE chromosomal reporter fusions. Taken together, these results demonstrate 
the role of RcsB and GrvA to EHEC virulence, and reveal a novel role for GrvA in of extreme 
acid resistance and LEE gene expression and in EHEC. 
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 Finally, production of the ECP pilus has been demonstrated in enterohemorrhagic 
Escherichia coli O157:H7 (EHEC), and has been shown to be required for efficient adherence to 
epithelial cells during colonization. The first gene of the ecpRABCDE operon encodes a 
transcriptional regulator (EcpR) that positively regulates its own transcription, and promotes 
transcription and production of the downstream gene, ecpA, encoding the major ECP subunit 
EcpA.  However, the distance between the ecpR and ecpA genes suggests the presence of 
regulatory elements that control ecpA directly. Therefore, it was hypothesized that an additional 
promoter was able to direct transcription of ecpA, independent of the promoter upstream of ecpR.  
To test this, promoter-lacZ transcriptional reporter fusions were created using the regions 
upstream of ecpR and ecpA to test for promoter activity, coupled with western blot analysis to 
detect EcpA in both wild-type and ecpR promoter mutant strains. In Aim 3, we showed that an 
additional promotable element, downstream of the EHEC O157:H7 strain TW14359 ecpR 
translational start site, is capable of driving transcription of ecpA, and that its activity is 
independent of an intact ecpR promoter. In addition, site-directed mutagenesis was used to 
characterize a TW14359 specific single nucleotide polymorphism within the predicted ecpA 
promoter region. Overproduction of EcpR was observed to increase cytosolic RcsB and Tir, 
indicating that ecp production is able to stimulate the LEE, and that the ecpA promoter 
polymorphism may contribute to intrinsically increased rcsB transcription in TW14359.  Taken 
together, the results, and those obtained in Aims 1 and 2, expand the model for regulation of the 
ecp operon in EHEC O157:H7 strain TW14359, and broaden the model for EcpR and RcsB in 
the coordinate regulation of E. coli common pilus and type III secretion. 
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Chapter 1: Introduction 
1.1 Enterohemorrhagic Escherichia coli (EHEC) 
 Escherichia coli is a facultatively anaerobic gram negative bacteria of the family 
Enterobacteriaceae, and is commonly found as a component of the normal mammalian lower 
intestinal flora (Giangrossi et al., 2005). And though it is found in the gut, E. coli can survive for 
extended periods of time in terrestrial and aquatic habitats (van Elsas et al., 2011). Since its 
discovery, E. coli has become an integral part of modern molecular biology as a model organism 
and has been intensively studied. Though the average genome size of E. coli is roughly 4.7 
Megabases (Mb), there exists a highly diverse subset of E. coli strains and pathotypes with 
unique properties and ecological niches (Touchon et al., 2009).  The core genome of E. coli is 
composed of roughly 2,000 genes, while the pan genome contains roughly 18,000 orthologous 
genes (Touchon et al., 2009). This extensive repertoire of genes provides E. coli with an 
enormous set of tools to adapt and respond to various environments, including those found in the 
human host. While some E. coli strains are non-pathogenic, a subset of important E. coli 
pathotypes exist which can cause overt disease in humans. These include enteropathogenic E. 
coli (EPEC), enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), enterotoxigenic 
E. coli (ETEC), extra-intestinal pathogenic E. coli (ExPEC), uropathogenic E. coli (UPEC), and 
enterohemorrhagic E. coli (EHEC) (Lim et al., 2011; Nataro and Kaper, 1998). 
 Enterohemorrhagic Escherichia coli is a zoonotic pathogen capable of causing severe 
diarrheagenic illness, as well as life-threatening kidney disease, in humans. There are an  
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Figure 1 - Model depicting the pathway for enterohemorrhagic E. coli host colonization 
The model for E. coli colonization of the human host, following ingestion of bacteria in contaminated 
water or food, involves passage through the gastric barrier and successful competitive colonization of the 
intestinal mucosa. 
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estimated 77,000 EHEC infections each year, resulting in 2,000 hospitalizations and 60 deaths, 
with an estimated annual cost of $405 million (Frenzen et al., 2005). An infection caused by 
EHEC typically presents with frankly bloody diarrhea (hemorrhagic colitis), and may progress to 
a toxin-associated illness known as hemolytic uremic syndrome, which is characterized by 
thrombocytopenia, and microangiopathic hemolytic anemia (Nataro and Kaper, 1998).   
 The primary reservoir of EHEC is domestic and wild ungulates, however colonized 
calves and adult cattle typically remain asymptomatic (Cray and Moon, 1995). Transmission 
generally occurs indirectly through the fecal-oral route (Fig. 1), with outbreaks originating from 
contaminated food (Nataro and Kaper, 1998). Other sources of infection include direct contact 
with infected persons or domestic animals, and tainted water (drinking and recreational) (Rangel 
et al., 2005). The low oral infectious dose of EHEC (<100 bacteria) is determined by its ability to 
successfully survive passage through the stomachs gastric acid barrier, and by competitive 
colonization of the host intestine (Kaper et al., 2004). As antibiotic use is contraindicated for 
EHEC infections, due to complications associated with Shiga toxin production and HUS, there 
are very few strategies in use for infection treatment and prevention (Jaeger and Acheson, 2000). 
This fact underscores the importance of further understanding the mechanisms which determine 
the virulence of this pathogen.   
 
1.2 Virulence determinants of EHEC and the mechanisms by which they cause disease 
1.2.1 Shiga Toxin.......... 
 The virulence of EHEC is largely dictated by production of Shiga toxin 2 (Stx2) (Boerlin 
et al., 1999; O'Brien et al., 1983).  Stx2 is an AB5 toxin, comprised of Stx2A and five Stx2B 
subunits. The genes which encode the toxin (stx2AB) are contained within a temperate lambdoid 
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prophage (Johannes and Romer, 2010; Unkmeir and Schmidt, 2000). The toxin can enter the host 
cell through binding of cell surface expressed glycolipids, specifically globotriaosylceramide 
(Gb3), leading to clathrin mediated endocytosis and retrograde transport of the toxin through the 
endoplasmic reticulum (Johannes and Romer, 2010). There, the A-subunit is released into the 
cytoplasm where it cleaves a single adenine base from the eurkaryotic 28S ribosomal RNA 
leading to an inhibition of protein synthesis, and cell death (Endo et al., 1988). It has been shown 
that cattle lack the vascular receptors for Stx2 binding, which can explain why they are 
asymptomatic carriers for stx2 positive EHEC serotypes (Pruimboom-Brees et al., 2000).  
Recently, it was shown that EHEC strain EDL933 carrying a non-inducible variant of Stx2 was 
able to colonize a mouse host, but was not able to produce any pathological changes without 
Stx2 production, underscoring the significant role of Stx2 in EHEC pathogenesis following 
colonization (Tyler et al., 2013).   
 
1.2.2 The Locus of Enterocyte Effacement (LEE) 
 Successful competitive colonization of the host intestine requires a 36 kb pathogenicity 
island termed the locus of enterocyte effacement (LEE), which contains five operons encoding 
structural, auxiliary and regulatory components of a contact-dependent type III secretion system 
(T3SS) (McDaniel et al., 1995; Moon et al., 1983) (Fig. 3A).  The LEE contains genes necessary 
for production of the T3SS, regulation of the LEE, and effectors required for intimate attachment 
to host cells (Deng et al., 2004; McDaniel et al., 1995; Perna et al., 1998).  Intimate attachment is 
dependent on the interaction of the TTSS translocated effector Tir, localized to the apical region 
of the host intestinal cell, with the EHEC-encoded adhesin, intimin (Kenny et al., 1997b).   
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Pedestal structures (attaching and effacing lesions) are a consequence of actin condensation 
below the attached bacterium (Campellone, 2010; Cheng et al., 2008; Garmendia et al., 2004; 
Knutton et al., 1989).  Previous studies have identified the conditions which stimulate T3SS 
production and subsequently enhance EHEC gut adherence, this includes growth at 37°C, 
physiologic osmolarity, and the presence of sodium bicarbonate (Kenny et al., 1997a; 
Rosenshine et al., 1996).  Abe et al. observed maximum expression of LEE genes in EHEC when 
grown in the presence of 44 mM sodium bicarbonate under nutrient-rich conditions, which has 
been proposed to be a similar environment to that of the intestinal ileum (Abe et al., 2002; 
Fordtran and Locklear, 1966).  Currently, no mechanism for bicarbonate stimulation of the LEE 
has been identified in EHEC or EPEC (Yang et al., 2008).   
 The ATPase EscN is localized to the base of the inner membrane T3SS ring and 
hydrolyzes ATP to provide the energy for effector translocation (Sorg et al., 2005; Tree et al., 
2009; Winnen et al., 2008; Yip et al., 2005; Zarivach et al., 2007). The type III secretion process 
in EHEC can be divided into two general modes of activity, (i) production and secretion of the 
filamentous translocon apparatus prior to contact and (ii) reduced secretion of translocon proteins 
following contact and intimate adherence with increased secretion of effector proteins (Tree et 
al., 2009) (Fig. 2).  The T3SS itself is composed of a multi-ring basal apparatus spanning the 
inner and outer membranes, composed of EscD, EscQ, EscR, EscS, EscT, EscU, and EscV 
(Efromovich et al., 2008; Gauthier et al., 2003; Ogino et al., 2006; Partridge et al., 2009).  The 
protein EscF forms the needle complex, a structure which spans the inner and outer membranes, 
onto which the EHEC translocon apparatus assembles.  In this regard, the T3SS of EHEC and 
EPEC is different from that of Yesinia pestis, where type III secretion is independent of a 
filament structure and relies solely on the needle complex for secretion (composed of YscF) 
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(Torruellas et al., 2005). The translocon apparatus is composed of three proteins to form a 
filament and pore complex. The filament structure is composed of multimeric EspA subunits 
extending outward from the needle complex, with a diameter of 120 Å and central channel 
diameter of 25 Å (Keller et al., 2002).  Each EspA filament is capped with a complex composed 
of two proteins, EspB and EspD, which serves to form a pore roughly 3-5 nm in diameter within 
the membrane of the host cell (Kresse et al., 1999; Mitra et al., 2012). Together, the T3SS 
filament and pore complex, formed by EspA and EspB/D, function to create a hollow conduit 
between the bacterial and host cell cytosol through which effector proteins are translocated. 
 Effector proteins that are encoded within the LEE, and those that are non-LEE-encoded, 
serve diverse functions in the infection process. The effector protein Tir (translocated intimin 
receptor) is preferentially secreted into the host cytoplasm, where it localizes to the host cell 
cytoplasmic membrane (DeVinney et al., 1999). There, it serves as a receptor for the EHEC 
outer membrane protein intimin. Binding of the host cell localized Tir with intimin facilitates 
intimate attachment of the bacterium, and is followed by the production of a pedestal structure 
formed by the condensation of actin below the bacterium (Garmendia et al., 2004; Kaper et al., 
2004; Knutton et al., 1989; Knutton et al., 1987).  Some effectors, such as NleE, NleC, and 
NleH, have been shown to modulate the host cell immune response (Hemrajani et al., 2008; Yen 
et al., 2010).  Others, such as Map and EspF, are able to disrupt tight-junctions and promote 
apoptosis, respectively (Crane et al., 2001; Dean and Kenny, 2009). The switch between 
secretion of translocators (i.e. structural proteins which constitute the filament and pore complex) 
and effectors is complex, and the proper timing/regulation of their secretion is vital for 
successful attachment. It has been shown that the LEE-encoded chaperone CesT serves to 
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Figure 2 - Model for type III secretion in hemorrhagic Escherichia coli (EHEC) 
(Left)The type III secretion system (T3SS) of EHEC is composed of the needle complex (Esc proteins) 
and the secreted translocon apparatus (Esp proteins). The EscF protein forms the minimal structure 
through which proteins can be secreted in a type III dependent manner. However the translocon apparatus 
proteins EspA, EspB, and EspD are required for pore complex formation and intimate adherence. 
(Middle) Loss of the ATPase EscN results in loss of ATP hydrolysis required for protein translocation 
through the T3SS. (Right) Secretion hierarchy of the T3SS is dictated by the SepD/SepL complex, and 
mutation of either results in hypersecretion of non-translocon effector proteins into the extracellular 
milieu.   
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localize effectors to the TTSS by association with the SepL/SepD complex, and that Tir is 
preferentially localized to the complex for secretion (Deng et al., 2005; Thomas et al., 2005; Yip 
et al., 2005). Secretion of both LEE- and non-LEE-encoded effectors is thought to occur in a 
rank order manner (Mills et al., 2008).  Due to preferential binding of Tir-bound-CesT to the 
SepD/L complex, other effectors are effectively blocked from being secreted (Thomas et al., 
2005).  Prior to attachment to a host cell, the proteins composing the translocon filament (EspA, 
EspB, and EspD) are preferentially secreted, along with Tir. Following attachment and 
translocation of Tir, CesT is able to stabilize other effectors prior to proteolytic degradation and 
direct them to be secreted (Leverton and Kaper, 2005; Mills et al., 2008; Winnen et al., 2008).   
 
1.2.3 Regulation of type III secretion in EHEC 
 The control and expression of the TTSS is tightly controlled and coordinated by factors 
which are both LEE- and non-LEE encoded (Fig. 3B). All of the genes required for formation of 
the TTSS are encoded within the 5 major operons of the LEE, LEE1-LEE5 (Elliott et al., 1999). 
The master LEE regulator Ler, encoded as the first gene of the LEE1 operon, positively 
stimulates LEE gene transcription by relieving H-NS mediated repression while negatively 
regulating its own transcription (Bingle et al., 2014; Elliott et al., 2000). It has been proposed 
that the antagonistic effect on H-NS repression by Ler is due to the formation of toroidal-protein 
DNA complexes, wherein Ler has a higher affinity for host DNA (Mellies et al., 2011). 
However, the precise mechanism of binding specificity remains unclear. Ler is also able to 
stimulate production of other LEE encoded regulators including GrlA and GrlR, which activate 
and repress ler transcription, respectively (Berdichevsky et al., 2005; Deng et al., 2004; Elliott et 
al., 2000; Haack et al., 2003; Islam et al., 2011; Sperandio et al., 2000). The genes grlA and grlR 
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are encoded as a discistron from an H-NS/Ler regulated promoter (Barba et al., 2005), and GrlA 
binds directly to the LEE1 promoter region (Huang and Syu, 2008). Activation of LEE1 
transcription by GrlA, through the specific interaction with a region between the -10 and -35 
sites of the LEE1 P1 promoter, is dependent on its helix-turn-helix (HTH) motif, and is not 
required following deletion of H-NS, supporting its role in anti-silencing the ler promoter (Islam 
et al., 2011; Jimenez et al., 2010). The regulator GrlA has two functional domains, including a 
transcriptional domain and a domain involved in specific interaction with GrlR (Jimenez et al., 
2010), a protein that binds directly with GrlA to inhibit its anti-silencing activity at the LEE1 
promoter (Iyoda et al., 2006). It was recently shown that the specific interaction of GrlR with 
GrlA inhibits the activity of GrlA by out-competing target DNA for its helix-turn-helix motif 
(Padavannil et al., 2013). 
 Further regulation of LEE gene transcription is mediated through numerous factors 
encoded outside of the LEE including RpoS, RpoN, EivF, EtrA, PchC, GrvA, Hfq, RgdR, QseA, 
and RcsB (Dong et al., 2009; Flockhart et al., 2012; Hansen and Kaper, 2009; Hengge, 2009; 
Iyoda and Watanabe, 2004; Kendall et al., 2010; Laaberki et al., 2006; Navarro Llorens et al., 
2010; Riordan et al., 2010; Russell et al., 2007; Sharp and Sperandio, 2007; Tobe et al., 2005; 
Zhang et al., 2004). Transcription of LEE genes in EHEC, and subsequent type III secretion, is 
maximal during exponential growth, with LEE gene transcription collapsing during stationary 
phase (Bergholz et al., 2007b; Mitra et al., 2012). Stationary phase regulation by sigma factor 
RpoS is partially dependent on the protease ClpXP, which is also able to promote the stability of 
the LEE gene repressor GrlR, and the accumulation of RpoS leads to activation of the LEE 
repressing acid resistance regulators (Dong and Schellhorn, 2009; Iyoda and Watanabe, 2005).  
The regulators EivF and EtrA are two LEE regulatory proteins encoded within a defunct type III 
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Figure 3 - Model for LEE gene regulation in EHEC 
Shown above is (A) the schematic organization of the 36-kb LEE pathogenicity island, and (B) a 
regulatory model for LEE gene regulation through the known RcsB-GrvA pathway, including the master 
motility regulatory flhDC. The LEE1 operon encodes Ler, a positive regulator of the remaining LEE2-
LEE5 operons.  Ler is also able to stimulate transcription of the LEE encoded grlRA operon, producing 
the LEE1 activator GrlA and the GrlA inhibiting protein GrlR. The Rcs phosphorelay response regulator 
RcsB directly represses motility, a phenotype also observed for GrlA, and stimulates transcription of the 
grvAB operon. Finally, in a direct or indirect manner, the GrvA transcriptional regulator positively affects 
LEE gene transcription through the LEE1 promoter. 
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secretion system, termed ETT2, found in both pathogenic and non-pathogenic strains of E. coli 
(Zhang et al., 2004). The cross-talk between the LEE and EivF/EtrA has not yet been shown to 
be direct, since only repression of LEE gene transcription was demonstrated following their 
overproduction. These regulators are particularly notable in that they are the regulatory remnants 
of a defunct T3SS exerting influence over an extant PAI (the LEE), a phenomena that has been 
described as the “Cheshire cat effect” (Zhang et al., 2004). Another notable non-LEE encoded 
regulator of the LEE is actually a class of regulators, termed PerC homologs (Pch), which is 
derived from their homology to the EPEC specific LEE regulator, PerC (Iyoda and Watanabe, 
2004). In some EPEC strains, the pEAF plasmid contains the perC gene which encodes a direct 
transcriptional activator of the LEE1 operon (Mellies et al., 1999).  However, as this plasmid is 
not found in EHEC, a search for other prophage encoded LEE regulators revealed a number of 
PerC homologs. These included PchA, PchB, PchC, PchD, and PchD; however, only PchA, 
PchB, and PchC had measurable effects on LEE1 promoter activity in EHEC and EPEC strains 
(Iyoda and Watanabe, 2004; Porter et al., 2005). The Per and Pch regulators likely function in 
concert with other nucleoid associated proteins, such as IHF, to de-repress the LEE1 promoter 
(Porter et al., 2005). 
 EHEC contains a number of horizontally acquired, multi-genic, elements termed O-
islands that contribute roughly 1.3 Mb of genomic content that is not present in K-12 (Hayashi et 
al., 2001). The genes contained within O-islands are diverse in function, and play a significant 
role in EHEC virulence and pathogenesis. Adherence modulation, specifically through regulation 
of the LEE, has been demonstrated through mutational analysis of O-islands in EDL933.  For 
example, the transcriptional regulator RgdR, located within O-island 51, was shown to activate 
transcription of LEE1, and promote type III secretion in a Ler dependent manner (Flockhart et 
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al., 2012). Moreover, two other transcriptional regulators were identified within O-islands 50 and 
57, termed PsrA and PsrB, respectively (Tree et al., 2011). These regulators are of particular 
interest as their LEE regulatory effects are directed through the gadE P3 promoter, increasing 
production of the acid fitness regulator GadE, a direct repressor at the LEE1 promoter (Kailasan 
Vanaja et al., 2009; Tree et al., 2011). Indeed, the acid fitness island (AFI) of E. coli contains 
numerous regulators which coordinate transcription of gadE, along with RcsB, to properly time 
its production. Loss of the Psr regulators was shown to significantly activate T3S during 
stationary growth, and they are believed to be involved in fine-tuning the activation of glutamate 
dependent acid resistance genes, and subsequently repress transcription of the LEE, to promote 
survival during gastric passage prior to colonization (Tree et al., 2011). Likewise, an additional 
prophage island encoded AraC type regulator, termed PatE, was shown to stimulate acid 
resistance through transcriptional regulation of the acid stress chaperone hdeA, and repress LEE 
gene transcription, which was hypothesized to occur through a pathway similar to that of PsrA/B 
(Bender et al., 2012). 
 Various host derived factors have been shown to directly and indirectly influence 
expression of EHEC virulence genes, and LEE gene transcription is enhanced during growth in 
media and conditions which are similar to those found in the gastrointestinal tract (Kenny et al., 
1997a). Following gastric passage, LEE gene transcription is stimulated by the bicarbonate ion 
(Abe et al., 2002) produced by the pancreas to neutralize the stomachs acid (Feldman, 1983; 
Fordtran and Locklear, 1966). Further, the QseBC two-component system is directly involved in 
sensing host derived epinephrine, norepinephrine and AI-3 (Alam et al., 2010; Russell et al., 
2007; Sharp and Sperandio, 2007; Sperandio et al., 2002). Phosphorylated QseB promotes 
transcription of the QseEFG phosphorelay system that senses epinephrine, sulfate, and phosphate 
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to activate transcription of LEE genes (Njoroge and Sperandio, 2012; Reading et al., 2010).  
Importantly, the regulator QseE has been shown to indirectly regulate the LEE through direct 
transcriptional repression of rcsB (Njoroge and Sperandio, 2012). The QseBC and QseEFG 
mutli-component phosphorelay systems provide a great example of the complex nature of 
bacterial interkingdom virulence gene regulation.  Furthermore, EHEC has recently been shown 
to respond to host derived ethanolamine (EA) through the metabolic sensing of EA and 
production of the eut operon regulator EutR; direct transcriptional regulation of the LEE1 operon 
by EutR occurs through direct binding at the ler promoter (Kendall et al., 2012; Luzader et al., 
2013). Beyond factors which are produced directly by the host, products of native microflora are 
capable of modulating LEE gene transcription and type III secretion mediated adherence. For 
example, fucose is released from host intestinal mucin in the gut by Bacteroides 
thetaiotaomicron produced fucosidases (Xu et al., 2003), and its FusSK dependent metabolism 
by EHEC leads to repression of the LEE (Pacheco et al., 2012). Likewise, the products of 
fermentative metabolic processes (such as acetate, propionate, and butyrate) from native bacteria 
can stimulate LEE gene transcription through activation of the leucine-responsive regulatory 
protein (Lrp) and the LEE1 transcriptional activator PchA (Nakanishi et al., 2009; Tobe et al., 
2011). 
 
1.2.4 The E. coli common pilus (ECP) 
 EHEC adherence to epithelial cells, and subsequent host colonization, is enhanced by a 
common pilus structure seen almost ubiquitously across E. coli strains, termed the E. coli 
common pilus (ECP) (Rendon et al., 2007). The E. coli common pilus is a chaperone-usher 
fimbrial adhesin, composed of a 21-kDa subunit encoded by the gene ecpA, and its production 
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plays a role in early-stage biofilm development for commensal and pathogenic E. coli and 
Klebsiella pneumonia strains (Alcantar-Curiel et al., 2013; Garnett et al., 2012; Lehti et al., 2010; 
Wurpel et al., 2013).  
 
1.3 Variation in virulence among EHEC O157:H7 strains 
 Although there are hundreds of O:H serotypes of EHEC, the O157:H7 serotype is most 
frequently associated with humans disease (Nataro and Kaper, 1998). Strains of O157:H7 belong 
to a clonal complex which has been recently organized by phylogenetic analysis into eight 
discrete clades (Manning et al., 2008). Belonging to clade 8, strain TW14359 has been associated 
with high incidents of HUS (15%) and hospitalization (51%), as compared to strain Sakai HUS 
(~1.5%) and hospitalization (~4%) (Clade 1, 1996 Sakai city outbreak) (Manning et al., 2008).  
Clade 8 strains have demonstrated increased association with epithelial cells, along with 
increased expression of LEE and other virulence factors, including Shiga toxin 2 (Stx2) (Abu-Ali 
et al., 2010a; Manning et al., 2008; Neupane et al., 2011). A comparative analysis of O157:H7 
strains Sakai and TW14359 revealed increased attachment to MAC-T epithelial cells 
corresponding to increased levels of LEE gene expression in TW14359, whereas Sakai showed 
higher expression levels for genes associated with motility (Abu-Ali et al., 2010b).  
 
1.4 The RcsCDB phosphorelay system 
 Formation of extracellular capsular polysaccharide has been shown to have a role in 
bacterial adherence, protection from desiccation, and resistance to both specific and non-specific 
host immunity (Horwitz and Silverstein, 1980; Ophir and Gutnick, 1994; Roberts, 1996). The 
capsules of E. coli are surface enveloping structures composed of high-molecular weight 
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polysaccharides, and consist of 4 major groups, including colonic acid (Whitfield, 2006). While 
typical capsules produced by E. coli form a surface layer associated with the bacteria, a large 
quantity of colonic acid produced is ultimately secreted into the growth medium as 
expolysaccharide (Whitfield and Paiment, 2003), resulting in a mucoidy phenotype. Indeed, up 
to 30% of the total dry weight of some K-12 strains has been observed to be colonic acid and 
slime (Ophir and Gutnick, 1994). However, there can be substantial variation in the types and 
quantity of colonic acid produced among E. coli strains. The group 1 and 4 capsules are related 
to O-antigen LPS, and are found among EPEC, ETEC, and EHEC strains (Whitfield, 2006). 
 The regulation of capsular polysaccharide (CPS) was initially shown to be dependent on 
Lon, an ATP hydrolysis and temperature dependent protease (Chung and Goldberg, 1981), that is 
active at 37°C but not at 30°C (Phillips et al., 1984; Trisler and Gottesman, 1984). Identification 
of the three key regulatory elements (RcsB, RcsC, and RcsA) involved in colonic acid synthesis, 
using a lon mutant K-12 strain, suggested that one of the three genes was regulated indirectly by 
the Lon protease (Gottesman et al., 1985). RcsA was further shown to be a target of ATP-
dependent Lon proteolysis, with a half-life of 5 minutes in wild type E. coli and 20 minutes in a 
lon defective E. coli. Temperature dependent CPS production is therefore dependent on the 
availability of RcsA for transcriptional activation of cps genes (Torres-Cabassa and Gottesman, 
1987).   
 The components of the Rcs phosphorelay system include a membrane bound sensor 
histidine kinase, RcsC, that transfers a phosphate to the histidine phospho-transferase RcsD, 
which transfers the phosphate to the response regulator RcsB (Fig. 4) (Clarke, 2010). The rcsB-
rcsC gene cluster was first identified as being required for CPS production. RcsC contains 
homology with known membrane bound sensor kinases, and was shown to act as a sensor 
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Figure 4 - The RcsCDB phosphorelay and regulation of type III secretion in EHEC 
The Rcs phosphorelay system indirectly promotes transcription of the LEE PAI through the OI-47 
encoded regulator GrvA. The Rcs relay is composed of 3 major components, including the sensory kinase 
(RcsC), the histidine phosphotransferase (RcsD), and the response regulator (RcsB). Signal transduction 
to RcsC occurs through different mechanisms, including activation by the outer-membrane lipoprotein 
RcsF.   
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activating the regulator RcsB (Brill et al., 1988; Stout and Gottesman, 1990). The sensor kinase 
RcsC is able to communicate membrane perturbations to RcsB caused by osmotic shock, 
membrane damaging agents, and growth on solid media; importantly, RcsC is required for 
normal biofilm formation (Ferrieres and Clarke, 2003). The response regulator RcsB binds to 
specific DNA sequences (RcsB box) at promoters to activate or repress transcription. In its 
phosphorylated state, RcsB can bind as a homodimer (RcsB2) or as a heterodimer (RcsB/X) with 
other regulatory proteins, such as RcsA (Majdalani and Gottesman, 2005). In its activated state, 
RcsB/RcsA can repress transcription of flagellar genes (Francez-Charlot et al., 2003) and 
simultaneously activate genes involved in capsule synthesis during growth at low temperatures 
(Torres-Cabassa and Gottesman, 1987). While the regulatory capacity of RcsB is broadly 
dictated through activation by RcsC, binding with other non-RcsA regulatory proteins has been 
reported (Torres-Cabassa and Gottesman, 1987) (Fig. 5). For example, RcsB forms a 
heterodimer with BglJ relieving HN-S mediated repression of the bgl operon, and is thus 
involved in the uptake and utilization of beta-glucosides (Venkatesh et al., 2010). Finally, and 
importantly, RcsB can form a heterodimer with the central regulator of glutamate dependent acid 
resistance (GDAR), GadE, to facilitate transcription of acid fitness genes (Castanie-Cornet et al., 
2010). As such, RcsB is required for wild-type levels of acid resistance, a factor that directly 
contributes to the low infectious dose of EHEC. 
 The RcsB response regulator is activated by the phosphorylation of an aspartic acid 
residue within the RcsB receiver domain through interaction with the membrane bound histidine 
phosphotransferase RcsD (Gupte et al., 1997), rather than by interaction with the cognate sensor 
kinase RcsC (Huang et al., 2006). In a typical two-component regulatory system, sensor kinase 
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Figure 5 - Homo- and hetero-dimerization of RcsB in E. coli 
The known heterodimerization proteins of RcsB in E. coli are listed with a brief description of their 
regulatory function.  In E. coli, RcsB can form a homodimer with itself to regulate transcription at 
promoters containing an RcsB consensus sequence.  Alternatively, RcsB can heterodimerize with RcsA, 
GadE, or BglJ to regulate transcription of motility, acid resistance, or the uptake and utilization of aryl 
beta-glucosides, respectively.   
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autophosphorylation is either enhanced or inhibited through the sensing of its specific signal, and 
the phosphate is typically transferred from a histidine residue on the sensor kinase to an aspartic 
acid residue within the cognate response regulator receiver domain (Stock et al., 1989). For 
example, this model of regulation is observed for a number of E. coli TCS, including 
CpxA/CpxR and EnvZ/OmpR (Danese and Silhavy, 1997; Egger et al., 1997), where the former 
is an example of a TCS sensor kinase that actively dephosphorylates its cognate response 
regulator in the absence of stimuli (Dorel et al., 2006). The multi-component RcsCDB 
phosphorelay utilizes a different method of activation, wherein the RcsD membrane bound 
histidine phospho-transferase acts as an adapter protein between RcsC and RcsB (Huang et al., 
2006).  Activated RcsC autophosphorylates at the His479 residue within its histidine-containing 
phosphotransmitter (Hpt) domain and transfers the phosphate to its phospho-acceping Asp875 
residue within its receiver domain (Fig. 6). The phosphate is then transferred to the His842 
residue on the RcsD Hpt domain (Takeda et al., 2001). Recent work has shown that the RcsD-
ABL (α-β-Loop) domain interacts directly with RcsB effector domain, while the RcsD Hpt 
domain interacts with the phosphor-accepting receiver domain, suggesting that RcsD and RcsB 
function together in a very limited orientation (Schmoe et al., 2011). Interestingly, in Salmonella 
enterica serovar Typhimurium, overexpression of truncated RcsC or RcsD cytoplasmic domains 
results in phosphorylation of RcsB and subsequent activation of Rcs regulated genes, revealing a 
potentially complex activation pathway hitherto unknown (Pescaretti Mde et al., 2013). 
However, this finding has not yet been replicated in E. coli.   
 An additional, alternative, mechanism for Rcs activation exists in E. coli that couples 
carbon metabolism and the accumulation of acetyl phosphate with phosphorylation of the 
response regulator RcsB. In two specific signal transduction systems with sensor kinases that 
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Figure 6 - Functional domains of the Rcs components in E. coli 
The Rcs phosphorelay is composed of a sensory kinase (RcsC), a histidine phosphotransferase (RcsD), 
and a response regulator (RcsB). The RcsC sensor kinase is bound to the inner membrane, and has both a 
periplasmic input domain and a cytosolic histidine kinase and receiver domain for autophosphorylation 
and phosphotransfer to RcsD. The histidine phosphotransferase RcsD is an adapter protein which 
functions as an additional control for regulation phosphorylation of the response regulator RcsB. To 
receive the phosphate from RcsC, the RcsB response regulator must bind at the RcsD-ABL domain.   
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favor phosphatase activity, CpxA and RcsC, the cognate response regulator can be 
phosphorylated by, and respond to levels of, acetyl phosphate (Aiso et al., 2011; Batchelor et al., 
2005). When excess carbon is present, particularly glucose, cells can accumulate acetyl 
phosphate. Similar levels of acetyl phosphate accumulation are observed following the mutation 
of ackA, the product of which is key in the Pta-AckA cycle for acetyl-coA and acetogenesis.  In 
this reversible pathway, Pta synthesizes acetyl phosphate and coenzyme A (CoA) from acetyl-
CoA, and AckA generates ATP and acetate from acetyl phosphate (Wolfe, 2005). Therefore, 
mutations or growth conditions which favor the accumulation of acetyl phosphate promote the 
promiscuous phosphorylation of RcsB, and can directly affect motility and virulence gene 
regulation in E. coli (Aiso et al., 2011; Wolfe, 2010). Beyond phosphorylation, the presence of a 
lysine acetylation domain was recently reported for RcsB which serves to regulate its activity at 
the rprA promoter, and is dependent on the lysine de-acetylase CobB (Hu et al., 2013; Stelzer et 
al., 2006). 
 While the RcsCDB mutli-component signal transduction pathway contains a sensor 
histidine kinase, activation and autophosphorylation requires the function of two membrane-
tethered proteins, specifically DjiA and RcsF (Clarke et al., 1997; Majdalani et al., 2005) (Fig. 
7). The overproduction of the membrane anchored DnaJ-like protein DjiA has been shown to 
significantly increase capsular polysaccharide production, dependent on GrpE and DnaK (Kelley 
and Georgopoulos, 1997). In the cytoplasmic membrane, the transmembrane domain of DjiA 
facilitates the formation of a DjiA-homodimer. However, while the transmembrane domain is 
required for DjiA-dependent activation of CPS production, dimerization alone is not sufficient to 
activate the Rcs phosphorelay (Clarke et al., 1997; Toutain et al., 2003). The specific factors 
which stimulate the dimerization of DjiA and subsequent activation of CPS production have not 
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yet been elucidated. Constitutively high production of DjiA is ultimately toxic to the cell.  Not 
surprisingly, the production of DjiA is tightly regulated and transcription is dependent on the 
extracytoplasmic-function sigma factor, RpoE (Kelley and Georgopoulos, 1997). Similarly, 
overproduction of RcsF has been shown to induce CPS production in an RcsC dependent manner 
(Gervais and Drapeau, 1992; Majdalani et al., 2005).   
 RcsF is a ~14-kDa outer-membrane bound lipoprotein which orients towards the 
periplasm and its activation has been demonstrated for mutations that affect the proper folding of 
periplasmic proteins, as well as those which disrupt the proper synthesis and localization of 
lipopolysaccharides and lipoproteins (Castanie-Cornet et al., 2006; Tao et al., 2012). The activity 
of RcsF is dependent on the formation of nonconsecutive dislufides and requires an unstructured 
proline rich region to properly convey signals to the sensor kinase RcsC for Rcs phosphorelay 
activation (Leverrier et al., 2011; Umekawa et al., 2013). Among enteric gram-negative bacteria 
that contain RcsF, the C-terminus contains high levels of amino acid sequence similarity, while 
the membrane anchored N-terminal domain is less conserved (Rogov et al., 2011). While the 
current model of RcsF-RcsC activation is believed to be through direct interaction of the 
periplasmic domains of both proteins, experiments performed to validate this hypothesis have 
been unable to confirm specific interaction (Rogov et al., 2011). Therefore, it remains a 
possibility that some other factor mediates signal transduction between RcsF and RcsC.  Similar 
to RcsF, overproduction of the putative lipoprotein YpdI is also able to activate the Rcs 
phosphorelay in an RcsF-independent and RcsA-dependent manner, however little is known 
about its specific function or role in E. coli (Rendon et al., 2007). Both DjiA and RcsF therefore 
fit within a model previously described for the outer membrane lipoprotein NlpE, which serves 
as an activator of the CpxAR stress response two-component system (Hirano et al., 2007; Snyder 
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et al., 1995). Interestingly, the lipoprotein-specific molecular chaperone LolA is required for 
efficient localization and trafficking of membrane bound lipoproteins, and lolA mutant or 
overexpression derivative E. coli strains result in Rcs activation directed through RcsF (Tao et 
al., 2012), a finding that supports the role for RcsF activation by misfolded/mislocalized 
periplasmic proteins. 
 The genes encoding RcsD, RcsB, and RcsC are organized into two distinct operons, with 
rcsDB and rcsC oriented and transcribed divergently.  The rcsB and rcsC ORFs were identified 
prior to that of rcsD, and early work suggested that their independent transcription might reflect 
a need to control the transcription of each gene alone (Stout and Gottesman, 1990).  For 
example, transcription of rcsB was suggested to be under the control of LexA and the alternative 
sigma factor RpoN, however direct experimental evidence for the latter has been contradictory 
(Gervais et al., 1992).  In one case, loss of rpoN resulted in decreased rcsB transcription, while 
another group independently reported no significant impact on rcsB following mutation of rpoN 
(Gervais et al., 1992; Stout and Gottesman, 1990).  A putative sigma-54 (RpoN) binding site was 
identified upstream of rcsB, within the rcsD ORF (Stout and Gottesman, 1990), but further work 
is required to determine if RpoN plays a significant direct role in the regulation of rcsB.  In E. 
coli strain K-12, the rcsDB operon is transcribed from a sigma-70 promoter upstream of rcsDB, 
and the rcsB gene is independently transcribed from at least two sigma-70 promoters 
intracistronic to rcsD, rcsBP1 and rcsBP2 (Krin et al., 2010). Importantly, transcription from the 
rcsD promoter, but not the rcsB promoters, is actively repressed through direct binding of H-NS 
(Krin et al., 2010). This model of regulation suggests a control scheme wherein the histidine 
phospho-transferase RcsD is a rate limiting step in the phosphorelay, preventing RcsB 
phosphorylation through the canonical RcsC-RcsD-RcsB route.  While the Rcs component genes  
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Figure 7 - RcsF and DjiA activation of the Rcs phosphorelay 
The current model for Rcs phosphorelay activation includes the components of the relay itself (RcsCDB), 
but also includes inner- and outer-membrane lipoproteins DjiA and RcsF. Overproduction of DjiA or 
RcsF has been shown to facilitate signal transduction, through an unknown mechanism, to the sensor 
kinase RcsC. The functional domains of DjiA are not well described, however the functional domains 
RcsF lipoprotein have been explored. RcsF contains a disordered proline rich region and a disulfide bond 
that is required for  
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are typically conserved in different gram-negative bacteria, their regulatory patterns can be 
divergent. For example, an analysis of rcsB regulation in the enteric pathogen Salmonella 
enterica serovar Typhimurium identified an additional stationary phase inducible rcsB promoter, 
and revealed a model of RcsB negative auto-regulation at the rcsD promoter to modulate 
swarming behavior (Pescaretti Mde et al., 2010; Pescaretti Mde et al., 2009); however, no such 
model of Rcs auto-regulation has been reported for E. coli. More recently, epinephrine sensing 
histidine sensor kinase QseE was shown to negatively regulate transcription of rcsB in EHEC, 
and therefore negatively affect virulence gene transcription (Deng et al., 2010). 
 The Rcs phosphorelay plays an important role during conditions which cause damage to 
the host membrane integrity, such as osmotic shock from high glucose or sodium chloride 
concentrations, and can protect the cell from desiccation (Sledjeski and Gottesman, 1996).  
Additionally, the loss of tolA, encoding a membrane spanning protein involved in cell envelope 
integrity, has been shown to activate the Rcs system through stimulation of the sensor kinase 
RcsC (Clavel et al., 1996). Mutation of tolA leads to highly mucoid colonies and decreased 
adherence in E. coli strain MG1655, a phenotype that is completely dependent on the membrane 
bound lipoprotein RcsF (Vianney et al., 2005). Further examination into activation of Rcs in 
response to different stimuli reveals that it plays a dynamic role in gene activation relative to 
growth phase and conditions. Specifically, the co-regulator of colonic acid synthesis RcsA binds 
with RcsB following phosphorylation at low temperatures, owing to temperature dependent  Lon 
protease activity (Torres-Cabassa and Gottesman, 1987). Independent of RcsA, activation in the 
presence of ZnCl2, Fe
3+
 and low Mg
2+
 leads to induction of ugd under specific conditions and is 
dependent on the regulator PhoP (Hagiwara et al., 2003; Mouslim et al., 2003). Beyond cell 
envelope stress, the Rcs response regulator RcsB is required for survival following exposure to 
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low acidic conditions, such as those present during gastric passage (Castanie-Cornet et al., 2007). 
This dependence is due to the heterodimerization of RcsB with the acid fitness island (AFI) 
regulator GadE, which is required for transcription of several key AFI encoded genes (Johnson et 
al., 2011; Krin et al., 2010).  Interestingly, the de novo generation of cell shape following 
lysozyme treatment was recently shown to require RcsB, revealing a specific role in the recovery 
from insults to the outer membrane, suggesting that the Rcs phosphorelay might play a role in 
survival following exposure to host immune responses leading to membrane perturbation (Ranjit 
and Young, 2013). Likewise, following exposure to human serum, extraintestinal pathogenic E. 
coli (ExPEC) activates the Rcs phosphorelay, along with other envelope stress regulators, as a 
protective measure in response to cell wall damage (Mellies et al., 2012). Furthermore, the Rcs 
components were required for survival during exposure to antibiotics that inhibit peptidoglycan 
synthesis, including the β-lactamases cefsulodin and amdinocillin, independent of RcsA, and 
more recently the exposure to antimicrobial peptides was observed to activate the Rcs 
phosphorelay through the membrane bound lipoprotein RcsF (Laubacher and Ades, 2008; 
Tucker et al., 2010). 
 While the Rcs phosphorelay has a distinct role in survival during specific stress 
conditions, it has also been shown to regulate the expression of virulence factors in E. coli and 
other enteric pathogens. Virulence and motility gene regulation has been shown to occur through 
the RcsC-RcsD-RcsB His-Asp phosphorelay system in E. coli (Francez-Charlot et al., 2003; Krin 
et al., 2010; Tobe et al., 2005). Importantly, overexpression of RcsB has been observed to 
increase LEE gene activity and attachment to HeLa cells (Tobe et al., 2005). RcsB was shown to 
positively regulate transcription of the LEE regulator ler by positively regulating grvA, an 
activator of ler (Tobe et al., 2005). The role for RcsB in TW14359 virulence, and the mechanism 
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by which RcsB contributes to the LEE overexpression and adhesion phenotype, is unknown. In 
Salmonella enterica serovar Typhimurium, RcsB binds and represses transcription from the 
flhDC promoter in an RcsA dependent manner, and subsequently impairs swarming motility and 
swimming (Chaand and Dziejman, 2013). However, unlike EHEC, virulence is significantly 
attenuated in Salmonella following Rcs activation. Specifically, a constitutively active RcsC 
allelic variant significantly decreases the expression of genes involved in macrophage survival 
and the invasion of non-phagocytic cells (Krogh et al., 2001). Conversely, virulence of 
enteropathogenic Yersinia pseudotuberculosis requires an intact Rcs phosphorelay (Sayed and 
Foster, 2009). In contrast to enteropathogenic Yersinia, the gene encoding RcsD has undergone 
mutational attrition in Yersinia pestis; this fact is important in light of a study demonstrating that 
RcsB negatively regulates biofilm formation in Yersinia pestis, indicating that rcsD was 
evolutionarily deselected to decrease RcsB phosphorylation (Sun et al., 2012). Beyond virulence 
in animal hosts, RcsB regulation of virulence in gram-negative pathogenic bacteria has also been 
reported. For the rosaceous plant pathogen Erwinia amylovoran, RcsB is required for the 
production of the exopolysaccharide amylovoran and directly contributes to bacterial survival 
and the disease symptom formation (Bereswill and Geider, 1997; Kelm et al., 1997; Santander et 
al., 2014). Ultimately, RcsB plays a broad role in the regulation of genes involved in survival and 
virulence gene regulation for a diverse population of gram-negative bacterial pathogens. 
 
1.5 The G. mellonella virulence model 
 Galleria mellonella, the greater wax worm, has been used as a virulence model in several 
important human pathogenic gram-negative bacteria, such as Pseudomonas, Listeria, Yersinia, 
Campylobacter, Klebsiella, and Legionella (Champion et al., 2009; Harding et al., 2012; Insua et 
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al., 2013; Miyata et al., 2003; Mukherjee et al., 2010; Senior et al., 2011). Importantly, the G. 
mellonella model has shown a positive correlation of virulence patterns in mice for major 
virulence determinants in gram-negative human pathogens, such as Pseudomonas aeruginosa 
and enteropathogenic Escherichia coli (EPEC) (Jander et al., 2000; Leuko and Raivio, 2012). 
Infection of larvae with bacteria results in a robust host immune response characterized by the 
formation of melanotic nodules, recruitment of hemocytes (Jiang et al., 2010), and the 
production  of both antimicrobial peptides and inhibitors of microbial proteinases (Vogel et al., 
2011). The G. mellonella model has not yet been used to explore the virulence properties of 
EHEC or, more specifically, factors which are unique to the O157:H7 serotype. However, at 
least in EPEC, loss of the T3SS resulted in attenuated virulence, suggesting that the G. 
mellonella model could be used to explore the contribution of GrvA to the overall virulence of 
EHEC, and specifically strain TW14359. 
 
1.6 Project aim 
Variation in virulence has been described between distantly related EHEC strains, specifically 
with higher levels of LEE gene transcription and subsequent adherence in strains which have 
been characterized with a high incidence of HUS.  More specifically, the 2006 U.S spinach 
outbreak strain TW14359 possess increased adherence and Stx2 production when compared with 
the less virulent EHEC strain Sakai. Transcriptomic studies for TW14359 revealed markedly 
higher levels of LEE gene transcription and decreased transcription of motility associated genes, 
likely contributing to the increased adherence phenotype.  However, the specific genetic 
mechanism underlying differential virulence had not yet been described. The recently published 
genome of TW14359 identified numerous factors which were unique to TW14359, and further 
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revealed polymorphisms which have not been observed in other EHEC strains to-date.  It is 
hypothesized that the hypervirulence of this strain, and closely allied clade 8 strains, is due to the 
increased expression of virulence factors common to all O157:H7 strains, as well as novel strain-
specific factors. Accordingly, the aim of this project is to identify the specific factor(s) which 
direct increased adherence in TW14359 and to further explore polymorphisms unique to 
TW14359 which contribute to altered virulence gene regulation. Overall, identifying factors 
which contribute to differential virulence will provide insight into the evolution of virulence in 
enterohemorrhagic E. coli.  
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Chapter 2: RcsB determines the locus of enterocyte effacement (LEE) expression and 
adherence phenotype of Escherichia coli O157:H7 spinach outbreak strain TW14359 and 
coordinates bicarbonate-dependent LEE activation with repression of motility 
 
Note to Reader. Portions of these results have been previously published (Morgan et al., 2013) 
and are utilized with permission of the publisher (Appendix A) 
 
2.1 Background 
 Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a virulent human pathogen 
attributed to sporadic cases and large outbreaks of bloody diarrhea (hemorrhagic colitis) (Rangel 
et al., 2005). In 2006, an outbreak in the United States of O157:H7 due to the consumption of 
tainted spinach was associated with unusually high rates of hospitalization and life-threatening 
sequelae (i.e. hemolytic uremic syndrome) (Manning et al., 2008). Phylogenetic analysis of over 
five hundred clinical O157:H7 isolates, suggested that the strain which caused this outbreak, 
TW14359, belongs to a discrete genetic group referred to as clade 8, the members of which are 
highly virulent (Manning et al., 2008). Consistent with this hypothesis, DNA sequencing of this 
strain has revealed the presence of virulence factors that are absent in the reference genomes of 
sequenced O157:H7 strains Sakai (1996 Japan) and EDL933 (1982 USA) (Kulasekara et al., 
2009; Manning et al., 2008). In addition, a virulence expression phenotype has been described 
for strain TW14359 characterized by increased basal transcription of locus of enterocyte 
effacement (LEE) genes, as well as Shiga toxin 2 genes (stx2AB) and Stx2 protein relative to 
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other O157:H7 strains (Abu-Ali et al., 2010a; Abu-Ali et al., 2010b; Neupane et al., 2011).  
Elevated basal LEE expression in TW14359 has further been correlated to increased adherence 
to bovine epithelial cells (Abu-Ali et al., 2010b). 
The LEE is a 35.6-kb pathogenicity island that encodes a type III secretion apparatus 
required for competitive colonization of the intestine and attaching/effacing (A/E) lesion 
formation in EHEC and enteropathogenic E. coli (EPEC) (Elliott et al., 1998; McDaniel and 
Kaper, 1997; Perna et al., 1998), and in the mouse pathogen Citrobacter rodentium (Schauer and 
Falkow, 1993). Regulation of LEE expression has been intensively studied (Mellies et al., 2007; 
Tree et al., 2009), but is still not fully understood. Four LEE-encoded proteins are currently 
known to control its expression: Ler (LEE encoded regulator), Mcp (multiple point controller), 
GrlR (global regulator of LEE repressor) and GrlA (global regulator of LEE activator).  ler is the 
first gene of the LEE1 operon, and is a master regulator of the LEE, activating transcription from 
all five LEE operons (Elliott et al., 1998; Sperandio et al., 1999). Mcp, when overexpressed, 
down-regulates LEE expression through interaction with Ler, and GrlA directly activates ler 
transcription (and thus the LEE), whereas GrlR represses ler transcription through interactions 
with GrlA (Creasey et al., 2003; Deng et al., 2004; Huang and Syu, 2008; Lio and Syu, 2004).  In 
addition, a myriad of non-LEE encoded regulators modulate LEE expression through ler in 
response to environmental cues such as growth phase, bicarbonate, stress, and others (Abe et al., 
1997; Abe et al., 2002; Bergholz et al., 2007a; Friedberg et al., 1999; Grant et al., 2003; Kenny et 
al., 1997a; Shin et al., 2001; Sperandio et al., 1999; Tobe et al., 2005; Umanski et al., 2002).   
In this study, the role for RcsB, a response regulator of the Rcs phosphorelay system, in 
the virulence expression phenotype of strain TW14359 was examined. In particular, the 
importance of RcsB to enhanced LEE expression and adherence characteristic of this strain was 
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investigated. In addition, the study sought to define the regulatory contribution of RcsB to 
bicarbonate-dependent activation of the LEE and LEE-dependent repression of motility.  
 
2.2 Methods… 
2.2.1 Bacterial strains and culture conditions   
 The strains and plasmids used in this study are listed in Table 2. Strains were stocked at -
80°C in glycerol diluted (15% v/v final) in Luria Broth (LB), and were maintained in LB or on 
LB with 1.5 % agar (LBA).  Unless otherwise noted, overnight (18-20 h) cultures grown in LB 
were used to inoculate fresh LB or LB buffered with sodium bicarbonate (44 mM NaHCO3) or 
fresh Dulbecco’s Modified Eagle’s Medium (DMEM) (4 g l-1 glucose, 4 mM glutamine, 44 mM 
NaHCO3, pH 7) to a final optical density 600 nm (OD600) of 0.05. Cultures were grown at 37°C 
in a rotary shaker (200 RPM) using a 1:10 media-to-flask volume. The growth of strains was 
monitored by taking OD600 readings at 1 h intervals for 11 h. Antibiotics (Sigma-Aldrich, St. 
Louis, MO) were added to cultures when required. For maximum expression from the PBAD 
promoter of pBAD22 (Guzman et al., 1995), cultures were grown in DMEM containing L-
arabinose (0.5% w/v) and glycerol (0.4% v/v). 
 
2.2.2 Genetic manipulations and chromosomal FLAG-fusion construction   
 Primers used for the genetic manipulation of TW14359 and Sakai are provided in Table 
3. Gene deletion and kanamycin (Kan) replacement mutants were constructed using the λ Red 
recombinase-assisted approach (Murphy and Campellone, 2003) and as described (Riordan et al., 
2010). To make a TW14359 grlA overexpression strain, an EcoRI/XbaI digested 413-bp PCR 
fragment containing the promoterless grlA ORF was cloned into similarly digested  pBAD22 
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(Guzman et al., 1995) to yield pRJM-15, which was then transformed by electroporation into 
TW14359 as described (Riordan et al., 2010). For rcsB complementation, a BamHI/XhoI 
digested 3,424-bp PCR fragment, containing the rcsB ORF and native promoters, was cloned 
into similarly digested pACYC177 to yield pRJM20, which was then transformed into 
TW14359ΔrcsB. To construct FLAG fusions to rcsB and tir, the approach of Uzzau et al. (Uzzau 
et al., 2001) was used. Primers FLAG-F and P2 used to amplify the FLAG epitope and Kan 
resistance cassette from pSU312 (Uzzau et al., 2001) were constructed with 40-bp 
oligonucleotide 5’ extensions with homology to a 3’ region of the target ORF and a downstream 
intergenic region, respectively. Homologous recombination of this product using λ Red 
recombinase replaces the native stop codon with the FLAG sequence in-frame with the target 
ORF. When expressed, the fusion protein contains a seven amino acid C-terminal epitope 
(FLAG) that can be detected by western blots using anti-FLAG mAbs (Uzzau et al., 2001). All 
genetic constructs were validated using a combination of PCR and restriction mapping, qRT-
PCR, and DNA sequencing (Eurofins MWG Operon, Huntsville, AL). DNA was purified using 
the QIAquick PCR Purification kit (Qiagen). 
 
2.2.3 Protein extraction, SDS-PAGE and western blots   
 Protein extraction, purification and western blots were performed as described previously 
(Mitra et al., 2012). To extract and purify secreted proteins, mid-exponential phase (OD600=0.5) 
cultures were centrifuged at 5,000 x g for 5 minutes and supernatants were passed through sterile 
0.22 μm Millex-GV syringe filters (Millipore, Billerica, MA). Filtrates were precipitated 
overnight (18-20 h) in 15% (v/v) trichloroacetic acid at 4°C and then centrifuged at 15,000 x g 
for 30 minutes at 4°C. Protein pellets were washed twice with 100% ice cold acetone before re-
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suspension in 1M triethyl ammonium bicarbonate (TEAB). The amount of protein loaded on 
SDS-PAGE gels for western blots was measured by a Bradford protein assay standard curve, and 
equal loading was validated by western blots for GroEL using anti-GroEL mAbs (Bio-Rad, 
Hercules, CA). Monoclonal antibodies against FLAG (Sigma-Aldrich) were also used.  Each 
experiment was repeated a minimum of three times in independent trials. Densitometry was used 
to estimate differences in protein levels for select experiments using a ChemiDoc XRS+ Imaging 
System and Image Lab 3.0 (BioRad).  
 
2.2.4 Proteomic analysis   
 Isobaric tag for relative and absolute quantitation (iTRAQ)-based mass spectrometry of 
strains TW14359 and Sakai followed a previously described protocol (Rivera et al., 2012).  
DMEM cultures (n=4 for cytosolic; n=3 for secreted) of TW14359 and Sakai were grown to 
OD600=0.5 (2.5 to 3 h) before sampling for protein extraction (see above Methods). Peptide 
labeling with isobaric tags 114 and 116 (strain Sakai) and 115 and 117 (strain TW14359) for 
iTRAQ was performed using the iTRAQ™ Reagents 4-plex reaction kit (Applied Biosystems) 
following the manufacturer’s instructions. Spectra data files (.RAW) were searched using 
Mascot Daemon ver. 2.3 against a Uniprot TW14359 protein database 
(http://www.uniprot.org/taxonomy/544404) downloaded on April 18
th
, 2011, containing 10,510 
total sequences (forward and reverse) using the Mascot search algorithm (Matrix Science). Data 
analysis for proteomics experiments followed a previously described procedure (Rivera et al., 
2012). Raw data files (.dat and .RAW) have been deposited in ProteomeXchange through the 
Proteomics Identification Database (PRIDE) (Vizcaino et al., 2009) (accession #PXD000023). 
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2.2.5 RNA purification and quantitative real-time PCR (qRT-PCR)   
 Primers for qRT-PCR are provided in Table S1. RNA purification, cDNA synthesis, 
qRT-PCR cycling conditions and data analysis followed previously described protocols (Riordan 
et al., 2010). For ler mRNA stability, cultures were growth to mid-exponential phase 
(OD600=0.4) before addition of a sub-inhibitory concentration of the transcription inhibitor 
rifampin (300 µg/ml final). Sampling for RNA extraction was performed immediately before 
addition of rifampin (Rif), and at 4 min intervals thereafter for 12 min. qRT-PCR was performed 
using a Realplex2 Mastercycler (Eppendorf). Cycle threshold (Ct) data were normalized to rrsA 
(16S rRNA gene) and normalized cycle threshold values (ΔCt) were transformed to arbitrary 
transcript expression levels using 2
-ΔCt
 /10
-6
  as described (Livak and Schmittgen, 2001; Riordan 
et al., 2010). Expression levels were compared using the appropriate t-test or by Tukey’s HSD 
following a significant F-test (n≥3, α=0.05) (R. ver. 2.13.0).  
 
2.2.6 Construction of lacZ transcriptional promoter fusions and β-galactosidase assays 
 The construction of lacZ reporter transcriptional fusions to the promoters of ler, rcsB, 
rcsD, and flhD, followed a previously described protocol using vector pRS551 (Simons et al., 
1987). For lerP905-lacZ, a 904-bp BamHI/EcoRI-digested PCR fragment generated using primers 
ler-905/EcoRI and ler-1/BamHI was cloned into similarly digested pRS551 using T4 DNA ligase 
(Fisher Scientific) to produce pRJM-2. Similarly, rcsB, rcsD, and flhD promoter fragments were 
cloned into pRS551 following BamHI/EcoRI digestion using primers rcsB-1/BamHI and rcsB-
1000/EcoRI (rcsBP1000-lacZ), rcsD-501/EcoRI and rcsD-1/BamHI (rcsDP501-lacZ), and flhD-
1/BamHI and flhD-1000/EcoRI (flhDP1000-lacZ).  ler-, rcsB-, rcsD-, and flhD- lacZ 
transcriptional fusion plasmids were transformed into WT and derivative backgrounds of strains 
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TW14359 and Sakai. All lacZ fusion constructs were confirmed by PCR and sequencing 
(Eurofins MWG Operon). β-galactosidase activity (Miller Units) was measured as previously 
described and compared between strains using a Student’s t-test or by Tukey’s HSD following a 
significant F-test (n≥3, α=0.05) (R) (Miller, 1972; Mitra et al., 2012).   
 
2.2.7 Adherence assays   
 Adherence to epithelial cells was determined following the method of Abe et al. (Abe et 
al., 2002). Briefly, human HT-29 (ATCC HTB-38, Manassas, VA) colonic epithelial cells were 
grown to confluence on polylysine-treated glass coverslips placed within the wells of 24 well 
culture plates at 37°C with 5% CO2. Overnight DMEM cultures were diluted 1:40 (v/v) in fresh 
DMEM and 0.05 ml of this dilution was used to inoculate each well which already contained 
0.45 ml of sterile DMEM. Culture plates were then gently centrifuged (1000 x g) for 5 min and 
incubated as above. After 3 h, plate wells were washed five times with PBS (137 mM NaCl, 2.7 
mM KCl, 10 mM Na2HPO4, pH 7) to remove non-adherent bacteria from the coverslips, and 
fresh DMEM was then added before incubating for an additional 3 h. Plate wells were 
subsequently washed three times in PBS, and then fixed with ice cold (−20°C) 100% methanol 
for 10 min before staining with Giemsa diluted in PBS 1:20 (v/v) for 20 min. Giemsa stain was 
aspirated from the wells, and each stained coverslip was then examined at 1000X magnification 
by oil immersion bright field microscopy using a binocular microscope (Fisher Scientific). 
Microcolonies, defined as a pattern of localized adherence (McKee and O'Brien, 1995; Nataro 
and Kaper, 1998), were scored as discrete clusters of five or more bacterial cells as previously 
defined (Abe et al., 2002; Iyoda and Watanabe, 2004). For each sample, a minimum of ten 
viewing frames were observed and the average number of microcolonies was reported per 80 
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HT-29 cells. Microcolony counts were compared between strains by Tukey’s HSD following a 
significant F-test (n≥3, α=0.05) (R). 
 
2.2.8 Motility assays   
Overnight LB cultures were diluted in fresh LB to OD600=0.5 and 2 μl samples were inoculated 
onto LB plates containing 0.25% (w/v) agar following a previous method (Krin et al., 2010). 
Plates were incubated upright for 5 hours at 37°C before the diameter of lateral growth on the 
agar surface was examined for each strain. Experiments were repeated in multiple trials using at 
least three biological replicates per trial. 
 
2.3 Results...... 
2.3.1 The LEE expression phenotype of strain TW14359   
 Quantitative real-time PCR of LEE transcript levels revealed the upregulation of LEE 
regulatory (ler, 3.8-fold), structural (espA, 2.3-fold), effector (tir, 2.7-fold) and effector 
chaperone (cesT, 2.3-fold) genes in TW14359  when compared to strains Sakai  and EDL933  
during exponential growth (OD600=0.5)  (p<0.05) (Fig. 8A), consistent with studies of LEE 
expression in TW14359 grown in DMEM when co-cultured with bovine mammary epithelial 
(MAC-T) cells (Abu-Ali et al., 2010b). Although expression of the LEE activator gene grlA was 
elevated 1.6-fold in TW14359, levels did not differ significantly when compared to Sakai and 
EDL933. Transcript levels for all LEE genes did not differ between Sakai and EDL933. The 
expression of LEE genes decreased markedly in stationary phase (OD600=3.0) for all strains and 
did not differ between them (Fig. 8A). This pattern of expression in DMEM is consistent with 
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previous observations of LEE gene expression during exponential and stationary growth phases 
in MOPS minimal media (Bergholz et al., 2007b). 
Expression from the ler promoter, as measured by β-galactosidase activity from lerP903-
lacZ, increased in both the TW14359 and Sakai backgrounds during exponential growth, and 
decreased as cultures transitioned into stationary phase (Fig. 8B), in agreement with qRT-PCR 
data (Fig. 8A). In TW14359 however, ler expression was consistently and significantly higher 
than in Sakai (p<0.05) during mid-exponential growth (between 2 and 3 h growth, corresponding 
to OD600=0.3 to 0.6), indicating that increased transcription was occurring at the ler promoter.  
Examination of DNA sequence for the ler ORF in TW14359 (ECSP_4703) and in Sakai 
(ECs4588), as well as ler core promoters P1 and P2 and 1,200-bp upstream of the translation 
initiation site revealed 100% nucleotide identity between these strains (NCBI).  Adding to this, 
the stability of ler mRNA during exponential growth following treatment of cultures with 
rifampin did not differ between strains; the ler mRNA half-life being estimated at 2.0-min for 
TW14359 and 2.1-min for Sakai (Fig. 9), which is congruent with a previous estimate (Laaberki 
et al., 2006). It was therefore hypothesized that the LEE expression phenotype in TW14359 is 
directed through increased transcription from the ler promoter by the influence of some trans-
acting factor(s) during exponential growth. 
 
2.3.2 Role for RcsB in the LEE expression and adherence phenotype of strain TW14359 
Quantitative analysis of the relative differences in protein levels using iTRAQ-based 
proteomics revealed a total of 116 proteins increased or decreased in abundance by at least 1.5-
fold in TW14359 relative to strain Sakai during exponential growth (OD600=0.5). In support of  
39 
 
 
Figure 8 - The LEE expression phenotype of strain TW14359 
 (1A): Transcript levels for LEE genes are plotted for exponential (OD600=0.5) and stationary (OD600=3.0) 
phase DMEM cultures of strains TW14359 (filled), Sakai (empty) and EDL933 (grey). (1B): β-
galactosidase activity in Miller Units for TW14359 (squares) and Sakai (triangles) containing a lerP903-
lacZ fusion plotted against time during growth in DMEM.  TW14359 containing an empty vector 
(pRS551) control is denoted by the hatched line. Asterisks denote significant differences in transcript 
levels of TW14359 compared to other strains by Tukey’s HSD following a significant F-test for 1A or 
Student’s t-test for 1B (p<0.05 [*], p<0.01 [**], n≥3). Error bars denote standard deviation. 
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Figure 9 - qRT-PCR for ler mRNA stability in TW14359 and Sakai. 
Stability of ler mRNA in EHEC strains TW14359 (dotted line) and Sakai (solid line) was determined for 
exponential phase (OD600= 0.5) DMEM cultures at 0, 2, and 4 minutes following the addition of rifampin. 
Data represents the average of three independent experiments. 
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previous microarray studies, a number of LEE-encoded proteins were increased in both cytosolic 
and secreted protein fractions of TW14359 compared to Sakai, including the T3SS needle 
protein EscF (1.94-fold), the EspA chaperone, CesA (1.72-fold), the type II secretion system 
protein EtpG (2.06-fold), Ler (1.74-fold), the T3SS translocon apparatus proteins EspA (2.45-
fold) and EspB (2.41-fold), the translocated intimin receptor Tir (1.56-fold), and other LEE-
encoded proteins (Table 1). Also increased in TW14359 was the IIA subunit of Stx2 by 2.11-
fold and RcsB (6.86-fold), the response regulator for a multi-component regulator of capsule 
synthesis (Rcs) phosphorelay system (Table 1). Importantly, when overexpressed, RcsB has 
been shown to activate ler transcription and increases adherence to Caco-2 cells (Tobe et al., 
2005).  It was thus of interest to determine whether the LEE expression and adherence phenotype 
of TW14359 was attributable to elevated levels of RcsB.   
 Western blots revealed that the basal level of RcsB in TW14359 was elevated ~2.7-fold 
when compared to Sakai, congruent with iTRAQ (Fig. 10A). In addition, expression of rcsB 
transcript was significantly higher in TW14359 compared to Sakai (p=0.001) (Fig. 10B), 
however, rcsD, which is transcribed as a dicistron with rcsB (i.e. rcsDB) from an upstream rcsDP 
promoter (Krin et al., 2010; Pescaretti Mde et al., 2009), was not altered in expression between 
strains (Fig. 10B). This suggests that basal levels of rcsB are intrinsically upregulated in 
TW14359 in a manner which is dependent on a promoter(s) that is intracistronic to rcsD.  
Consistent with a role for RcsB in the LEE expression phenotype of TW14359, ler transcript 
levels were higher in TW14359 than Sakai (p=0.017), but did not differ between 
TW14359ΔrcsB and SakaiΔrcsB (Fig. 11A). Complementation of TW14359ΔrcsB and 
SakaiΔrcsB with rcsB did not restore differential ler expression as observed for WT strains (Fig. 
11A), supporting the hypothesis that the elevated basal expression of rcsB in TW14359 relative  
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Table 1 - Select list of proteins identified by iTRAQ proteomics 
 
Protein Name
a
 Gene/ORF
a
 
Fold 
change
b
 SD
c
 
Intracellular       
DNA-binding response regulator for Rcs phosphorelay rcsB 6.86 0.11 
Protein-export protein secB secB 2.93 1.99 
Envelope stress induced periplasmic protein spy 2.72 1.73 
Conserved metal-binding protein yodA 2.39 1.23 
Predicted DNA-binding transcriptional regulator yheO 2.14 1.61 
Type II secretion protein etpG 2.06 1.37 
Predicted DNA-binding transcriptional regulator yhaJ 2.00 1.43 
Mannonate dehydratase uxuA 1.99 0.94 
Nucleoside (Except guanosine) transporter nupC 1.98 1.26 
Conserved protein ycaO 1.98 1.58 
LEE-encoded type III secretion system component escF 1.94 0.98 
Predicted chaperone yegD 1.86 0.54 
Aminoacyl-histidine dipeptidase (Peptidase D) pepD 1.84 1.04 
AMP nucleosidase amn 1.81 0.90 
Putative uncharacterized protein; homolog of pO157p81  ECSP_6104 1.78 0.67 
Isoprenoid biosynthesis protein elbB 1.76 0.54 
Locus of enterocyte effacement (LEE)-encoded regulator ler 1.74 0.70 
Bifunctional nitric oxide dioxygenase hmp 1.73 0.10 
LEE-encoded chaperone cesA 1.72 0.69 
Putative cytoplasmic membrane export protein ECSP_0558 1.71 0.31 
Selenide, water dikinase selD 1.67 0.98 
Protein assembly complex, lipoprotein component yfgL 1.65 0.83 
Malic enzyme predicted oxidoreductase maeB 1.65 0.61 
Colicin resistance and tellurite resistance protein terE 1.64 0.76 
Ferrichrome outer membrane transporter fhuA 1.64 0.15 
3-methyl-2-oxobutanoate hydroxymethyltransferase panB 1.63 0.42 
a 
Protein/gene names and open reading frame (ORF) IDs based on EHEC strain TW14359 
(accession NC_013008, NCBI) and K-12 strain MG1655 (EcoCyc, REF). 
b 
Mean fold change in protein level as determined by iTRAQ MS for strain TW14359 relative to 
Sakai. 
c 
Standard deviation (SD) of the mean fold change.       
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Table 1 - Select list of proteins identified by iTRAQ proteomics, continued. 
Protein Name
a
 Gene/ORF
a
 
Fold 
change
b
 SD
c
 
10 kDa chaperonin groS 4.57 2.92 
Stress protein, member of the CspA-family  cspC 4.53 3.24 
Osmotically inducible, stress-inducible membrane protein osmC 4.42 3.83 
Conserved protein  yifE 4.35 2.52 
Phosphohistidinoprotein-hexose phosphotransferase ptsH 4.34 3.07 
30S ribosomal subunit protein S1 rpsA 4.08 1.96 
Conserved metal-binding protein yodA 4.05 1.31 
Component of a tripartite ferrous iron transporter efeO 3.93 1.05 
Glycine cleavage system H protein  gcvH 3.80 2.02 
50S ribosomal protein L24  rplX 3.71 1.73 
Periplasmic chaperone hlpA 3.70 0.85 
Scaffold protein  iscU 3.64 1.79 
Phosphate transporter subunit pstS 3.61 3.59 
30S ribosomal protein S14  rpsN 3.55 2.53 
Glutaredoxin 3  grxC 3.51 2.27 
50S ribosomal protein L9 rplI 3.38 1.73 
tetrahydrodipicolinate succinylase subunit dapD 3.29 0.72 
Peptidyl-prolyl cis-trans isomerase (PPIase)  surA 3.26 0.74 
High-affinity zinc uptake system periplasmic protein  znuA 3.18 0.88 
Thioredoxin 1  trxA 3.12 1.59 
Ecotin  eco 2.70 0.74 
LEE-encoded type III secreted effector  espF 2.66 0.65 
Ribosome-recycling factor frr 2.62 0.51 
Heme oxygenase  chuS 2.59 0.43 
Periplasmic protein  osmY 2.58 0.70 
DnaK suppressor protein  dksA 2.52 0.75 
Secreted protein EspA  espA 2.45 1.98 
Secreted protein EspB espB 2.41 2.04 
Catalase-peroxidase 2  katP 2.38 2.39 
Conserved protein yebT 2.31 2.74 
a 
Protein/gene names and open reading frame (ORF) IDs based on EHEC strain TW14359 
(accession NC_013008, NCBI) and K-12 strain MG1655 (EcoCyc, REF). 
b 
Mean fold change in protein level as determined by iTRAQ MS for strain TW14359 relative to 
Sakai. 
c 
Standard deviation (SD) of the mean fold change.       
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Table 1 - Select list of proteins identified by iTRAQ proteomics, continued. 
Protein Name
a
 Gene/ORF
a
 
Fold 
change
b
 SD
c
 
Glucose-specific enzyme IIA component of PTS crr 2.26 1.16 
Protein grpE grpE 2.18 0.90 
Serine endoprotease (Protease Do), membrane-associated degP 2.13 0.14 
Shiga toxin II subunit A stx2A 2.11 1.51 
Protein TolB tolB 2.09 0.13 
Porphobilinogen deaminase hemC 2.03 0.38 
Alkyl hydroperoxide reductase, C22 subunit ahpC 2.00 1.10 
DNA-binding transcriptional repressor cspE 1.91 1.30 
Thiol:disulfide interchange protein DsbA dsbA 1.82 0.56 
Chaperone Hsp70, co-chaperone with DnaJ dnaK 1.80 0.31 
Putative uncharacterized protein ECSP_3241 1.79 0.48 
Carbon storage regulator csrA 1.79 1.39 
50S ribosomal protein L23 rplW 1.70 1.13 
Predicted uncharacterized protein ECSP_0343 1.66 1.03 
Adenylate kinase adk 1.65 0.43 
Glutamine synthetase glnA 1.56 0.26 
Translocated intimin receptor protein tir 1.56 1.20 
60 kDa chaperonin groL 1.55 1.49 
Thiosulfate:cyanide sulfurtransferase (Rhodanese) pspE 1.54 0.36 
Sorbitol-6-phosphate dehydrogenase srlD -1.50 0.02 
Putative exoprotein-precursor espP -1.50 0.68 
F9 fimbriae chaperone fmlB -1.53 0.17 
Molybdate transporter subunit modA -1.66 0.69 
Hydrogenase 2, large subunit hybC -1.72 0.25 
Cystine transporter subunit fliY -1.78 0.75 
Predicted protein; homolog of VT2-Sap55 in Sakai ECSP_3238 -2.04 0.14 
D-ribose transporter subunit rbsB -3.21 0.06 
L-rhamnose isomerase rhaA -3.44 0.01 
Oligopeptide transporter subunit oppA -3.49 0.21 
Putative uncharacterized prophage protein ECSP_2949 -4.21 0.21 
Predicted protein ECSP_5384 -6.07 0.22 
a 
Protein/gene names and open reading frame (ORF) IDs based on EHEC strain TW14359 
(accession NC_013008, NCBI) and K-12 strain MG1655 (EcoCyc, REF). 
b 
Mean fold change in protein level as determined by iTRAQ MS for strain TW14359 relative to 
Sakai. 
c 
Standard deviation (SD) of the mean fold change.       
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Figure 10 - rcsB expression in Sakai and TW14359. 
(2A): Representative western blot for FLAG-tagged RcsB in strains Sakai and TW14359 grown in 
DMEM (OD600=0.5). Equal loading was controlled for by westerns for GroEL. (2B, top): Transcript 
levels of rcsB and rcsD plotted for Sakai (filled) and TW14359 (empty) grown in DMEM.  The asterisk 
denotes significant differences between strains by Student’s t-test (p=0.001, n≥3). Error bars denote 
standard deviation. (2B, bottom): Graphic depicts the rcsDB and rcsC open reading frames with their 
respective promoters, the location of qRT-PCR priming sites, and the location of amplified promoter lacZ 
fusion fragments for rcsD and rcsD in pRS551. 
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to Sakai is responsible for the LEE expression phenotype.  The fact that ler transcript levels were 
higher in rcsB complement strains relative to WT (Fig. 11A), likely reflects expression from 
pACYC177. Although this plasmid is low-copy, rcsB transcript levels were still 20-fold higher 
in complement strains compared to WT (data not shown). In strain Sakai, the activation of ler by 
rcsB overexpression in-trans requires an intact global regulator of virulence (grvA) gene, the 
product of which activates transcription from the LEE1 promoter (Tobe et al., 2005). As such, 
this study sought to determine if in TW14359, which intrinsically overexpresses rcsB, ler 
activation also required grvA, or if activation was through a different pathway.  Deletion of grvA 
reduced ler expression to the same extent as observed for TW14359ΔrcsB when compared to 
TW14359 (Fig. 11B) (p<0.05). Moreover, deletion of grvA in TW14359ΔrcsB did not further 
significantly alter ler expression when compared to TW14359ΔrcsB or TW14359ΔgrvA. The 
expression of ler was however slightly, but significantly higher in the TW14359ΔrcsBΔgrvA 
backgrounds when compared to Sakai (p<0.05). Therefore, increased basal expression of rcsB in 
TW14359 and interaction with grvA is required for the LEE expression phenotype of this strain. 
This study further ascertained the contribution of intrinsic rcsB overexpression to the TW14359 
adherence phenotype using the human colonic cell line HT-29. As observed for bovine MAC-T 
cells (Abu-Ali et al., 2010a), adherence to HT-29 cells, as measured by microcolony formation, 
was significantly higher for TW14359 than Sakai (p=0.006) (Fig. 11C). Consistent with ler 
expression data, adherence did not differ between Sakai and SakaiΔrcsB, but was reduced in 
TW1359ΔrcsB to a level comparable to Sakai and SakaiΔrcsB. As anticipated, the adherence of 
T3SS-deficient TW14359ΔescN and SakaiΔescN strains to HT-29 cells was significantly 
reduced when compared to WT and rcsB isogenic backgrounds (p<0.05), but not between escN  
isogenic strains (Fig. 11C), indicating that the adherence phenotype of TW14359 is dependent 
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Figure 11 - rcsB, grvA and the LEE expression and adherence phenotype of TW14359. 
(3A): ler transcript levels plotted for WT, ΔrcsB , and complement ΔrcsB prcsB versions of Sakai (solid) 
and TW14359 (empty) grown in DMEM (OD600=0.5). (3B): ler transcript levels plotted for WT strains 
and mutant derivative strains of TW14359 during growth in DMEM. (3C): Adherence to HT-29 cells as 
measured by microcolony formation plotted for WT, ΔrcsB and ΔescN versions of Sakai (solid) and 
TW14359 (empty).  For 3A, the asterisk denotes a significant difference between Sakai and TW14359 by 
Student’s t-test (p=0.017, n≥3). For 3B and 3C, plots which differ by lower case letter, differ significantly 
by Tukey’s HSD following a significant F-test (p<0.05, n≥3). Error bars denote standard deviation for all 
panels. 
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on intrinsic rcsB upregulation, as well as a functional T3SS. 
 
2.3.3 Control of rcsB by the LEE-encoded regulator GrlA, and GrlA-RcsB dependent 
repression of motility...... 
 In TW14359, genes associated with motility, including structural and regulatory genes 
for flagellar biosynthesis (flg and fli genes), and chemotaxis (cheB, tsr and tar) are reduced in 
expression compared to Sakai (Abe et al., 2002; Abu-Ali et al., 2010a). In the present study, this 
has been observed to correspond with a 30-40% reduction in the lateral growth of TW14359 on 
motility plates relative to Sakai (Fig. 12A). Importantly, both RcsB and LEE-encoded activator 
GrlA are known to negatively regulate motility (Francez-Charlot et al., 2003; Iyoda et al., 2006), 
and both are increased in expression in TW14359. It was therefore of interest to investigate the 
potential genetic interaction of rcsB and grlA, and their contribution to the regulation of motility 
in TW14359. 
As expected, deletion of rcsB in TW14359 enhanced the lateral growth of TW14359 on 
motility plates by 30-40% (Fig. 13A), suggesting that the motility deficiency of TW14359 when 
compared to Sakai is connected to intrinsic rcsB overexpression. Also, the inactivation of grlR 
(strain TW14359grlR::kan) leading to grlA overexpression (Fig. 12) (Iyoda et al., 2006), 
substantially impaired lateral growth on motility plates (Fig. 13A). Most importantly, deletion of 
rcsB in the TW14359grlR::kan background restored lateral growth on motility plates to the level 
observed for TW14359ΔrcsB, revealing that the control of motility by grlA is epistatic to rcsB.  
Negative regulation of motility by RcsB has been shown to result from direct transcriptional 
repression of the global regulator of motility genes flhDC (Francez-Charlot et al., 2003). 
Consistent with this, expression from the flhDP promoter, as measured by β-galactosidase  
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Figure 12 - qRT-PCR for ler and grlA mRNA in TW14359 and TW14359grlR::kan. 
TW14359 and TW14359grlR::kan grown to mid-logarithmic phase (OD600=0.5) in LB. The asterisks 
denotes significance by a Student’s t-test (p<0.05, n≥3). Error bars indicate standard deviation for both 
plots. 
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Figure 13 - GrlA-RcsB dependent repression of motility. 
(4A): Motility as measured by lateral growth on representative motility plates for Sakai and TW14359 
(top), and mutant derivatives of TW14359 (bottom); EHEC O157:H− strain 493/89 is included as a non-
motile control. (4B): β-galactosidase activity in Miller Units for TW14359 and mutant derivatives 
containing an fhlDP1000-lacZ fusion during growth in DMEM. (4C): Representative western blot for 
FLAG-tagged RcsB in LB plotted for TW14359 (WT) with and without 44 mM HCO3−, and for grlA 
overexpression strains of TW14359 (grlA
+++
 and grlR::kan). Equal loading was controlled for by westerns 
for GroEL. (4D): β-galactosidase activity in Miller Units plotted for TW14359 (filled) and 
TW14359grlR::kan (empty) grown in LB and containing rcsDP501-lacZ, rcsBP1000-lacZ, or lerP903-lacZ 
fusions. For 4B, plots which differ by lower case letter, differ significantly by Tukey’s HSD following a 
significant F-test (p<0.05, n≥3). For 4D, the asterisk denotes significance by a Student’s t-test (p=0.010, 
n≥3). Error bars indicate standard deviation for all panels. 
 
51 
 
activity from flhDP1000-lacZ, was significantly increased in TW14359ΔrcsB, but decreased in 
TW14359grlR::kan when compared to WT (p<0.05) (Fig. 13B). flhDP promoter expression did 
not differ however between TW14359grlR::kanΔrcsB and TW14359ΔrcsB indicating that RcsB-
dependent repression of flhDC and motility is positively regulated by GrlA. In further support of 
this, levels of RcsB were increased (~2.4-fold) in TW14359grlR::kan and in a grlA 
overexpression strain compared to WT (Fig. 13C). Interestingly however, expression from rcsDP 
or rcsBP promoters was not observed to be altered in TW14359grlR::kan (Fig. 13D), indicating 
that control of RcsB by GrlA is at the post-transcriptional level; increased expression from the 
lerP promoter was included as a positive control for grlA overexpression. Collectively, these 
experiments reveal a reciprocating regulatory mechanism in which RcsB and LEE-encoded GrlA 
coordinate LEE activation with repression of flhDC and motility. 
 
2.3.4 Role for Rcs phosphorelay and grvA in bicarbonate-dependent activation of the LEE  
 In the preceding experiments the addition of bicarbonate to TW14359 cultures growing in 
LB, and added as a positive control for LEE stimulation (Abe et al., 2002), was also observed to 
increase RcsB levels ~5.4-fold (Fig. 13C). The bicarbonate ion (HCO3−) has been shown to 
activate LEE expression and adherence in a dose-dependent manner in EHEC (Abe et al., 2002).  
This has been reported to be through increased transcription from the grlRA promoter in C. 
rodentium (Tauschek et al., 2010), however the mechanism by which bicarbonate stimulates 
LEE expression in EHEC is unknown. In this study, the increase in RcsB levels with bicarbonate 
was higher than that observed for grlA overexpression strains (Fig. 13C), suggesting that this 
added bicarbonate stimulation of RcsB was, at least in part, independent of grlA. It was therefore 
predicted that the Rcs phosphorelay system was in some way involved in bicarbonate-directed  
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Figure 14 - Effect of bicarbonate on RcsB, and rcsB-dependent LEE activation. 
(5A): Representative western blot for FLAG-tagged RcsB as a function of increasing bicarbonate 
(HCO3−) molarity (mM) (top), and for FLAG-tagged Tir in TW14359 and TW14359ΔrcsB grown in LB 
or LB with 44 mM HCO3−  (OD600=0.5) (bottom).  Equal loading was controlled for by westerns for 
GroEL.  (4B): ler transcript levels plotted for TW14359, TW14359ΔrcsB, and complement 
TW14359ΔrcsBprcsB strains grown in LB (−) or LB with 44 mM HCO3− (+) (OD600=0.5).  (4C): β-
galactosidase activity in Miller Units plotted for TW14359 and TW14359 containing rcsDP501-lacZ or 
rcsBP1000-lacZ fusions grown in LB (−) or LB with 44 mM HCO3− (+).  (4D): β-galactosidase activity in 
Miller Units plotted for TW14359 (WT) and mutant derivative strains containing lerP903-lacZ and grown 
in LB (−) or LB with 44 mM HCO3− (+).  For 5B and 5C, the asterisks denote a significant difference 
between treatments by Student’s t-test (p<0.05 [*], p<0.01 [**], n≥3).  For 5D, plots which differ by 
lower case letter differ significantly by Tukey’s HSD following a significant F-test (p<0.05, n≥3).  Error 
bars denote standard deviation for all panels. 
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activation of LEE expression.  In agreement with the dose-dependence of bicarbonate for LEE 
stimulation, the addition of bicarbonate up to 44 mM (a physiologically relevant molarity) 
(Feldman, 1983) to LB was observed to incrementally increase RcsB levels (Fig. 14A). rcsB was 
shown to be required for full activation of LEE expression in response to bicarbonate, as the 
levels of Tir protein were increased substantially in TW14359 grown with bicarbonate, but only 
marginally increased in the TW14359ΔrcsB background (Fig. 14A). In addition, growth with 
bicarbonate increased ler transcript levels 5-fold in the WT (p=0.001) compared to only 1.24-
fold in TW14359ΔrcsB (Fig. 14B). Bicarbonate stimulation of ler was restored in complement 
strain TW14359ΔrcsB prcsB.   
Expression from both rcsDP and rcsBP promoters was significantly increased in the 
presence of bicarbonate (p<0.05) (Fig. 14C), revealing that bicarbonate is stimulating 
transcription of rcsDB from the rcsDP promoter, as well as rcsB alone from at least one of two 
mapped promoters intracistronic to rcsD. Expression from the lerP promoter was expectedly 
increased with bicarbonate addition for TW14359 (p<0.05), but not for TW14359ΔrcsB (Fig. 
14D). In addition, deletion of the Rcs phosphorelay sensor kinase rcsC significantly reduced 
bicarbonate stimulation of lerP promoter activity compared to WT (p<0.05). And consistent with 
an RcsB-GrvA dependent pathway of LEE activation, lerP promoter expression with bicarbonate 
addition was reduced in TW14359ΔgrvA and TW14359ΔrcsBΔgrvA when compared to WT 
(p<0.05), but not compared to TW14359ΔrcsB or TW14359ΔrcsC (Fig. 14D). Collectively, this 
reveals that bicarbonate-dependent stimulation of LEE expression in EHEC is at least partly 
dependent on components of the Rcs phosphorelay system, and on the RcsB-GrvA pathway of 
LEE activation. 
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2.4 Discussion 
 It is predicted that rcsB, encoding the response regulator of the Rcs system, is 
intrinsically upregulated in TW14359, and that this is responsible for the enhanced LEE 
expression and adherence phenotype of this strain. It is not yet clear why rcsB is upregulated in 
TW14359.  rcsB is co-transcribed as the second gene of a dicistron with rcsD (Krin et al., 2010) 
and yet rcsD transcript levels by qRT-PCR (Fig. 10) and protein levels by iTRAQ proteomics 
did not differ in TW14359 when compared to Sakai. This is consistent with the observation that 
rcsB overexpression can upregulate the LEE independent of rcsD (Tobe et al., 2005).  
Alternatively, rcsB can be expressed as a monocistron from at least two promoters which are 
intracistronic to rcsD (i.e. rcsBP1 and rcsBP2) (Krin et al., 2010), but upstream of the priming 
sites used for qRT-PCR in this study.  Since there are no differences in the sequence of these 
promoters between TW14359 and Sakai, it is predicted that intrinsic upregulation of rcsB is 
therefore dependent on some trans-factor(s) acting on the rcsBP1 and/or rcsBP2 promoters.  
Unfortunately, how these promoters are expressed and regulated is unknown, and needs to be 
further examined. A genetic polymorphism unique to strain TW14359 was initially hypothesized 
in this study to be important for the rcsB expression phenotype of this strain.  Kulasekara et al. 
(Kulasekara et al., 2009) had described a 90-bp insertion in the ORF of tolA, the product of 
which is an inner membrane component of the Tol-Pal envelope complex involved in 
maintaining cell envelope integrity (Bernadac et al., 1998; Cascales et al., 2000). Importantly, 
mutations in tolA have been reported to substantially upregulate rcsB (Clavel et al., 1996).  
Indeed, rcsB expression in strains TW14359tolA::kan and SakaitolA::kan was increased 
compared to their WT counterparts. However, the level of rcsB transcript was still 
proportionately increased in TW14359tolA::kan relative to SakaitolA::kan (p=0.016), suggesting 
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that the tolA polymorphism is not responsible for increased basal expression of rcsB in 
TW14359. 
The results also indicated that deletion of rcsB had no effect on ler expression or HT-29 
adherence in strain Sakai.  This latter finding is inconsistent with a study demonstrating that both 
the overexpression and deletion of rcsB in Sakai can lead to increased LEE expression and 
adherence through independent regulatory pathways: RcsB was predicated to upregulate the LEE 
through activation of grvA, and downregulate LEE expression through repression of pchA, a 
positive regulator of the LEE (Tobe et al., 2005). The reason for this disparity in results is not yet 
known.  However, the direction and magnitude at which RcsB regulates LEE expression is likely 
to be sensitive to differences in growth phase, nutrient availability, as well as signals which 
activate Rcs phosphorelay. In this study, the influence of RcsB on ler expression was only 
examined in mid-exponential cultures (OD600=0.5), and may differ substantially with even a 
subtle change in the phase of growth or experimental condition. For example, in Tobe et al (Tobe 
et al., 2005) Caco-2 cells were used for adherence studies, whereas this study utilized HT-29 
cells. 
The RcsB-dependent LEE expression phenotype of strain TW14359 was further shown to 
require an intact global regulator of virulence grvA gene. The mechanism by which RcsB 
controls grvA, and how RcsB-GrvA regulate ler is unknown. Tobe et al. (Tobe et al., 2005) 
observed increased expression of grvA in response to rcsB overexpression and described RcsB 
boxes in the predicted grvA promoter region with some homology to the RcsB consensus 
(Wehland and Bernhard, 2000), suggesting direct regulation of grvA transcription. Alternatively, 
RcsB may interact with GrvA to directly activate the expression of ler and other genes. There is 
precedent for this, as RcsB has been shown to regulate transcription as a heterodimer with RcsA 
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(Francez-Charlot et al., 2003; Stout et al., 1991), GadE (Castanie-Cornet et al., 2010), and BglJ 
(Venkatesh et al., 2010). If RcsB-GrvA activate ler transcription as a heterodimer, they likely 
bind upstream of the core promoter region (i.e. upstream of -35) as is typical for RcsB promoter 
activation (Boulanger et al., 2005; Castanie-Cornet et al., 2010; Sturny et al., 2003; Venkatesh et 
al., 2010). However, there is no RcsB binding site upstream of and including the ler P1 and P2 
promoters. 
The results of this study suggest that RcsB is involved in the inverse regulation of genes 
that control motility (i.e. flhDC) and those for intimate colonization (i.e. the LEE) in EHEC.  
This opposing relationship between colonization and motility may be important for the 
establishment of E. coli in the gut. For example, constitutive expression of FlhDC regulon in 
EHEC markedly reduced adherence to HeLa cells (Iyoda et al., 2006), whereas the deletion of 
flhDC and lack of motility in K12 increased colonization in a murine model (Gauger et al., 2007; 
Leatham et al., 2005). It is important to note however that FlhDC also controls the expression of 
genes which serve no direct role in motility but which could contribute in some way to 
colonization. In EHEC, the LEE encoded activator GrlA indirectly downregulates transcription 
of flhDC leading to reduced motility (Iyoda et al., 2006). This study has revealed that mutation 
of rcsB masks the negative regulatory effect of GrlA on motility and flhDC transcription, and 
that the overexpression of grlA increases RcsB levels. This suggests that RcsB and GrvA are 
members of a reciprocating regulatory mechanism in EHEC which, at a minimum, coordinates 
the upregulation of LEE genes with a downregulation of the flhDC flagellar regulon. Activation 
of RcsB by GrlA appears to be at the post-transcriptional level, as increased protein levels did 
not correspond with increased transcription from promoters driving expression of rcsDB or rcsB.   
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 In EHEC, bicarbonate has been shown to stimulate LEE transcription through ler, and to 
increase adherence to Caco-2 cells in a pH-independent manner (Abe et al., 2002). It has been 
hypothesized that bicarbonate produced naturally in the small bowel to neutralize gastric acid 
may serve as a biological cue for T3SS-dependent colonization (Abe et al., 1997; Abe et al., 
2002).  In C. rodentium bicarbonate interacts with the AraC-type regulator RegA to directly 
upregulate grlA expression (Tauschek et al., 2010).  In EHEC and EPEC however, there are no 
homologs of RegA, and the genetic determinant(s) which regulate bicarbonate-dependent 
induction of the LEE in these pathogens is unknown. This study has shown that Rcs 
phosphorelay components RcsB and RcsC and the global regulator of virulence GrvA are 
required for full stimulation of the LEE in response to bicarbonate in EHEC. Despite the 
interplay of GrlA and RcsB in the control of flhDC and motility, there is no evidence that grlA is 
important for bicarbonate dependent LEE expression through this pathway. For instance, 
overexpression of grlA did not increase rcsB transcription, whereas bicarbonate addition did 
enhance rcsB transcription (Figs. 13D and 14C). Furthermore, the level of RcsB induction was 
markedly higher in WT cells grown with bicarbonate than in strains which overexpress grlA 
alone (Fig. 13C). Therefore in EHEC it is predicted that bicarbonate stimulates LEE expression 
through an RcsB-GrvA-Ler activation pathway.   
 To conclude, the LEE expression phenotype of TW14359 is hypothesized to result from 
intrinsically increased basal levels of the response regulator RcsB, activating LEE expression 
through a GrvA-Ler pathway.  In addition, increased adherence of strain TW14359 to intestinal 
cells was shown to be dependent on elevated rcsB expression and a functional T3SS. Whether or 
not this dysregulated pathway is responsible for the severe disease attributed to infections with 
this strain is not yet clear. Furthermore, the LEE-encoded activator GrlA was determined to 
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require rcsB for repression of the flhDC flagellar regulon, suggesting that GrlA and RcsB work 
together to coordinate the activation of genes for colonization with the repression of genes for 
motility. Finally, bicarbonate was proposed to be a physiological signal for an Rcs phosphorelay- 
and GrvA-directed pathway activating LEE expression and colonization in EHEC. 
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Table 2 - Strains and plasmids used in Chapter 2 
  
    
            Nucleotide
a
 
Strain/plasmid Relevant characteristics Reference         Position 
Strain name:         
DH5α Vector propagation, recA1 endA1       
Sakai WT 1996 outbreak, Osaka Japan Michino, 1999   
TW14359 WT 2006 outbreak, western U.S.A. Manning, 2008   
EDL933 
WT 1982 outbreak, MI and OR, 
U.S.A. Riley, 1983   
EcRJM-1 TW14359∆escN This study 4665071-4666029 
EcRJM-2 Sakai∆escN This study 4605926-4606884 
EcRJM-3 TW14359∆sepD This study 4670066-4670518 
EcRJM-5 TW08264∆rcsB This study 3049164-3049814 
EcRJM-6 TW14359∆rcsB This study 3045397-3046047 
EcRJM-7 TW14359∆rcsC This study 3046247-3049096 
EcRJM-8 TW08264rcsB-FLAG::kan This study 3049812-3049864 
EcRJM-9 TW14359rcsB-FLAG::kan This study 3046045-3046097 
EcRJM-10 TW14359rcsB-FLAG This study 3046045-3046097 
EcRJM-11 TW14359∆grvA This study 1282113-1282867 
EcRJM-12 TW14359∆rcsB ∆grvA This study     
EcRJM-13 TW14359tir-FLAG This study 4659012-4659077 
EcRJM-14 TW08264tir-FLAG This study 4599867-4599932 
EcRJM-15 TW14359∆rcsB tir-FLAG This study     
EcRJM-16 TW08264∆rcsB tir-FLAG This study     
EcRJM-22 Sakai pRJM-2 This study     
EcRJM-23 TW14359 pRJM-2 This study     
EcRJM-29 TW14359 pRJM-7 This study     
EcRJM-34 TW14359 pRJM-8 This study     
EcRJM-35 TW14359∆grlR::kan This study 4673380-4673731 
EcRJM-36 TW14359∆grlR::kan pRJM-2 This study     
EcRJM-37 TW14359∆grlR::kan pRJM-8 This study     
EcRJM-38 TW14359∆grlR::kan pRJM-7 This study     
EcRJM-39 TW14359∆rcsB pRJM-2 This study     
EcRJM-40 TW14359∆rcsC pRJM-2 This study     
EcRJM-55 TW14359 pRJM-15 This study     
a
 Nucleotide positions based on the published Sakai (NC_002695) and TW14359 (NC_013008) 
genome sequences (NCBI) 
 
 
60 
 
Table 2 
Strains and plasmids used in Chapter 2, 
continued.     
            Nucleotide
a
 
Strain/plasmid Relevant characteristics Reference         Position 
Strain name:         
EcRJM-59 TW14359∆rcsB ∆grlR::kan This study     
EcRJM-60 TW14359∆grlR::kan pRJM-17 This study     
EcRJM-61 
TW14359∆rcsB ∆grlR::kan pRJM-
17 This study     
EcRJM-62 TW14359∆rcsB pRJM-17 This study     
EcRJM-63 TW14359∆rcsC pRJM-17 This study     
EcRJM-64 TW14359∆grvA pRJM-17 This study     
EcRJM-65 TW14359∆rcsB ∆grvA pRJM-17 This study     
EcRJM-66 TW14359∆escN ∆sepD This study     
EcRJM-67 TW14359∆escN ∆sepD pRJM-10 This study     
EcRJM-68 Sakai∆tolA::kan This study 860848-862032 
EcRJM-69 TW14359∆tolA::kan This study 865712-866986 
EcRJM-70 Sakai∆tolA::kan pRJM-19 This study     
EcRJM-71 TW14359∆tolA::kan pRJM-18 This study     
Plasmid name:         
pACYC177 
Low copy cloning vector, Amp
R
 
Kan
R
 Chang, 1978   
pBAD22 
Ara inducible expression vector, 
Amp
R 
 Guzman, 1995   
pRS551 lac fusion vector, Amp
R
 Kan
R
 lacZ
+
 Simons, 1987   
pCP20 Flp recombinase expression vector Datsenko, 2000   
pKD4 Template plasmid for Kan cassette Datsenko, 2000   
pKM208 Red-recombinase expression vector Datsenko, 2000   
pBAD-TOPO® Ara inducible expression vector Invitrogen     
pSU312 
FLAG epitope template, Amp
R
, 
Kan
R
 Uzzau, 2001   
pRJM-2 pRS551 containing lerP905-lacZ This study 4680206-4679303 
pRJM-7 pRS551 containing rcsBP1000-lacZ This study 3044397-3045396 
pRJM-8 pRS551 containing rcsDP501-lacZ This study 3042208-3042707 
pRJM-15 pBAD22 containing grlA This study 4672912-4673325 
pRJM-17 pRS551 containing flhDP1000-lacZ This study 2485401-2486400 
pRJM-18 pACYC177-tolA (Sakai) This study 860790-862067 
pRJM-19 pACYC177-tolA (TW14359) This study 865654-867021 
a
 Nucleotide positions based on the published Sakai (NC_002695) and TW14359 (NC_013008) 
genome sequences 
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Table 3 - Primers used in Chapter 2 
  
    
Primer name Sequence (5'→ 3') Function/Ref. 
FLAG-F gactacaaagatgacgacga Uzzau, 2001 
P1 gtgtaggctggagctgcttc Datsenko, 2000 
P2 catatgaatatcctccttag Datsenko, 2000 
RcsB+609/Fla
g-F 
TTATCTCTCTTCAGTAACGTTAAGTCCGGCAGATAAAGACgactacaaag
atgacgacga FLAG fusion 
RcsB+741/P2 
CGTAGGACGGATAAGGCGTTTACGCCGCATCCGGCAATCGcatatgaat
atcctccttag FLAG fusion 
RcsB+585 CGAGAACGATATCGCCCTGC  
FLAG fusion 
validation 
RcsB+831 CCGCATCTGGCATTCAGTGC  
FLAG fusion 
validation 
Tir-1635/Flag-
F 
TTCGAATAACCCACCAGCGCCGGGATCCCATCGTTTCGTCgactacaaag
atgacgacga FLAG fusion 
Tir-1741/P2 
AGCTCAAGAGTTGCCCATCCTGCAGCAATGTTATTCCCTGcatatgaatat
cctccttag FLAG fusion 
Tir+1613 GGAGTAATAGCGCTGTGAAT  
FLAG fusion 
validation 
Tir+1968 AATTTCCCACAGACACCATA  
FLAG fusion 
validation 
EspD+1083/Fl
ag-F 
TTCAGCACGGGTAAATAGTCGTATTGTTAGTGGCCGAATTgactacaaa
gatgacgacga FLAG fusion 
EspD+1136/P2 
CGTTACTTGAGTATTATCAATAGTATTCATAATAAAATTCcatatgaatat
cctccttag FLAG fusion 
EspD+1042 CAGGCGAGCTATTTACAAAG  
FLAG fusion 
validation 
EspD+1198 CTCTCCGAAGCGGAATTAAC  
FLAG fusion 
validation 
EscN+0/P1 
ATGATTTCAGAGCATGATTCTGTATTGGAAAAATACCCAC 
gtgtaggctggagctgcttc 
Deletion 
primer 
EscN+1338/P2 
GGCAACCACTTTGAATAGGCTTTCAATCGTTTTTTCGTAAcatatgaatat
cctccttag 
Deletion 
primer 
EscN-45 GGAGGTTGGGAATAATATCG  
Deletion 
validation 
EscN+1405 CCATTGATTCTCTCAATCGG  
Deletion 
validation 
RcsB-41/P1 
AGTTATGTCAAGAGCTTGCTGTAGCAAGGTAGCCTATTACgtgtaggctg
gagctgcttc 
Deletion 
primer 
RcsB+691/P2 
CAGATAAGACACTAACGCGTCTTATCTGGCCTACAGATGAcatatgaata
tcctccttag 
Deletion 
primer 
RcsB-95 CTGATTCGTGAGAAGGATGT  
Deletion 
validation 
a 
Restriction sites indicated by bolded and underlined nucleotides     
 
62 
 
Table 3 Primers used in Chapter 2, cont.     
Primer 
name Sequence (5'→ 3') Function/Ref. 
RcsB+880 GAGAGGGTCAGGAAATCGCG  
Deletion 
validation 
GrlR-41/P1 
AAATTGAAAGGAGTGAGGTTAGTATGAAACTGAGTGAGTTgtgtaggct
ggagctgcttc Deletion primer 
GrlR+412/P
2 
TTATTTGATAAATAAATCGACATAAAAAACATACATAAAAcatatgaata
tcctccttag Deletion primer 
GrlR-78 GGTCTCCATTATTCTTGATATTGCTTATGG 
Deletion 
validation 
GrlR+472 CTGAGTCAGGAATTACATAGTCGCCATTTT 
Deletion 
validation 
RcsC-41 /P1 
ACCACACTCCATCGGTCACCTGAGGCGGAGCTTCGCCCCTgtgtaggctg
gagctgcttc Deletion primer 
RcsC+2890/
P2 
ACCACACTCCATCGGTCACCTGAGGCGGAGCTTCGCCCCTcatatgaatat
cctccttag Deletion primer 
RcsC-207 GGATATAACCATTAACAAGC 
Deletion 
validation 
RcsC+2974 CTTATCCGTCCTACGATTCC 
Deletion 
validation 
TolA+1/P1 
GTGTCAAAGGCAACCGAACAAAACGACAAGCTCAAGCGGGgtgtaggc
tggagctgcttc Deletion primer 
TolA+1185/
P2 
TTACGGTTTGAAGTCCAATGGCGCGTTTTTGAACACTTCAcatatgaatatc
ctccttag Deletion primer 
TolA-93 GGTTGGTTTAATGACGCAGC  
Deletion 
validation 
TolA+1346 CCAAATGCTACTCGTAATGC  
Deletion 
validation 
GrvA-41/P1 
AATACTGGATTTGTAATACACAACTAAGGTATAAAATGTAgtgtaggctg
gagctgcttc Deletion primer 
GrvA+795/P
2 
GAGAGAGTTGCAATTATTTGGTGATTCAGAGTTTAACATCcatatgaatat
cctccttag Deletion primer 
GrvA-115/F-
Val CAGATAATTCAGATTTGCAT  
Deletion 
validation 
GrvA+959/R
-Val CGGTGAAATTAATAACATGG  
Deletion 
validation 
Ler-
905/EcoRI CGGAATTCTCTTTATAGAGGGGCGCATT  
lacZ promoter 
fusion 
Ler-
1/BamHI CGGGATCCAATAAATAATCTCCGCATGC  
pRS551 lacZ 
fusion 
a 
Restriction sites indicated by bolded and underlined nucleotides     
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Table 3 Primers used in Chapter 2, cont.     
Primer name Sequence (5'→ 3') Function/Ref. 
RcsB-
1,000/EcoRI CGCGGAATTCCGCGGCGATCGCGATGCATTACGACGTATT 
pRS551 lacZ 
fusion 
RcsB-
1/BamHI CGCGGGATCCGTAATAGGCTACCTTGCTACAGCAAGCTCT 
pRS551 lacZ 
fusion 
RcsD-
501/EcoRI CGCGGAATTCATAATAATTCAAGGTTAAAATCAATAACTT 
pRS551 lacZ 
fusion 
RcsD-
1/BamHI CGCGGGATCCTCGTGTTTATGACCTGTTAAAACTTCGCGA 
pRS551 lacZ 
fusion 
GrlA+1/EcoR
I CGGAATTCATGGAATCTAAAAATAAAAATGGCGACTAT 
pBAD22 
cloning 
GrlA+414/Xb
aI GCTCTAGATTATTTTAAATAAACTTGTG 
pBAD22 
cloning 
ECSP_3286+
1 GAGGAATAATAAATGACCACTATAACCGATAA 
pBAD-TOPO 
cloning 
ECSP_3286+
504 TCAGTGGTGGTGGTGGTGGTGCAGTAGAGATGCATGGTGTAAC 
pBAD-TOPO 
cloning 
ECSP_0242+
1 GAGGAATAATAAATGGAGGAAGCCAATGGGGGGGAG 
pBAD-TOPO 
cloning 
ECSP_0242+
747 
TCAGTGGTGGTGGTGGTGGTGTTCAGAAACATGAGAAATATAAC
C 
pBAD-TOPO 
cloning 
ECSP_1773+
1 GAGGAATAATAAATGAAAATAATATCCACTGTTATTCAAACAC 
pBAD-TOPO 
cloning 
ECSP_1773+
588 
TCAGTGGTGGTGGTGGTGGTGTAAATATTTTCTGTTTAATAATGA
ATAAAAATC 
pBAD-TOPO 
cloning 
a 
Restriction sites indicated by bolded and underlined nucleotides     
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Chapter 3: Function and regulation of the RcsB-GrvA pathway controlling virulence and 
fitness factors in enterohemorrhagic Escherichia coli 
3.1 Background 
 Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a virulent intestinal pathogen, 
attributed to food-borne outbreaks of bloody diarrhea (hemorrhagic colitis) and the life-
threatening kidney disease hemolytic uremic syndrome (HUS) (Nataro and Kaper, 1998; Rangel 
et al., 2005). Intimate attachment of this pathogen to the intestine requires a functional type III 
secretion system (T3SS) and is characterized by the formation of attaching and effacing (A/E) 
lesions (Kaper et al., 2004). This T3SS is encoded on a 36-kb pathogenicity island referred to as 
the locus of enterocyte effacement (LEE) containing 41 genes organized into five operons 
(LEE1-LEE5) (McDaniel et al., 1995). The master LEE regulator Ler, encoded as the first gene 
of the LEE1 operon, positively stimulates LEE gene transcription by relieving H-NS mediated 
repression while negatively regulating its own transcription. Ler is also able to stimulate 
production of other LEE encoded regulators including GrlA and GrlR, which activate and repress 
ler transcription, respectively (Berdichevsky et al., 2005; Deng et al., 2004; Elliott et al., 2000; 
Haack et al., 2003; Islam et al., 2011; Sperandio et al., 2000). The genes grlA and grlR are 
encoded as a discistron from an H-NS/Ler regulated promoter (Barba et al., 2005), and GrlA 
binds directly to the LEE1 promoter region (Huang and Syu, 2008); Further regulation of LEE 
gene transcription is mediated by numerous non-LEE encoded factors that converge on the ler 
and grlA promoters to direct the proper spatio-temporal production of the T3SS (Flockhart et al., 
2012; Hansen and Kaper, 2009; Iyoda and Watanabe, 2004; Kendall et al., 2010; Leverton and 
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Kaper, 2005; Luzader et al., 2013; Nakanishi et al., 2006; Russell et al., 2007; Sharp and 
Sperandio, 2007; Zhang et al., 2004).   
 One such regulator, RcsB, has been shown to both activate and repress LEE transcription, 
and more recently to be required for upregulation of the LEE in response to the bicarbonate ion 
(Morgan et al., 2013; Tobe et al., 2005). RcsB is the response regulator of the Rcs phosphorelay 
system, a multi-component signaling pathway including RcsC (sensor kinase), RcsD (histidine 
phosphotransferase) and RcsB, which is activated by cell envelope stresses (Brill et al., 1988; 
Gottesman and Stout, 1991; Huang et al., 2006; Stout and Gottesman, 1990). Upon 
phosphorylation, RcsB can bind to target promoters as either a homodimer or as a heterodimer in 
conjunction with other regulatory proteins, such as BglJ, GadE, or RcsA (Gottesman et al., 1985; 
Johnson et al., 2011; Venkatesh et al., 2010). Binding occurs at specific RcsB consensus sites 
(Francez-Charlot et al., 2003; Wehland and Bernhard, 2000), and the location of binding relative 
to the -35 consensus sequence can dictate whether RcsB positively or negatively affects 
transcription (Majdalani and Gottesman, 2005). RcsB mediated regulation of the LEE requires 
LEE transcriptional regulators PchA and GrvA. In one study, overexpression of RcsB was 
observed to repress LEE transcription through down-regulation of LEE activator, PchA, while 
positive stimulation of the LEE by RcsB overexpression occurs through transcriptional activation 
of grvA (Tobe et al., 2005). In agreement with this mechanism, a strain that intrinsically 
overexpressed RcsB is characterized by grvA-dependent increased LEE expression (Morgan et 
al., 2013). 
  EHEC contains a number of horizontally acquired, multi-genic, elements termed O-
islands that contribute roughly 1.3 Mb of genomic content that is not present in K-12 (Hayashi et 
al., 2001). The genes contained within O-islands (OI) are diverse in function, and play a 
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significant role in EHEC fitness and virulence. The OI-47 locus, containing grvAB, is inserted 
between the ycdU and ycdT K-12 backbone genes, and is only present within the O157:H7 and 
O55:H7 pathogenic E. coli serotypes. GrvA is a predicted ToxR family membrane-bound 
transcriptional regulator. Analysis of the amino acid sequence, using the TMHMM v2.0 analysis 
program (http://www.cbs.dtu.dk/services/TMHMM/) (Krogh et al., 2001), suggests that GrvA 
contains a single transmembrane domain, similar to ToxR of Vibrio cholera encoded on the 
toxRS operon. The downstream gene, grvB, encodes a product with a single transmembrane 
domain, and may serve to allow GrvA to dimerize and form an active transcriptional complex, as 
is the case with ToxR and ToxS (DiRita and Mekalanos, 1991). While grvAB is found in EPEC 
O55:H7 and EHEC O157:H7 serotypes, another ToxR homolog, YqeI, is encoded within the 
defunct ETT2 type III secretion system found in pathogenic and some non-pathogenic E. coli 
strains (Ren et al., 2004). The gene downstream of yqeI also encodes a protein with a single 
transmembrane domain, similar to that of ToxS (Vibrio), GrvB (EHEC), and FidL (Salmonella). 
The ToxR family of regulators identified in E. coli contain significant amino acid sequence 
diversity compared between each other and homologues found in Salmonella. YqeI from EHEC 
and MarT from Salmonella share 41.5% amino acid homology, whereas GrvA and MarT share 
only 28.3% homology. Interestingly, GrvA and YqeI share only 29.5% amino acid sequence 
homology, suggesting divergent functions even within the strain.  
 While GrvA homologues were not identified through BLASTp search, several 
homologues for YqeI were identified among Escherichia, Yersinia, Serratia, and 
Pseudoalteromonas strains. The ToxR homolog identified in Pseudoalteromonas tunicata, 
WmpR, has been shown to regulate genes associated with biofilm, virulence, and survival in low 
iron media (Stelzer et al., 2006). Additionally, VttRA and VttRB are ToxRS homologues of non-
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O1/non-O139 serogroup strains of V. cholera that regulate bile-dependent TTSS activation, 
stress responses, and motility (Alam et al., 2010; Chaand and Dziejman, 2013).  The ToxR 
family of regulators is diverse in function and, to-date, have been largely associated with 
virulence and fitness gene regulation. 
 The specific factors that function at the grvA promoter are not presently known and, 
although a putative RcsB consensus sequence upstream of grvA was identified, direct 
transcriptional control at the grvA promoter by RcsB has not been shown. Importantly, 
overproduction of RcsB cannot activate transcription from the ler promoter in K-12 without co-
expression of grvA (Tobe et al., 2005). While the RcsB-GrvA-Ler regulatory pathway has been 
previously shown, the contribution of GrvA to the virulence of O157 strains and the specific 
mechanism through which GrvA regulates LEE gene transcription have not yet been described.  
The goals of this study were to explore the RcsB-GrvA mechanism of LEE gene activation, 
characterize the GrvA regulon in EHEC O157:H7, and explore its significance in virulence and 
stress fitness. As such, the transcriptome of GrvA was determined by RNA sequencing, and 
increased stress fitness was observed for the grvA isogenic mutant. This study further expands 
the role of GrvA in virulence of EHEC, and reveals a novel pathway for LEE gene regulation by 
GrvA, through the acid resistance regulator gadE.   
 
3.2 Methods……..…… 
3.2.1 Bacterial strains and culture conditions 
 The strains and plasmids used in this study are listed in Table 6. Strains were stocked at -
80°C in glycerol diluted (15% v/v final) in Luria Broth (LB), and were maintained in LB or on 
LB with 1.5% agar (LBA). Unless otherwise noted, overnight (18-20 h) cultures grown in LB 
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were used to inoculate fresh LB or LB buffered with sodium bicarbonate (44 mM NaHCO3) or 
fresh Dulbecco’s Modified Eagle’s Medium (DMEM) (4 g/l glucose, 4 mM glutamine, 44 mM 
NaHCO3, pH 7.4) to a final optical density 600 nm (OD600) of 0.05. Cultures were grown at 37°C 
in a rotary shaker (200 RPM) using a 1:10 media-to-flask volume. Antibiotics (Sigma-Aldrich, 
St. Louis, MO) were added to cultures when required. 
 
3.2.2 Genetic manipulations and complementation 
Primers used for genetic manipulation and complementation are listed in Table 7. For 
construction of deletion mutants and chromosomal FLAG-epitope fusions the λ-Red assisted 
one-step deletion method, adapted for EHEC, was used as described (Datsenko and Wanner, 
2000; Lippolis et al., 2009; Morgan et al., 2013). A previously published approach was used to 
construct FLAG fusions to rcsB, tir, and zinT (Morgan et al., 2013) based on the method of 
Uzzau et al. (Uzzau et al., 2001). When expressed, the fusion protein contains a seven amino 
acid C-terminal epitope (FLAG) that can be detected by western immunoblots using anti-FLAG 
mAbs (Sigma-Aldrich. St. Louis, MO). Confirmation of genetic constructs was done using a 
combination of BccI (NEB) restriction mapping and DNA sequencing (MWG Operon, 
Huntsville, AL).  
 Complementation of rcsB was performed using vector pRJM-20, as previously described 
(Morgan et al., 2013).  Additionally, a fragment containing the entire rcsDB operon, including 
the rcsD promoter region (nucleotide positions 3041665-3046191, GenBank Ref# 
NC_013008.1), was cloned into BamHI/XbaI-digested low-copy expression vector pMPM-K3 
(Kan
R
) (Mayer, 1995) using primers RcsB-3732/BamHI and RcsB+794/XbaI, to produce pRJM-
21.  To complement grvA, a PCR product corresponding to the grvA ORF and including a 267-bp 
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upstream region of grvA containing the predicted promoter (nucleotide positions 1281984-
1283134, GenBank Ref# NC_013008.1), was produced using primers GrvA-268/XhoI and 
GrvA+884/BamHI, and cloned into  XhoI/BamHI digested low-copy expression vector pMPM-
A2 (Amp
R
) (Mayer, 1995), creating pRJM-22. To create a vector expressing a C-terminal 6xHIS 
tagged variant of GrvA under the control of the native grvA promoter, a PCR product including 
the grvA ORF and a region extending 267-bp upstream and 810-bp downstream of the 
translational start site (including the predicted promoter but not the native stop codon) 
(nucleotide positions 1282059-1283134, GenBank Ref# NC_013008.1), was produced using 
primers GrvA-268/XbaI and GrvA+810/EcoRI-6xHIS, with the reverse primer containing the 
nucleotide sequence for the 6xHIS epitope. This PCR product was cloned into XbaI/EcoRI 
digested pUC19 to create pRJM-32. 
 To complement gadE, a PCR product corresponding to the gadE ORF and 762-bp 
upstream of gadE (containing the native promoters) (nucleotide positions 4458857-4460195, 
GenBank Ref# NC_013008.1) was produced using primers GadE-763/XbaI and 
GadE+577/BamHI, and cloned into the XbaI/BamHI digested vector pMPM-A2, to create pRJM-
30.   
 
3.2.3 Protein extraction, SDS-PAGE and western immunoblots 
 Protein extraction, purification and western immunoblots were performed as described 
previously (Mitra et al., 2012). The amount of protein loaded on SDS-PAGE gels for western 
blots was measured by a Bradford protein assay standard curve, and equal loading was validated 
by western blots for GroEL using anti-GroEL mAbs (Bio-Rad, Hercules, CA). Monoclonal 
antibodies against FLAG (Sigma-Aldrich, St. Louis, MO) were also used. Each experiment was 
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repeated a minimum of three times in independent trials. Densitometry was used to estimate 
differences in protein levels for select experiments using a ChemiDoc XRS+ Imaging System 
and Image Lab 3.0 (BioRad). 
  
3.2.4 RNA purification and quantitative real-time PCR (qRT-PCR) 
 Primers for qRT-PCR are provided in Table 7 in supplemental materials. RNA 
purification, cDNA synthesis, qRT-PCR cycling conditions and data analysis followed 
previously described protocols (Riordan et al., 2010). qRT-PCR was performed using a 
Realplex2 Mastercycler (Eppendorf). Cycle threshold (Ct) data were normalized to rrsH (16S 
rRNA gene) and normalized cycle threshold values (ΔCt) were transformed to arbitrary transcript 
expression levels using 2
-ΔCt
 /10
-6
 as described (Livak and Schmittgen, 2001; Mitra et al., 2012). 
Expression levels were compared statistically using the appropriate t-test or by Tukey’s HSD 
following a significant F-test (n≥3, α=0.05) (R. ver. 3.1.0).  
 
3.2.5 Construction of single copy luxE operon fusions 
 Strains containing single-copy chromosome-plasmid luxE reporter fusions were 
constructed using a protocol adapted from Shimizu et. al. (Shimizu et al., 2011). To make rcsDB-
luxE  and grvAB-luxE fusions, the kan cassette and flanking FRT sites were amplified from 
pKD4 (Datsenko and Wanner, 2000) using primers pKD4forward/SacI and 
pKD4reverse/BamHI. This product was SacI/BamHI-digested and cloned into the BamHI/SacI 
site of pMPM-T3 (Mayer, 1995) to produce pMPM-T3-kan. An XhoI/BamHI-digested PCR 
product containing the luxE gene and native RBS was amplified from placlux8 (Shimizu et al., 
2011) using primers LuxE-18/XhoI and LuxE+1,450/BamHI and cloned into the XhoI/BamHI 
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site of similarly digested pMPM-T3-kan to create pMPM-T3-luxE-kan.  For rcsDB-luxE, a luxE-
kan PCR product amplified from pMPM-T3-luxE-kan using primers RcsB+625/LuxE and 
RcsB+838/P2 and Phusion© High-Fidelity DNA Polymerase (NEB) was fused to a region 13-bp 
downstream of the rcsB ORF, and 53-bp downstream of the convergently-transcribed rcsC ORF 
(nucleotide position in TW14359) using λ Red assisted homologous recombination (Datsenko 
and Wanner, 2000). A similar approach was used to construct grvAB-luxE using primers 
GrvA+1,283/LuxE and GrvA+1,431/P2. Kanamycin resistance cassettes were removed using  
FLP recombinase as described (Datsenko and Wanner, 2000), and luxE fusion constructs were 
validated using a combination of restriction mapping and DNA sequencing (MWG Operon). lux 
operon genes luxCDAB were constitutively expressed in trans in TW14359rcsDB-luxE and 
TW14359grvAB-luxE backgrounds from pluxCDAB3 (Shimizu et al., 2011; Shimizu et al., 
2012).  
  
3.2.6 Luciferase plate assays 
 Overnight cultures grown in either LB or DMEM were used to inoculate fresh  LB 
containing 44 mM NaHCO3, or DMEM with 44 mM NaHCO3 and ampicillin (100 µg/ml) to an 
OD600=0.05. Cultures (0.2 ml) were inoculated into 96-well, clear bottom white-walled plates 
(Greiner Bio-One 655098) and incubated at 37°C in a rotary shaker (200 RPM). Luciferase and 
OD600 measurements were taken every hour for 10 hours using a Biotek Synergy 2 plate reader 
(1 sec integration) pre-warmed to 37°C. Assays were performed in quadruplicate (n=4), and 
mean luciferase activity was compared using the appropriate t-test (n=4, α=0.05) (R. ver. 3.1.0). 
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3.2.7 Electrophoretic mobility shift assay (EMSA) 
 EMSA experiments were performed as previously described (Mitra et al. 2014). Briefly, 
the forward primer used to PCR amplify rcsB from TW14359 DNA contained a new start codon 
and a 6xHis epitope tag, and the PCR product was cloned into the NcoI/XhoI sites of similarly 
digested vector pET-24d, to create pRJM-27. N-terminal 6xHis-RcsB fusion proteins have wild-
type RcsB activity (Carballes et al., 1999). N-terminal 6xHis tagged RcsB was purified from 
strain BL21(DE3)pLysS using Ni-NTA Spin Columns (Qiagen) according to the manufacturer’s 
protocol. Briefly, overnight cultures grown in LB (supplemented with 1 mM IPTG and Kan (50 
µg/ml), at 18°C and 200 rpm) were pelleted and re-suspended in 1.5 ml of Lysis Buffer (50 mM 
NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed by sonication for 3 min (50 % 
amplitude, 10 sec interval, 30 sec pause) while chilled on ice. The lysate was centrifuged at 
21,000 x g to remove insoluble cellular debris, and the supernatant was used for column 
purification, and subsequently eluted with Elution Buffer (50 mM NaH2PO4, 300 mM NaCl, 500 
mM imidazole, pH 8.0). Purified 6xHis-RcsB protein was quantified using a Bradford protein 
assay. 5’-biotin labeled primers (IDT Oligos) were used to amplify the grvA promoter region 
containing the RcsB consensus binding site. An additional fragment, with no predicted RcsB 
consensus sequence, was amplified and used as a negative binding control. Amplified biotin 
labeled probes were gel purified (QIAquick Gel Extraction Kit), and diluted to a concentration of 
0.5 ng/μl. All EMSA experiments were performed using the LightShift Chemiluminescent 
EMSA Kit (Thermo Pierce) according to the manufacturer’s specifications. Prior to 
electrophoresis, purified 6xHis-RcsB and biotin labeled fragments were co-incubated for 40 min 
in Binding Buffer (1x binding buffer, 50 ng/μl sheared salmon sperm DNA, 2.5% glycerol, 
0.05% NP-40, 5 mM MgCl2, 50 mM KCl, and 1 mM EDTA) at room temperature. Samples were 
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loaded into a pre-run and cooled, 8% native polyacrylamide gel, and run at 20 V/cm for 1 hour. 
Following electrophoresis, biotin labeled DNA was transferred (25V for 20 minutes) to a 
Biodyne B Pre-Cut Modified Nylon Membrane (Thermo Pierce) and UV crosslinked for 60 sec. 
Biotin labeled DNA fragments were detected using Streptavidin-HRP conjugated antibodies 
(1:300) in blocking buffer, and membranes were washed, equilibrated, and subsequently detected 
using luminol/enhancer solutions in a ChemiDoc XRS+ Imaging System and Image Lab 3.0 
(BioRad). 
 
3.2.8 Construction of lacZ transcriptional promoter fusions and β-galactosidase assays 
 Construction of the grvAP-lacZ reporter transcriptional fusion followed a previously 
described protocol using vector pRS551 (Morgan et al., 2013). Briefly, a 306-bp PCR product 
containing the predicted grvA promoter was amplified from TW14359 genomic DNA using 
primers GrvA-268/EcoRI and GrvA+38/BamHI, BamHI/EcoRI digested, and cloned into the 
similarly digested pRS551, resulting in pRJM-31. Four different gadEP-lacZ promoter fusions 
were created by cloning BamHI/EcoRI-digested PCR products into similarly digested pRS551 
using primers GadE-320/EcoRI and GadE-1/BamHI, GadE-276/EcoRI and GadE-516/BamHI, 
GadE-773/EcoRI and GadE-497/BamHI, and GadE-773/EcoRI and GadE-1/BamHI. β-
galactosidase activity (Miller Units) was measured as previously described and compared 
between strains using the appropriate t-test or by Tukey’s HSD following a significant F-test 
(n≥3, α=0.05) (R ver. 3.1.0) (Miller, 1972; Mitra et al., 2012).   
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3.2.9 RNA-seq and data analysis 
 RNA sequencing experiments were performed as previously described (Weiss et al., 
2014). RNA extractions were performed as described for qRT-PCR, except residual genomic 
DNA was digested using TURBO™ DNase (Ambion, cat. AM2238) following the 
manufacturers' protocol. Three independent RNA samples for each strain (TW14359, 
TW14359∆grvA, and TW14359∆rcsB∆grvA) were mixed in a 1:1:1 ratio to account for inter-
sample variability, and rRNA was removed using the MICROBExpress™ Bacterial mRNA 
Enrichment Kit (Ambion, cat. AM1905) according to instructions. The integrity and 
concentration of purified and enriched mRNA was determined using an Agilent 2100 
Bioanalyzer (Agilent Technologies). mRNA was converted to strand specific cDNA using the 
Ion Total RNA-Seq Kit v2 (Ion Torrent™, cat. 4475936) and samples were sequenced using an 
Ion Personal Genome Machine® (PGM™) System (Ion Torrent™). Sequence mapping and data 
analysis was performed using CLC Main Workbench 6 (CLC bio). Subsequent RPKM (reads per 
kilobase per million mapped reads) values were converted to fold change relative to wild-type 
TW14359 for both TW14359∆grvA and TW14359∆rcsB∆grvA. Genes of interest with an RPKM 
below the 1-RPKM cut-off were individually examined for significance between samples. 
Circular plots were created using Circos v0.65 (http://www.circos.ca) (Krzywinski et al., 2009). 
 
3.2.10 Adherence assays 
 The maintenance and culture of HT-29 colonic intestinal cells was performed as 
previously described (Morgan et al., 2013). Adherence competition indexes were determined 
using the method of Gabbianelli et al. (Gabbianelli et al., 2011).  Briefly, overnight DMEM 
cultures were used to inoculate fresh DMEM to OD600=0.05, and were incubated for 3 hours at 
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37°C with shaking (200 RPM). Cultures were then diluted to an OD600 = 0.5 and mixed in a 1:1 
ratio (test strain:control strain), and  200 μl of each was used to inoculate HT-29 cells in 6-well 
culture plates. For the control strain, the entire lacZ ORF was deleted in TW14359 to produce a 
strain incapable of utilizing lactose, for use in differential selection in competition assays. Each 
plate was gently mixed before centrifugation at 500 x g for 5 min and then incubated as above. 
Following 3 h of incubation, each well was washed four times using sterile PBS to remove non-
adherent cells and adherent cells were removed using 500 μl of 0.1% Triton X-100. Cells were 
enumerated (CFU/ml) by serial dilution in PBS and plating onto MacConkey agar, which is a 
differential media used to indicate lactose utilization. After overnight growth on MacConkey 
agar, pink colonies (Lac+) were scored as test strain CFU/ml, whereas white colonies (Lac-) 
were scored as TW14359ΔlacZ CFU/ml. The competitive index was derived by dividing 
CFU/ml of the test strain by the CFU/ml of TW14359∆lacZ, and was compared statistically 
using the appropriate t-test (n≥3, α=0.05) (R ver. 3.1.0).    
  
3.2.11 Acid resistance assays 
 Acid resistance by the glutamate-dependent system was measured as described (Riordan 
et al., 2010) with slight adaptations. Mid-exponential phase (OD600=0.5)  DMEM cultures were 
inoculated to 10
6
 CFU/ml final cell density in E minimal glucose (EG) media with or without 5.7 
mM L-glutamate at pH 7 (control) or acidified with HCl (pH 2). For cell counts (CFU/ml) and 
percent survival determinations, samples were serially-diluted in PBS (pH 7), plated to LBA and 
incubated overnight at 37°C. 
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3.3 Results……. 
3.3.1 Expression profiles of the rcsDB and grvAB operons, and molecular basis for grvA 
activation by RcsB 
 Previous work has shown RcsB to be an activator of grvA, and that both factors are 
required for bicarbonate-dependent upregulation of the LEE-encoded regulator, Ler, and 
subsequent stimulation of LEE expression in EHEC (Tobe et al; Morgan et al 2013). RcsB is 
predicted to act upstream of grvA in the regulation of ler, yet the mechanism underlying the 
control of grvA by RcsB is as yet unknown. In addition, the expression profile for both rcsDB 
and grvAB operons under LEE-inducing conditions has not been determined 
 In both DMEM and LB, expression of rcsDB was highest during exponential phase 
growth as measured by luciferase activity (Fig. 15A). For DMEM, rcsDB expression declined 
during transition into stationary phase (after 3 h growth), but for LB, expression declined earlier 
(after 1 h growth) and during exponential phase. For both DMEM and LB, rcsDB expression 
continued to decline into stationary phase. The expression of rcsDB was significantly higher (2- 
to -4-fold) in DMEM over the course of the first 6 h of growth compared to LB (p<0.05) (Fig. 
15A). Addition of bicarbonate to LB increased rcsDB expression during early exponential 
growth (1 h) (p=0.001), however levels were still significantly less than that observed for 
DMEM at the same time point (p<0.001 and Fig. 15A). Furthermore, during the later stages of 
growth (5–10 h), rcsDB expression in LB with bicarbonate was significantly lower than LB. This 
suggests that, while bicarbonate is able to stimulate rcsDB transcription, growth in DMEM leads 
to markedly higher levels of rcsDB transcription during early stages of growth.  Finally, this data 
indicates that bicarbonate stimulation of rcsDB expression in LB is dependent on growth-phase. 
 Like rcsDB, grvAB expression was growth-phase dependent. In both DMEM and LB, 
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Figure 15 - Temporal expression of rcsDB and grvAB operons in TW14359 
Analysis of rcsB promoter activity and temporal expression of the rcsDB and grvAB operons in 
TW14359. Luciferase activity of (A) rcsDB-luxE and (B) grvAB-luxE strains containing plasmid 
pluxCDAB3, measured over 10 hours, in DMEM with 44 mM bicarbonate (triangle), LB (diamond), and 
LB with 44 mM bicarbonate (square). RLU values are a function of total luciferase activity divided by 
OD600 measurements at each time point. The OD600 valuse of all cultures are indicated by dashed lines. 
The means at each time point varied by less than 10% for each sample. (C) Representative western blot 
for RcsB-FLAG grown to mid-exponential phase (OD600=0.5) in LB, LB supplemented with 44 mM 
bicarbonate, and DMEM. Non-specific binding was used as to control for loading. (D) Schematic diagram 
for the construction of chromosomal rcsDB- and grvAB-luxE fusions in TW14359. 
 
 
 
 
 
78 
 
expression peaked during early exponential phase, declining rapidly between 1-2 h growth to 
substantially lower levels of expression for the remaining course of the experiment (2-10 h) (Fig. 
15B). As for rcsDB, grvAB expression was significantly higher (1.5- to 3.5-fold) in DMEM 
compared with LB up until transition to stationary phase (0-4 h) (p<0.05). Bicarbonate addition 
to LB increased grvAB expression slightly during early exponential growth, however for 
stationary-phase cultures, levels were significantly less in LB with bicarbonate (p<0.05, 5-10 h) 
(Fig. 15B). The patterns of rcsDB and grvAB expression were consistent with cytosolic levels of 
RcsB during exponential (OD600=0.5, or 2 h) growth, with higher levels of proteins observed in 
LB with HCO3, and substantially higher levels during growth in DMEM (Fig. 15D). This data 
indicates that GrvA controls several genes, including those involved in colonization and acid 
resistance, but also includes a number of genes which are not associated with virulence directly.  
 While RcsB has been shown to upregulate grvA (Tobe et al., 2005), the mode of 
activation is not known. Overexpression of rcsDB in trans in a grvAB-luxE reporter background 
(strain EcRJM105) substantially increased RLUs of luciferase (Fig. 16A), suggesting that RcsB 
is working directly on the promoter of grvAB for activation. Consistent with this, two putative 
RcsB boxes were identified in tandem and proximal to a predicted -35 site (nucleotides 1282968-
1282982 in TW14359) of the grvA promoter (grvAP) (Wehland and Bernhard, 2000) (Tobe et al., 
2005) (Fig. 16B). To test this hypothesis, purified RcsB was co-incubated with a fragment of the 
core grvAP element including the putative RcsB boxes and analyzed using electrophoretic 
mobility shift assays (EMSA). As anticipated, the 235-bp grvAP fragment was visibly shifted 
with the addition of increasing amounts (1-12 μg) of purified RcsB, while no shift was observed 
for the control fragment (Fig. 16C). Based on these findings, it is predicted that RcsB is a direct 
transcriptional activator of grvA and that activation occurs at the grvA promoter region 
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Figure 16 - Direct transcriptional regulation of grvA by RcsB 
(A) Luminesence was visualized from strain TW14359 grvAB-luxE pluxCDAB3 with empty vector 
pMPM-K3 or vector pMPM-rcsDB. Empty vector and rcsDB expressing strains were streaked onto an 
LBA plate and incubated at 37°C for 8 hours before detection. (B) Genomic DNA sequence upstream of 
grvA ORF containing the putative sigma-70 promoter (grey fill), RcsB consensus binding sites 
(unerlined), and grvA translational start site (bold italics) (C) Electrophoretic mobility shift assay for 
biotinylated grvA promoter fragments containing an (bottom left) RcsB consensus sequence and (bottom 
right) no consensus sequence. RcsB concentration was increased from 1 to 12 μg for the fragment 
containing the  RcsB consensus binding site, and at 12 μg for the fragment with no consensus binding 
site. The arrow indicates location of the shifted grvA sequence. 
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containing at least one RcsB box.  
 
3.3.2 The GrvA regulon of EHEC 
While GrvA clearly contributes to the regulation of Ler (Tobe et al 2005; Morgan et al 2013), the 
precise mechanism by which it upregulates the LEE and the breadth of genes controlled by GrvA 
is unknown. To determine this, the transcriptome of EHEC O157:H7 strain TW14359 and its 
grvA isogenic derivative (TW14359ΔgrvA) was measured by RNA-seq analysis during 
exponential growth (OD600=0.5) in DMEM. As RcsB is a direct activator of grvA (above) and 
required for GrvA-dependent control of the LEE (Tobe et al; Morgan et al), the transcriptome of 
TW14359ΔrcsBΔgrvA was measured in parallel.  
 In TW14359ΔgrvA, 765 genes were altered in expression >2-fold above the RPKM 
cutoff when compared to TW14359 (Fig. 17A and 17B); of these, 264 were upregulated and 501 
were downregulated. Gene ontologies were determined based on known and predicted gene 
product function and included 31% as cellular and metabolic roles (74 up; 162 down), 9% as 
known or predicted regulators (23 up; 45 down), and 8% involved in transport (18 up; 42 down) 
(Table 4). For those genes in which GrvA is dependent on rcsB for regulation, it was expected 
that the direction and magnitude of expression would not differ between TW14359ΔgrvA and 
TW14359ΔgrvAΔrcsB backgrounds. Of the genes differentially expressed in TW14359ΔgrvA, 
33% (250/765) were similarly altered in expression for TW14359ΔgrvAΔrcsB (Table 4; Fig. 
17A and 17B).  However, while 63% (485/765) of genes altered in TW14359ΔgrvA were 
unchanged in TW14359ΔgrvAΔrcsB, 4% (30/765) were altered in the opposite direction. 
Specifically, 13 genes which were upregulated in TW14359ΔgrvA were down in  
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Figure 17 - Circular plot of RNA-Seq in EHEC strain TW14359 and mutant derivatives 
(A) Circular plots represent data from RNA sequencing of strains TW14359, TW14359∆grvA, and 
TW14359∆grvA∆rcsB. Plots represent data and information as follows: (outer, black) Numeric genomic 
location based on nucleotide position. Heatmaps of fold change in expression for TW14359∆grvA (outer) 
and TW14359∆grvA∆rcsB (inner), with select key locations indicated with black arrows; fold changes 
represented as the wild type RPKM divided by the mutant derivative RPKM value for each gene. The 
inner three histograms represent the RPKM of TW14359 (black), TW14359∆grvA (red), and 
TW14359∆grvA∆rcsB (blue). Circular plots created using Circos v0.65 (http://www.circos.ca). (B) Venn 
diagram representing the number of genes up- or down-regulated by at least 2-fold between TW14359 
(blue), TW14359∆grvA (grey), and TW14359∆grvA∆rcsB (red). (C) Ontological grouping of genes 
influenced by GrvA in TW14359. A total of 765 genes showed at least 2-fold alteration up (red) or down 
(blue) in expression, and  genes are grouped by their known or predicted ontologies. 
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Table 4 - RNA-seq transcriptome data 
ECSP ID
a Gene ∆grvA ∆grvArcsB Description
ECSP_4665 espF -3.08 -1.18 LEE-encoded type III secreted effector
ECSP_4666 orf29 -3.36 -5.13 LEE-encoded predicted type III secretion system factor
ECSP_4667 escF -5.79 -5.06 LEE-encoded type III secretion system component
ECSP_4668 cesD2 -8.31 -5.08 predicted chaperone
ECSP_4669 espB -6.55 -5.82 secreted protein EspB
ECSP_4670 espD -4.49 -3.85 secreted protein EspD
ECSP_4671 espA -4.39 -4.31 secreted protein EspA
ECSP_4672 sepL -4.53 -5.69 LEE-encoded type III secretion system component
ECSP_4673 escD -4.03 -3.36 LEE-encoded type III secretion system component
ECSP_4674 eae -4.76 -2.91 intimin adherence protein
ECSP_4675 cesT -5.95 -3.98 molecular chaperone
ECSP_4676 tir -4.01 -3.10 translocated intimin receptor protein
ECSP_4677 map -4.42 -3.48 type III secreted effector protein
ECSP_4678 cesF ND (-) -1.08 chaperone for type III secretion of EspF
ECSP_4679 espH -4.79 -5.49 LEE-encoded type III secreted effector
ECSP_4680 escQ -1.91 -2.79 LEE-encoded type III secretion system factor
ECSP_4681 orf16 -8.06 -6.16 LEE-encoded predicted type III secretion system factor
ECSP_4682 orf15 -1.21 -6.16 LEE-encoded predicted type III secretion system factor
ECSP_4683 escN -2.70 -1.69 LEE-encoded type III secretion system factor
ECSP_4684 escV -2.29 -3.59 LEE-encoded type III secretion system factor
ECSP_4685 orf12 -1.26 ND (-) LEE-encoded predicted type III secretion system factor
ECSP_4686 espZ -3.48 -1.85 translocated effector protein
ECSP_4687 escI -1.28 1.09 LEE-encoded predicted type III secretion system component
ECSP_4688 escJ -2.80 -4.53 LEE-encoded type III secretion system factor
ECSP_4689 sepD -1.26 -1.93 LEE-encoded type III secretion system component
ECSP_4690 escC -1.73 -2.38 type III needle complex subunit
ECSP_4691 cesD -1.08 -5.78 LEE-encoded type III secretion system factor
ECSP_4692 grlA -1.11 -4.62 LEE-encoded positive regulator of transcription
ECSP_4693 grlR -1.93 -2.72 LEE-encoded negative regulator of transcription
Fold Change
b
LEE PAI genes, and non-LEE encoded effectors
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ECSP_4694 etgA -1.51 ND (-) predicted lytic transglycosylase
ECSP_4695 escU ND (+) 1.02 LEE-encoded type III secretion system factor
ECSP_4696 escT ND (-) -2.70 LEE-encoded type III secretion system factor
ECSP_4697 escS 3.97 -1.54 LEE-encoded type III secretion system factor
ECSP_4698 escR -1.64 ND (-) LEE-encoded type III secretion system factor
ECSP_4699 escL -2.94 -3.85 LEE-encoded predicted type III secretion system factor
ECSP_4700 orf4 -1.83 -4.47 LEE-encoded type III secretion system factor
ECSP_4701 cesA -1.01 1.14 LEE-encoded chaperone
ECSP_4702 escE -1.13 -2.60 LEE-encoded type III secretion system factor
ECSP_4703 ler -2.45 -2.33 locus of enterocyte effacement (LEE)-encoded regulator
ECSP_4704 espG -3.69 -1.61 LEE-encoded type III secreted effector
ECSP_4705 rorf1 -1.01 ND (-) LEE-encoded type III secretion system factor
ECSP_0061 espY1 1.98 3.25 non-LEE-encoded type III secreted effector
ECSP_0866 nleC -2.27 -3.08 non-LEE-encoded type III secreted effector
ECSP_0868 nleD -1.66 -1.97 non-LEE-encoded type III secreted effector
ECSP_1702 nleA -4.03 -2.46 non-LEE-encoded type III secreted effector
ECSP_1704 nleH2 2.25 1.21 non-LEE-encoded type III secreted effector
ECSP_1705 nleF -3.69 -3.99 non-LEE-encoded type III secreted effector
ECSP_3954 nleE -4.03 -4.11 non-LEE-encoded type III secreted effector
ECSP ID Gene ∆grvA ∆grvArcsB Description
ECSP_0704 gltL -3.89 -4.56 glutamate and aspartate transporter subunit, ATP-binding 
component of ABC superfamily
ECSP_0705 gltK -3.02 -3.29 glutamate and aspartate transporter subunit, membrane 
component of ABC superfamily
ECSP_0706 gltJ -2.49 -2.99 glutamate and aspartate transporter subunit, membrane 
component of ABC superfamily
ECSP_0707 gltI -2.98 -2.39 glutamate and aspartate transporter subunit, periplasmic-
binding component of ABC superfamily
ECSP_0906 glnQ -2.35 -2.06 glutamine transporter subunit; ATP-binding component of 
ABC superfamily
Metabolism and Acid Resistance
Table 4 - RNA-seqtTranscriptome data, continued.
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ECSP_0907 glnP -2.33 -1.24 glutamine transporter subunit; membrane component of 
ABC superfamily
ECSP_0908 glnH -1.51 -1.36 glutamine transporter subunit; periplasmic binding 
component of ABC superfamily
ECSP_1977 gadC 15.63 1.79 predicted glutamate:gamma-aminobutyric acid antiporter
ECSP_1978 gadB 14.58 1.30 glutamate decarboxylase B, PLP-dependent
ECSP_2312 astE -4.03 -2.93 succinylglutamate desuccinylase
ECSP_2313 astB -5.95 -5.34 succinylarginine dihydrolase
ECSP_2314 astD -9.07 -5.74 succinylglutamic semialdehyde dehydrogenase
ECSP_2315 astA ND (+) -11.87 arginine succinyltransferase
ECSP_2316 astC -66.00 -11.40 succinylornithine transaminase, PLP-dependent
ECSP_2329 gdhA -1.84 -2.32 glutamate dehydrogenase
ECSP_3185 argT -3.53 -1.78 lysine/arginine/ornithine transporter subunit, periplasmic-
binding component of ABC superfamily
ECSP_4065 uxaA 1.69 4.10 altronate hydrolase
ECSP_4066 uxaC 1.76 4.91 uronate isomerase
ECSP_4486 slp 1.98 3.56 outer membrane lipoprotein
ECSP_4498 hdeB ND (+) 1.00 acid-resistance protein
ECSP_4499 hdeA ND (+) ND (+) stress response protein acid-resistance protein
ECSP_4500 hdeD ND (+) ND (+) acid-resistance membrane protein
ECSP_4501 gadE ND (+) ND (+) acid-induced positive regulator of glutamate-dependent acid 
resistance
ECSP_4502 mdtE ND (+) ND (+) multidrug resistance efflux transporter
ECSP_4503 mdtF ND (+) ND (+) multidrug transporter, RpoS-dependent
ECSP_4504 gadW ND (+) ND (+) DNA-binding transcriptional activator
Table 4 - RNA-seq transcriptome data, continued.
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ECSP_4505 - 1.00 1.00 hypothetical protein
ECSP_4506 gadX ND (+) ND (+) DNA-binding transcriptional dual regulator
ECSP_4507 gadA ND (+) ND (+) glutamate decarboxylase A, PLP-dependent
ECSP_4508 yhjA 1.00 ND (+) predicted cytochrome C peroxidase
ECSP_4509 treF ND (+) ND (+) cytoplasmic trehalase
ECSP_4510 yhjB 1.00 ND (+) predicted DNA-binding response regulator in two-
component regulatory system
ECSP_4511 yhjC ND (+) ND (+) predicted DNA-binding transcriptional regulator
ECSP_4512 yhjD ND (+) ND (+) conserved inner membrane protein
ECSP_4513 yhjE 87.33 159.09 predicted transporter
ECSP_4921 - ND ND (+) hypothetical protein
ECSP_4922 - -1.06 1.44 hypothetical protein
ECSP_4923 glnG -3.74 -5.30 fused DNA-binding response regulator in two-component 
regulatory system
ECSP_4924 glnL -3.71 -7.85 sensory histidine kinase in two-component regulatory 
system with GlnG
ECSP_4925 glnA -4.32 -6.22 glutamine synthetase
ECSP_0518 glnK ND (+) ND (+) nitrogen assimilation regulatory protein for GlnL, GlnE, and 
AmtB
ECSP_0519 amtB -74.77 -69.89 ammonium transporter
ECSP_4793 asnC -2.02 -4.62 DNA-binding transcriptional dual regulator
ECSP_4794 asnA -4.97 -6.59 asparagine synthetase A
ECSP_0721 asnB -7.58 -6.67 asparagine synthetase B
ECSP_2651 cbl -4.79 -10.97 DNA-binding transcriptional activator of cysteine 
biosynthesis
Table 4 - RNA-seq transcriptome data, continued.
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ECSP_2652 nac -63.48 -21.56 DNA-binding transcriptional dual regulator of nitrogen 
assimilation
ECSP_3790 galR -2.05 1.20 DNA-binding transcriptional repressor
ECSP_3791 lysA -4.28 -3.59 diaminopimelate decarboxylase, PLP-binding
ECSP_3792 lysR -2.77 1.65 DNA-binding transcriptional dual regulator
ECSP ID Gene ∆grvA ∆grvArcsB Description
ECSP_0334 ykgL ND (+) ND (+) predicted protein
ECSP_0335 rpmJ 170.69 438.30 putative second copy of 50S ribosomal protein L36
ECSP_0336 rpmE2 565.67 1205.82 Zn(II)-responsive ribosomal protein
ECSP_0622 cusS -1.30 -1.61 sensory histidine kinase in two-component regulatory 
system with CusR, senses copper ions
ECSP_0623 cusR 1.07 -1.79 DNA-binding response regulator in two-component 
regulatory system with CusS
ECSP_0624 cusC -1.04 -1.67 copper/silver efflux system, outer membrane component
ECSP_0625 cusF -1.79 -5.08 periplasmic copper-binding protein
ECSP_0626 cusB -1.35 -5.78 copper/silver efflux system, membrane fusion protein
ECSP_0627 cusA -1.41 -6.60 copper/silver efflux system, membrane component
ECSP_0731 fur 1.69 6.09 DNA-binding transcriptional dual regulator of siderophore 
biosynthesis and transport
ECSP_2430 yebA 4.47 11.31 predicted peptidase
ECSP_2431 znuA 17.68 39.94 High-affinity zinc uptake system periplasmic protein
ECSP_2432 znuC 2.48 6.41 High-affinity zinc uptake system ATP-binding protein
ECSP_2433 znuB 4.23 9.00 High-affinity zinc uptake system membrane protein
Metal Stress Response and Import/Export
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ECSP_2579 zinT 163.75 484.95 conserved metal-binding protein
ECSP_4263 zntR -1.15 -1.17 DNA-binding transcriptional activator in response to Zn(II)
ECSP_4425 zntA -1.39 -3.45 zinc, cobalt and lead efflux system
ECSP ID Gene ∆grvA ∆grvArcsB Description
ECSP_1968 ddpF 1.10 1.80
D-ala-D-ala transporter subunit, ATP-binding component of 
ABC superfamily
ECSP_1969 ddpD 1.49 1.62
D-ala-D-ala transporter subunit, ATP-binding component of 
ABC superfamily
ECSP_1970 ddpC 1.59 -1.93
D-ala-D-ala transporter subunit, membrane component of 
ABC superfamily
ECSP_1971 ddpB -6.55 -20.02
D-ala-D-ala transporter subunit, membrane component of 
ABC superfamily
ECSP_1972 ddpA -28.72 -6.75
D-ala-D-a la transporter subunit, periplasmic-binding 
component of ABC superfamily
ECSP_1973 ddpX ND (-) -15.40 D-ala-D-ala dipeptidase, Zn-dependent
ECSP_2574 yedV -1.82 -1.78
predicted sensory kinase in two-component regulatory 
system with YedW
ECSP_2575 yedW 1.00 -5.56
predicted DNA-binding response regulator in two-
component system with YedV
ECSP_5434 yjiA 2.78 1.91 predicted GTPase
ECSP_5435 yjiX 27.79 25.32 conserved protein
ECSP_5436 yjiY 3.81 3.00 predicted inner membrane protein
ECSP_2492 - -2.36 -16.79 hypothetical protein
ECSP_4094 - -1.87 -25.76 hypothetical protein
For inclusion, genes were selected with a fold change greater than 2 in either the single or double mutant strains. 
Additionally, genes that are part of an operon were included, with their respective fold change and RPKM data, 
if a component gene was notably altered in expression.
Other Functions
Table 4 - RNA-seq transcriptome data, continued.
a 
Protein/gene names and open reading frame (ORF) IDs based on EHEC strain TW14359                     (accession 
#XXX, NCBI) and K-12 strain MG1655 (EcoCyc, REF).
b 
fold change calculated as either wild-type RPKM value divided by the mutant strain RPKM value.
c 
RPKM denotes Reads Per Kilobase per Million mapped reads
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TW14359ΔgrvAΔrcsB, and 17 were downregulated in TW14359ΔgrvA were upregulated in 
TW14359ΔgrvAΔrcsB.    
In agreement with the role of GrvA in ler activation, 21 LEE-encoded genes were 
downregulated in TW14359ΔgrvA, including ler, the translocon genes espA, espB and espD, 
eaeA (intimin) and tir (translocated intimin receptor) (Table 4; Fig. 17). As anticipated, LEE 
expression was also decreased in TW14359ΔrcsBΔgrvA compared to TW14359, but was not 
further decreased when compared to TW14359ΔgrvA. Decreased transcription of ler in 
TW14359ΔgrvA and TW14359ΔrcsBΔgrvA was validated by qRT-PCR, and complementation 
of grvA was shown to restore ler expression to wild-type levels (Table 5).   
 Interestingly, genes encoded within the 15 kb genomic acid fitness island (AFI), the 
products of which are required for survival at low pH (Foster, 2004), were upregulated in 
TW14359ΔgrvA when compared to TW14359, in which the expression of AFI genes was barely 
detectable (Fig. 17; Table 4). Most notably, genes of the glutamate-dependent acid resistance 
(GDAR) system were upregulated, including gadA, gadE, gadW, gadX, and the non-AFI 
encoded gadCB operon. Increased transcription of gadE, encoding the central regulator of 
GDAR, was validated through qRT-PCR, and complementation with grvA was shown to restore 
gadE expression to levels observed for TW14359 (Table 5). While there was no difference in 
gadE and gadW expression between TW14359ΔgrvA and TW14359ΔrcsBΔgrvA,  the expression 
of gadA, gadBC, and hde genes was markedly reduced in TW14359ΔrcsBΔgrvA compared to 
TW14359ΔgrvA (Table 4). This observation likely reflects the fact that RcsB directly activates  
transcription from the promoters of these genes as a heterodimer with GadE (Castanie-Cornet et 
al., 2010; Johnson et al., 2011), and suggests that the effect of grvA deletion on the expression of 
GDAR genes is independent of rcsB. 
89 
 
  
 
 
 
 
 
Table 5 - qRT-PCR validation of RNA-seq data 
 Strain Expression Unitsa 
Gene
b
: ler gadE astC znuA 
TW14359 1054.77 (51.81) 0.18 (0.06) 111.56 (1.55) 8.02 (2.34) 
∆grvA 78.28 (21.68) 61.11 (8.22) 1.21 (0.67) 551.15 (150.90) 
∆rcsB∆grvA  127.97 (33.65) 87.87 (4.10) 2.5 (1.49) 622.03 (46.05) 
∆grvA pgrvA 556.98 (180.36) 12.94 (0.81) 6.87 (2.24) 20.46 (8.28) 
a 
Expression units for each gene were calculated relative to rrsH expression, and 
standard deviation is in parentheses. 
b 
Gene names IDs based on EHEC strain TW14359 (accession #NC_013008.1, NCBI) 
 
Table 5:  qRT-PCR validation of RNA-seq data   
Select genes (ler, gadE, astC, and znuA) were validated through qRT-PCR from exponential phase 
(OD600=0.5) DMEM cultures.  Numbers represent the expression units for each gene in the noted strain, 
with the standard deviation listed adjacently in parentheses.  Each value represents the average of three 
independent experiments (n=3). 
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Genes for zinc binding, transport and resistance to zinc and other metals including znuA, znuCB, 
zinT (formerly yodA), rpmE2, rpmJ, ykgL, and yebA  (Ferianc et al., 1998; Hensley et al., 2012; 
Kershaw et al., 2007) were upregulated in TW14359∆grvA and TW14359ΔrcsBΔgrvA compared 
to TW14359 (Fig. 17, Table 4); for rpmE2, expression was increased by >500-fold in 
TW14359∆grvA and TW14359ΔrcsBΔgrvA. Increased expression of znuC, encoding a high 
affinity zinc uptake protein, was validated by qRT-PCR, and expression was restored with 
complementation (Table 5). This data indicates that GrvA controls several genes, including 
those involved in colonization and acid resistance, but also includes a number of genes which are 
not associated with virulence directly.   
  
3.3.3 GrvA/GadE control of ler and adherence to HT-29 colonic epithelial cells 
RNAseq analysis revealed that deletion of grvA leads to the de-repression of gadE, a recognized 
transcriptional repressor of the LEE-encoded regulator, ler (Kailasan Vanaja et al., 2009). It was 
thus of interest to determine if this interaction between grvA and gadE was the underlying 
mechanism by which GrvA controls LEE expression and influences adherence. In 
TW14359∆grvA, ler expression was observed to be significantly reduced compared to TW14359 
and TW14359∆gadE (p<0.05), but was increased to near wild-type levels in 
TW14359∆grvA∆gadE (Fig. 18A). In addition, complementation of TW14359∆grvA∆gadE with 
gadE constitutively expressed restored ler transcript levels to that observed for TW14359∆grvA.  
These findings are in agreement with GadE dependent repression of ler, and support a hypothesis 
in which GrvA activation of ler is directed through the repression of gadE. 
 The effect of grvA and gadE interaction on in-vitro adherence was determined by a 
competition assay. Strains were co-incubated in a 1:1 ratio with HT-29 intestinal cells, followed 
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Figure 18 - Analysis of the gadE dependent GrvA regulation of ler and competitive adherence to 
HT-29 colonic epithelial cells 
(A) ler transcript levels plotted for TW14359, TW14359ΔgrvA, TW14359ΔgadE, 
TW14359ΔgrvAΔgadE, complement strain TW14359ΔgadE pgadE,  and complement strain 
TW14359ΔgrvAΔgadE pgadE grown in DMEM (OD600=0.5). Plots which differ by lower case letter, 
differ significantly by Tukey’s HSD following a significant F-test (p<0.05, n≥3). Error bars denote 
standard deviation. (B) Competitive adherence to confluent monolayers of HT-29 colonic epithelial cells 
was determined for each strain; adherence was assessed for cultures following 3 hours of co-incubation 
with HT-29 cells and EHEC strains mixed in a 1:1 ratio with TW14359∆lacZ.  Bars represent the ratio of 
CFU/ml recovered for the strain indicated divided by the CFU/ml of TW14359∆lacZ, as determined by 
serial dilution and enumeration on MacConkey agar. Asterisks denote significance compared with 
TW14359, as determined using the Student’s t-test (*, p<0.05; **, p<0.01; ***, p<0.001); Error bars 
denote standard deviation. 
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by plating and enumeration on MacConkey differential media. The control strain 
(TW14359∆lacZ) was Lac-, and thus colonies on MacConkey were white, whereas test strains 
(TW14359 and mutant derivatives) were Lac+, and colonies were thus pink. An adherence index 
was determined for each test strain from plate counts as the ratio of CFU/ml for the test strain 
relative to TW14359∆lacZ.  
Consistent with the effect of grvA and gadE interaction on LEE expression, the adherence 
index of TW14359∆grvA was significantly decreased when compared to TW14359, 
TW14359∆gadE, and grvA complemented strain TW14359∆grvA pgrvA (p<0.05) (Fig. 18B). In 
strains where gadE was expressed constitutively in-trans (plasmid pgadE), the adherence index 
was uniformly reduced to levels lower than in all other strains, including TTSS-defective strain 
TW14359∆escN (p<0.001) (Fig. 18B). These experiments reveal that GrvA-dependent 
regulation of ler and adherence to intestinal cells is dependent on an intact gadE gene and are in 
agreement with a hypothesis in which control of the LEE and LEE-dependent adherence by 
GrvA is directed through the repression of gadE. 
 
3.3.4 Effect of grvA mutation on gadE promoter activity 
GadE is a negative regulator of LEE expression, acting directly on the LEE1 promoter to repress 
ler transcription (Kailasan Vanaja et al., 2009; Tree et al., 2011). Since GrvA requires gadE for 
LEE activation, it was of interest to define cis elements of the gadE promoter region, which 
encompasses over 1-kb of DNA upstream of the ORF, needed for this control. To determine this,  
transcription from four different gadE promoter lacZ reporter constructs (Fig. 19A bottom) in 
TW14359 and TW14359ΔgrvA were compared during exponential and stationary phase growth 
in DMEM. During exponential growth, transcription from gadEP1-P3-lacZ containing  
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Figure 19 - Investigating the individual contribution of gadE promoters using promoter lacZ 
fusions 
β-galactosidase activity in Miller Units for TW14359 and mutant derivatives containing a gadEP-lacZ 
fusion during growth in DMEM. (A) (top) Activity measured at an OD600=0.5 (exponential phase) and 
OD600=2 (stationary phase) for TW14359 and TW14359∆grvA.  (bottom) Relative location of amplified 
P1, P2, P3, and P1P2P3 gadE promoter fragments, with location of individual promoters indicated with 
black arrows; relative location of mapped RNA-seq transcripts are aligned roughly with their relative 
position in the above gadE promoter diagram. (B and C) Activity measured at an OD600=0.5 (exponential 
phase) for TW14359, TW14359∆grvA, and TW14359∆grvA∆gadE with a gadE promoter fusion 
containing the P1 and P3 fragments, respectively. Asterisks denote significance by a Student’s t-test 
(p<0.05, n≥3).  Error bars indicate standard deviation for all panels. 
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all three (P1 though P3) gadE promoters was significantly increased in TW14359∆grvA 
compared to TW14359 (p=0.002) (Fig. 19A). Promoter activity from fragments containing the 
P1 (gadEP1-lacZ) or P3 (gadEP3-lacZ) promoters alone were also significantly higher in 
TW14359∆grvA (p<0.05), while activity from the fragment containing only the P2 promoter 
(gadEP2-lacZ) did not differ between TW14359∆grvA and TW14359. As anticipated, promoter 
activity from all fragments increased significantly during stationary growth for TW14359 
(p<0.001), however only slightly for P2 (p<0.001) (Fig. 19A). For TW14359∆grvA, promoter 
activity only further increased from P1 during stationary phase (p=0.015), and was higher than 
P1 activity in TW14359. This latter observation was predicted to be due to auto-activation of the 
P1 promoter by GadE, as previously shown (Ma et al., 2004). Indeed, the deletion of gadE in 
TW14359∆grvA completely abrogated P1 activation during exponential growth, but had no 
effect on P3 activity (Fig. 19B and 19C). Based on these findings it is predicted that GrvA-
dependent repression of gadE transcription is directed solely through the P3 promoter.  
 Transcription from the gadE P3 promoter is directly controlled by the AFI encoded 
regulators GadX and GadW (Sayed et al., 2007), and RNAseq analysis of TW14359∆grvA 
revealed both genes to be elevated in expression when compared to TW14359 (Table 5). It was 
thus suspected that repression of P3 by GrvA was mediated through one or both of these 
regulators. To test this, the effect of gadX and gadW deletion in TW14359∆grvA on P3 activity 
during exponential growth (OD600=0.5) in DMEM was measured. Only the deletion of gadW was 
observed to reduce transcription from P3. Activity from P3 in TW14359∆gadW and 
TW14359∆grvA∆gadW was reduced significantly compared to TW14359∆grvA (p=0.01 and 
0.03, respectively), but not when compared to TW14359 (Fig. 20). Conversely, P3 activity was  
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Figure 20 - Investigating the contribution of GadX and GadW to increased gadE promoter activity 
β-galactosidase activity in Miller Units for TW14359 and mutant derivatives containing a gadEP3-lacZ 
fusion during growth in DMEM. Activity measured at an OD600=0.5 (exponential phase) for either (A) 
TW14359, TW14359∆grvA, TW14359∆grvA∆gadX, and TW14359∆grvA∆gadW or (B) TW14359, 
TW14359∆grvA, TW14359∆grvA∆gadW, and TW14359∆gadW with a gadE promoter fusion containing 
the P3 fragment. Plots which differ by lower case letter, differ significantly by Tukey’s HSD following a 
significant F-test (p<0.05, n=3).  Error bars denote standard deviation. 
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slightly but significantly increased in TW14359∆grvA∆gadX when compared to TW14359∆grvA 
(p=0.01) (Fig. 20). Taken together, this data indicates that GrvA indirectly represses 
transcription from the gadE P3 promoter during exponential growth in a manner that is 
dependent on gadW. 
 
3.3.5 Acid Resistance experiments in TW14359 and grvA mutant strains 
The expression of glutamate-dependent acid resistance (GDAR) genes is growth phase 
dependent; it is low during exponential growth and increases markedly as cells transition into 
stationary phase (Castanie-Cornet et al., 1999). Correspondingly, exponential phase cultures are 
generally acid susceptible, while stationary phase cultures are acid resistant. Since deletion of 
grvA was shown to de-repress the GadW pathway activating gadE during exponential growth 
(Table 4), the contribution of GrvA to the GDAR was determined for exponential cultures and 
was compared to that of the GDAR phenotype of stationary phase cultures.  
 As expected, no colonies of wild-type TW14359 could be recovered on LBA after a 1 h 
exposure of exponential cultures to acidified EG media (pH 2) (Fig.21A). However for strain 
TW14359∆grvA, in which GDAR genes are de-repressed during exponential growth, 400 
CFU/ml were recovered, representing 9% of the original inoculum. Complementation of 
TW14359∆grvA with grvA restored wild-type levels of acid sensitivity (Fig. 21A). While GDAR 
genes are upregulated in TW14359∆grvA during exponential growth, the deletion of rcsB in 
TW14359∆grvA counteracts this effect for GDAR structural genes gadA and gadBC (Fig. 17). 
Decreased expression of these genes in TW14359∆grvA∆rcsB was shown to correspond with a 
complete loss of the GDAR phenotype during exponential growth in DMEM (Fig. 21A).  
 Complementation with rcsB expressed from a low-copy vector and under the control of  
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Figure 21 - GrvA dependent exponential phase acid resistance phenotype 
Representative experiments for acid resistance in TW14359 and mutant derivative strains during 
exponential (top) and stationary (bottom) growth.  Each plate represents 10-fold microdilutions of control 
or acid challenged (pH 2.0) samples for each strain before and after acid challenge for 1 hour.   
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its native promoters restored GDAR in TW14359∆grvA∆rcsB, but not in TW14359∆rcsB, 
suggesting that expression of the phenotype requires an rcsB+ grvA¯ background. During 
stationary phase, deletion and complementation of grvA had no effect on survival in acid with 
100% of the initial inoculum being recovered following a 1 h challenge, suggesting that 
regulation of GDAR genes by GrvA is relegated to exponential phase (Fig. 21B). For 
TW14359∆rcsB and TW14359∆grvA∆rcsB however, no colonies were recovered following acid 
challenge, while complementation of these mutants with rcsB restored wild-type levels of 
GDAR. This effect of rcsB deletion on acid resistance is consistent with its role as an activator of 
GDAR in both exponential and stationary phase cultures (Johnson et al., 2011). Interestingly 
however, overexpression of rcsB has also been determined to indirectly repress GDAR genes 
gadE, gadX and gadW (Castanie-Coronet et al 2010). Since rcsB overexpression also leads to 
grvA upregulation (Tobe et al., 2005), it is plausible that this negative regulation of GDAR 
requires the interaction of RcsB and GrvA. 
 
3.4 Discussion 
 In this study, we examined the TW14359 transcriptome and defined the RcsB-GrvA 
transcriptome using RNA sequencing, and identified a novel pathway for LEE gene regulation in 
EHEC. RNA sequencing has been performed with E. coli strains in the past, with the commensal 
MG1655 and the pathogenic EHEC O157:H7 strain Xuzhou21 (Haas et al., 2012; Zhao et al., 
2013). Both previous studies were from cultures grown LB media, which is not ideal for 
examination of LEE gene transcription. In this study, cultures were grown in DMEM 
supplemented with sodium bicarbonate, conditions known to induce LEE gene expression.  And, 
in agreement with previous accounts of differential gene expression in LB and DMEM (Iyoda et 
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al., 2006; Tobe et al., 2011), flagellin (fliC) was among the most abundant transcripts detected 
for LB cultures in the aforementioned studies, while motility associated genes were barely 
detected in our analysis of exponentially growing cultures in DMEM. This observation is 
congruent with previous work demonstrating increased transcription of genes promoting 
colonization in DMEM, such as those encoding the E. coli common pilus (ECP) and long-polar 
fimbriae (LPF) (Rendon et al., 2007; Torres et al., 2002).  Thus, the results of this study provide 
insight into the regulatory interplay of the RcsB-GrvA-GadE pathway in conditions which favor 
colonization, and importantly, transcription of the LEE pathogenicity island.  
 Transcription of the rcsDB and grvAB operons was shown to be maximal during growth 
in DMEM containing 44 mM bicarbonate.  grvAB is growth phase dependent, indicating tight 
transcriptional regulation. Previous reports, and our own analyses, have demonstrated that RcsB 
activates grvA transcription from cultures grown at 37°C (Morgan et al., 2013; Tobe et al., 
2005). However, a recent report on curli variants in a 1993 hamburger-associated EHEC 
outbreak strain demonstrated decreased transcription of grvA following the repair of a strain 
specific rcsB deletion mutation (Carter et al., 2012). Possible explanations for this disparity may 
include differences in the experimental conditions employed, specifically growth at 28°C. In 
support of this, in EHEC strain Sakai, grvAB transcription was reported to be decreased 
following transition to growth at both 25°C and 14°C compared to growth at 35°C 
(Kocharunchitt et al., 2012). These observations suggest that regulation of grvAB at low 
temperatures may be different from that at physiological temperatures. Importantly, the predicted 
grvAB promoter contains putative RcsAB binding sites upstream of the -35 site, indicating direct 
transcriptional regulation by at least RcsB.  Indeed, purified RcsB was able to shift the grvA 
promoter fragment containing the predicted consensus sequences, validating direct 
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transcriptional regulation of grvA by RcsB alone. It is therefore possible that, during low 
temperature growth conditions which do not favor Lon-dependent RcsA proteolysis (Torres-
Cabassa and Gottesman, 1987), an RcsAB heterodimer may bind at the grvA promoter to repress 
transcription, but at physiological growth temperatures RcsB alone acts as a transcriptional 
activator. Such a model of transcriptional regulation exists for RcsAB potentiated repression of 
the flhDC promoter (Francez-Charlot et al., 2003).  However future work is required to define 
the specific regulatory factors functioning at the predicted grvAB promoter.  
 Importantly, our data revealed substantially increased transcription of genes involved in 
acid fitness and metal stress in mutants for strains TW14359∆grvA and TW14359∆rcsB∆grvA. 
Interestingly, transcription of genes involved in zinc import and acquisition, such as znuA and 
zinT, was substantially higher in both mutant strains. Modulation of zinc fitness was of particular 
interest as zinc has been shown to have a negative effect on type III secretion in EPEC and 
EHEC (Mellies et al., 2012) and, importantly, to inhibit Stx production (Crane et al., 2011). 
Previous reports have revealed ZinT as being required for curli production in zinc limiting 
conditions (Lim et al., 2011), and EHEC znuA mutants were deficient in adherence to Caco-2 
cells, where a zinT mutation alone did not result in decreased adherence (Gabbianelli et al., 
2011). Thus, it is clear that alterations in zinc acquisition and export can have pleiotropic effects 
on EHEC adherence, through direct or indirect means. One possibility is that GrvA effects basal 
levels of zinc through a metabolic pathway and indirectly contributes to cytosolic zinc transport 
and export. In such a model, GrvA could indirectly regulate the transcription of Zur-dependent 
genes, and subsequently alter colonization and pathogenesis through subtle changes in cytosolic 
zinc concentrations. Interestingly, the Rcs phosphorelay has been shown to be activated by the 
presence of 1 mM ZnCl2 (Hagiwara et al., 2003), suggesting an even more complex regulatory 
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relationship between RcsB, GrvA, and the zinc stress response in EHEC. However, this potential 
regulatory relationship was not examined in this study. 
 The RNA-seq data also revealed increased transcription of genes encoded within the AR2 
acid fitness island, including the transcriptional regulator gadE that activates the glutamate-
dependent acid resistance (GDAR) system. Importantly, GadE has been shown to repress LEE1 
transcription following overproduction (Kailasan Vanaja et al., 2009), and is able to bind directly 
to the LEE1 and LEE2/3 promoters in-vitro (Tree et al., 2011). This is particularly salient in light 
of recent studies identifying three EHEC specific prophage encoded regulators (PsrA/ PsrB, and 
PatE) that activate transcription of gadE and hdeA to direct repression of both the LEE1 and 
LEE2/3 operons and modulate acid fitness (Bender et al., 2012; Tree et al., 2011). Conversely, a 
recent study has suggested that GadE and GadX both negatively regulate the LEE indirectly 
following exposure to nitric oxide stress (Branchu et al., 2014). Our data suggests that GrvA 
plays an antagonistic role in regulating the LEE, through gadE, to promote transcription of the 
LEE during early exponential growth.  A report in Salmonella described a reverse phenotype 
following expression of mart-fidL (a grvAB operon homolog) from S. typhimurium in S. typhi, 
which lacks the mart-fidL genes, where expressing the marT-fidL operon in S. typhi reduced acid 
resistance (Retamal et al., 2010). In this study, mutation of grvA resulted in increased glutamate-
dependent acid resistance (GDAR), but was completely dependent on an intact rcsB gene. This 
finding is markedly consistent with previous accounts of RcsB-dependent activation of several 
key GadE regulated GDAR genes (Johnson et al., 2011). Thus, while GrvA mediated regulation 
of exponential phase glutamate-dependent acid resistance through is wholly dependent on RcsB, 
GrvA regulation of the LEE is independent of RcsB.   
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 Based on the results of this study it is predicted that the gadEP3 promoter is likely the 
target for transcriptional repression by GrvA, either direct or indirect. Indeed, the mapped reads 
from TW14359∆grvA RNA sequencing correlate well with the mapped location of the gadEP3 
promoter. This finding was of interest as the previously identified AraC-family prophage 
encoded regulators PsrA and PsrB bind directly to the gadEP3 promoter region to stimulate 
transcription of gadE following attachment (Tree et al., 2011).  The 750-bp region upstream of 
gadE contains 3 mapped promoters (P1, P2, and P3) and has been termed a sensory integration 
region (Sayed and Foster, 2009). Indeed, there exists a complex cascade of regulatory factors 
that collapse at one or more of the gadE promoters to modulate acid resistance in response to 
growth phase and nutritional availability (Aiso et al., 2011; Ma et al., 2004; Sayed et al., 2007). 
In this study, during exponential growth, wild-type transcription arising from the gadEP3 
promoter is repressed activated following deletion of grvA.  Thus, our results extend the temporal 
regulation of this region during exponential growth, and further validate GadE auto-regulation at 
the gadEP1 promoter. However, attempts to validate direct binding of GrvA at the gadE promoter 
were unsuccessful (data not shown), suggest that its regulatory effects are indirect.      
 While both gadX and gadW were more highly transcribed in TW14359∆grvA, gadX 
transcription in TW14359∆grvA∆rcsB was lower than the isogenic grvA mutant alone, but still 
higher than wild type TW14359. This observation is agreement with RcsB mediated 
transcriptional activation of the gadE independent gadX promoter (Johnson et al., 2011).  Loss of 
gadW abrogated the increased gadEP3 promoter activity observed in TW14359∆grvA, while 
activity in TW14359∆gadX was not similarly reduced. Therefore, it is proposed that GrvA 
mediated regulation of acid resistance genes occurs through a GadW-GadE pathway.  
Transcription of gadW can arise from one of two mapped promoters (Tramonti et al., 2008), 
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though our RNA sequencing data suggests that in TW14359∆grvA, during exponential growth, 
only the gadWP1 promoter is actively transcribed. This is not surprising, as the gadX and gadW 
promoters are under complex transcriptional and post-transcriptional regulation (Giangrossi et 
al., 2005; Sayed et al., 2007; Tramonti et al., 2008).  Further analysis is required to determine if 
GrvA regulation of gadW transcription is direct, or if it is functioning through an additional 
factor to influence transcriptional repression of gadW.  Because increased grvAB transcription 
was observed during lag and early exponential growth, it is possible that GrvA is required for 
full repression of gadE transcription through gadW following transition from stationary to active 
growth. Such a regulatory pathway would ensure that AFI encoded regulators, such as GadE, are 
efficiently repressed during periods when adherence is advantageous.    
 We further went on to show that GrvA mediated activation of ler transcription is at least 
partly dependent on an intact gadE gene, establishing a pathway for LEE gene regulation. The 
possibility remains that one or more additional factors are controlling LEE gene repressing in the 
absence of GrvA, such as cytosolic zinc levels (discussed above). Competitive adherence assays 
revealed a dependence on gadE for grvA mediated regulation of adherence to HT-29 epithelial 
cells.  Interestingly, attempts to complement and express gadE ectopically resulted in adherence 
that was reduced to levels lower even than the TTSS deficient strain TW14359∆escN. One 
explanation for this observation is that, while loss of escN abrogates type III secretion, LEE 
encoded regulatory genes remain intact. It is possible that some adhesin, under the control of ler, 
is transcriptionally altered by overexpression of gadE. Indeed, lpf genes, encoding long polar 
fimbriae, are known to be positively regulated by ler (Torres et al., 2007), and could partially 
account for the disparity.   
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 The 32-kb O-island (OI-47) encoding the grvAB operon remains largely uncharacterized. 
The vmpA gene immediately downstream of grvAB, encoded in the opposite direction, was 
recently characterized and encodes a c-di-GMP phosphodiesterase that contributes to biofilm 
formation and motility in EHEC strain EDL933 (Branchu et al., 2013).  Mutation or 
overexpression of grvA was not observed to effect motility in TW14359 (data not shown). The 
remaining OI-47 genes are functionally diverse, encoding a predicted pilus, adhesin, and usher 
protein (sharing amino acid homology to the Klebsiella Mrk pilus proteins), a predicted 
hemolysin-like protein, and proteins predicted to be involved in fatty-acid biosynthesis.  A 
CDART search (NCBI) (Geer et al., 2002) of GrvA identified an N-terminal DNA-binding 
winged HTH-domain and a predicted C-terminal methylenetetrahydrofolate reductase (MTHFR) 
domain, including a predicted FAD binding domain. The N-terminal domain is predicted to be 
localized to the periplasmic space, and the C-terminal, DNA-binding domain, is predicted to be 
located in the cytoplasm. Whether any or all of the OI-47 component genes share regulatory cues 
or biological functions, or if they are independent of one another, remains to be explored. It is 
interesting to speculate on the potential for periplasmic FAD activation of GrvA. Additionally, 
while GrvB shares homology with ToxS, its contribution to GrvA regulation and potential 
dimerization requires further analysis. 
 To conclude, we propose a model where, following gastric passage, bicarbonate 
stimulates activation of the Rcs phosphorelay and transcription of rcsB. Subsequent high levels 
of RcsB directly positively regulate transcription of the grvAB operon. As GrvA is activated, 
transcription of genes associated with acid resistance and gastric passage are down-regulated, 
and subsequent LEE gene transcription is stimulated to promote colonization. Work remains to 
be done to establish whether GrvA is indeed a membrane bound regulator and if it binds directly 
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to the gadW promoter. It is also of interest to explore the contribution, if any, of YqeI to 
virulence and fitness gene regulation in EHEC and other pathogenic E. coli strains.   
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Table 6 - Strains and plasmids used in Chapter 3 
        
Strain/plasmid Relevant characteristics Reference 
Strain name:     
DH5α Vector propagation, recA1 endA1   
BL21(DE3)pLysS BL21 with IPTG inducible T7 polymerase Pan, 2000 
MG1655 F-, lambda-, rph-1    
E2348/69 Escherichia coli O127:H6; (typical EPEC) Iguchi, 2009 
3256-97 Escherichia coli O55:H7; (atypical EPEC) Zhou, 2010 
TW14359 WT 2006 outbreak, western U.S.A. Manning, 2008 
EcRJM-1 TW14359∆escN Morgan, 2013 
EcRJM-6 TW14359∆rcsB Morgan, 2013 
EcRJM-10 TW14359rcsB-FLAG Morgan, 2013 
EcRJM-11 TW14359∆grvA Morgan, 2013 
EcRJM-12 TW14359∆rcsB ∆grvA Morgan, 2013 
EcRJM-13 TW14359tir-FLAG Morgan, 2013 
EcRJM-35 TW14359∆grlR::kan Morgan, 2013 
EcRJM-72 TW14359∆rcsB pRJM20 Morgan, 2013 
EcRJM-73 TW14359∆lacZ This study 
EcRJM-74 TW14359 pRJM-23 This study 
EcRJM-75 TW14359 pRJM-24 This study 
EcRJM-76 TW14359 pRJM-25 This study 
EcRJM-77 TW14359 pRJM-26 This study 
EcRJM-78 TW14359∆grvA pRJM-23 This study 
EcRJM-79 TW14359∆grvA pRJM-24 This study 
EcRJM-80 TW14359∆grvA pRJM-25 This study 
EcRJM-81 TW14359∆grvA pRJM-26 This study 
EcRJM-82 TW14359∆grvA∆gadE::kan pRJM-24 This study 
EcRJM-110 TW14359∆grvA∆gadE::kan pRJM-26 This study 
EcRJM-83 TW14359∆grvA pRJM-22 This study 
EcRJM-84 TW14359∆rcsB∆grvA pRJM-22 This study 
EcRJM-85 TW14359∆rcsB∆grvA pRJM-20 This study 
EcRJM-86 TW14359 rcsDB-luxE This study 
EcRJM-87 TW14359 grvAB-luxE This study 
EcRJM-88 TW14359 rcsDB-luxE pluxCDAB3  This study 
EcRJM-89 TW14359 grvAB-luxE pluxCDAB3  This study 
EcRJM-90 TW14359∆gadE::kan This study 
EcRJM-91 TW14359∆grvA∆gadE::kan This study 
EcRJM-92 TW14359∆gadE::kan pRJM30 This study 
EcRJM-93 TW14359∆grvA∆gadE::kan pRJM30 This study 
EcRJM-94 TW14359zinT-FLAG::kan This study 
EcRJM-95 TW14359∆grvA zinT-FLAG::kan This study 
EcRJM-96 TW14359 pRJM-31 This study 
EcRJM-97 EPEC E2348/69 pRJM-31 This study 
EcRJM-98 MG1655 pRJM-31 This study 
a
 Nucleotide positions based on the published TW14359 (NC_013008) genome sequences 
(NCBI) 
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Table 6 Strains and plasmids used in Chapter 3, continued. 
      
Strain/plasmid Relevant characteristics Reference 
EcRJM-99 DH5α pRJM-31 This study 
EcRJM-100 TW14359 pRJM-32 This study 
EcRJM-101 EPEC E2348/69 pRJM-32 This study 
EcRJM-102 MG1655 pRJM-32 This study 
EcRJM-103 DH5α pRJM-32 This study 
EcRJM-104 TW14359 rcsDB-luxE pluxCDAB3 pRJM-21 This study 
EcRJM-105 TW14359 grvAB-luxE pluxCDAB3 pRJM-21 This study 
EcRJM-106 TW14359∆grvA pRJM-23 This study 
EcRJM-107 TW14359∆grvA pRJM-24 This study 
EcRJM-108 TW14359∆grvA pRJM-25 This study 
EcRJM-109 TW14359∆grvA pRJM-26 This study 
Plasmid name:     
pACYC177 Low copy cloning vector, Amp
R
 Kan
R 
P15A Chang, 1978 
pBAD22 Ara inducible expression vector, Amp
R 
M13 Guzman, 1995 
pMPM-A2 Low copy cloning vector, Amp
R
 pMB1/f1
 
 Mayer, 1995 
pMPM-K3 Low copy cloning vector, Kan
R
 p15A/f1  Mayer, 1995 
pMPM-T3 Low copy cloning vector, Tet
R 
p15A/f1  Mayer, 1995 
pUC19 High copy cloning vector, Amp
R 
pMB1 Yanisch-Perron, 1985 
pRS551 lac fusion vector, Amp
R
 Kan
R
 lacZ
+
 ColE1 Simons, 1987 
pCP20 Flp recombinase expression vector Datsenko, 2000 
pKD4 Template plasmid for Kan cassette Datsenko, 2000 
pKM208 Red-recombinase expression vector Datsenko, 2000 
pET-24d T7 promoter, His tag vector, Kan
R
 f1, pBR322  Novagen 
pSU312 FLAG epitope template, Amp
R
, Kan
R
, R6K Uzzau, 2001 
pRJM-20 pACYC177-rcsB Morgan, 2013 
pRJM-33 pACYC177-grvAB This study 
pRJM-21 pMPM-K3-rcsDB This study 
pRJM-22 pMPM-A2-grvA This study 
pRJM-23 pRS551-gadEp(-773,-1) This study 
pRJM-24 pRS551-gadEp(-320,-1) This study 
pRJM-25 pRS551-gadEp(-516,-276) This study 
pRJM-26 pRS551-gadEp(-773,-497) This study 
pRJM-27 pET-24d-6xHis-rcsB This study 
pRJM-28 pMPM-T3-kan  This study 
pRJM-29 pMPM-T3-luxE-kan This study 
pRJM-30 pMPM-A2-gadE This study 
pRJM-31 pRS551-grvAp(-268,+38) This study 
pRJM-32 pUC-grvA-6xHIS This study 
placlux8 placlux8 Shimizu, 2011 
pLuxCDAB3 pLuxCDAB3 Shimizu, 2011 
a
 Nucleotide positions based on the published TW14359 (NC_013008) genome sequences 
(NCBI) 
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Table 7 - Primers used in Chapter 3 
Primers used in this study.
Primer name Sequence (5'→ 3')a Function/Reference
FLAG-F gactacaaagatgacgacga (Uzzau, 2001)
P1 gtgtaggctggagctgcttc (Datsenko, 2000)
P2 catatgaatatcctccttag (Datsenko, 2000)
Ler+109 CGAGAGCAGGAAGTTCAA qRT-PCR Primer/(Mitra, 2012)
Ler+214 GTCCATCATCAGGCACAT qRT-PCR Primer/(Mitra, 2012)
GadE +309 TGGTAAACACTTGCCCCATA qRT-PCR Primer/(Mitra, 2012)
GadE +419 AGCGTCGACGTGATATTGCT qRT-PCR Primer/(Mitra, 2012)
ZnuA+218 AGAACGCGGACTTAGTCGT qRT-PCR Primer
ZnuA+309 CGTTACCTGCTTCGCTTCT qRT-PCR Primer
AstC+419 GTCGCACGCTGTTTACTGT qRT-PCR Primer
AstC+519 GCATGACGGATATCTGGTG qRT-PCR Primer
GadE-320/EcoRI CGCGGAATTCTCGGATTACTTTTTAACT
TT 
pRS551 lacZ  promoter fusion
GadE-1/BamHI CGCGGGATCCAACTTGCTCCTTAGCCGTT
A 
pRS551 lacZ  promoter fusion
GadE-276/EcoRI CGCGGAATTCGGTTAAATAAGTAATCCG
GG 
pRS551 lacZ  promoter fusion
GadE-516/BamHI CGCGGGATCCGTTTGTGATCTCTGAAGA
AT 
pRS551 lacZ  promoter fusion
GadE-773/EcoRI CGCGGAATTCGTCACTTGATGTGACTAT
GA 
pRS551 lacZ  promoter fusion
GadE-497/BamHI CGCGGGATCCGCAATGTAATCAACGCCA
GT
pRS551 lacZ  promoter fusion
GrvA-268/EcoRI CGCGGAATTCGGAGGATGCGTCCCGTTCT
T
pRS551 lacZ  promoter fusion
GrvA+38/BamHI CGCGGGATCCGAGTTGAATCTTACTTCA
TC
pRS551 lacZ  promoter fusion
LuxE-18/XhoI CCGACTCGAGGGAGGGGTAAAACAGGT luxE  cloning primer
LuxE+1450/BamHI CCGAGGATCCTGAGAATTTCCCTCAAAT
TT
luxE  cloning primer
pKD4For/SacI GCGGAGCTCGTGTGTAGGCTGGAGCTGCT
TC                           
kan  from pKD4 primer
pKD4Rev/BamHI CCGAGGATCCCATATGAATATCCTCCTT
AG
kan  from pKD4 primer
GrvA+1283/LuxE CCACGCTTCATATGTATTTCCCACTAAC
AGCATTGTTGCTGGAGGGGTAAAACAGG
T
grvAB,  luxE  insertion primer
a
 Restriction sites indicated by bolded nucleotides
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Table 7
Primer name Sequence (5'→ 3')a Function/Reference
GrvA+1431/P2 CAATGGTATGTAAACAGATAAATAATT
AACCAATATTGGAGTGTAGGCTGGAGCT
GCTTC
grvAB,  luxE  insertion primer
RcsB+625/LuxE ACGTTAAGTCCGGCAGATAAAGACTAA
TCATCTGTAGGCCGGAGGGGTAAAACAG
GT
rcsDB,  luxE  insertion primer
RcsB+838/P2 GTTTACGCCGCATCTGGCATTCAGTGCA
AATGCCAGATGCGTGTAGGCTGGAGCTG
CTTC
rcsDB,  luxE  insertion primer
LacZ-1/P1 GAAATTGTGAGCGGATAACAATTTCAC
ACAGGATACAGCTGTGTAGGCTGGAGCT
GCTTC
Deletion primer
LacZ+3115/P2 TTACACGAAATACGGGCAGACATGGCCT
GCCCGGTTATTACATATGAATATCCTCC
TTAG
Deletion primer
LacZ-178/FVal CGATTCATTAATGCAGCTGG Deletion validation
LacZ+3,263/RVal CCCGTATCACTTTTGCTGAT Deletion validation
EtpD-43/P1 GCATTTATTGCTGTAGGAGAAAACTGAT
TGTTCAGGAAATGTGTAGGCTGGAGCTG
CTTC
Deletion primer
EtpD+1,993/P2 CTGTACTACTCTGCTCAAGGGGACGTGA
TTCACTGACATTCATATGAATATCCTCC
TTAG
Deletion primer
EtpD-122/FVal GGCGCAGCAGATAATGAAGC Deletion validation
EtpD+2,077/RVal GTGTCCTCCATGCAGAACAC Deletion validation
GadE+35/P2 TACAGGGCTTTTGGCAGTTGAAAGATAA
TCACGAAATGATCATATGAATATCCTC
CTTAG
Deletion primer
GadE+521/P1 TAAGATGTGATACCCAGGGTGACGATGT
CGCTCATACGTCGTGTAGGCTGGAGCTGC
TTC
Deletion primer
GadE-74/FVal CAACGATTCGGACAAGGATG Deletion validation
GadE+590/RVal ATGAAATCAGCATCTGCATC Deletion validation
GadE-763/XbaI CCGATCTAGAGTGACTATGATCCGATTA
ATACTCTCTCCG
pMPM-A2 cloning primer
GadE+577/BamHI CCGAGGATCCCTGCATCCCTCGTCATGCC
AGCCATCAATT
pMPM-A2 cloning primer
RcsB-3732/BamHI CCGAGGATCCCTATTTCACAAATAATT
AACATCAGCATAA
pMPM-K3 cloning primer
RcsB+794/XbaI CCGATCTAGACTGACGCGTCTTATCTGGC
CTACTTTAATG
pMPM-K3 cloning primer
GrvAB-679/BamHI CCGAGGATCCTGCTCCTTATGAGTAAGT
AATATTTAAGGG
pACYC177 cloning primer
a
 Restriction sites indicated by bolded nucleotides
Primers used in this study, continued.
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Table 7
Primer name Sequence (5'→ 3')a Function/Reference
GadE+577/BamHI CCGAGGATCCCTGCATCCCTCGTCATGCC
AGCCATCAATT
pMPM-A2 cloning primer
RcsB-3732/BamHI CCGAGGATCCCTATTTCACAAATAATT
AACATCAGCATAA
pMPM-K3 cloning primer
RcsB+794/XbaI CCGATCTAGACTGACGCGTCTTATCTGGC
CTACTTTAATG
pMPM-K3 cloning primer
GrvAB-679/BamHI CCGAGGATCCTGCTCCTTATGAGTAAGT
AATATTTAAGGG
pACYC177 cloning primer
GrvAB+1417 /XhoI CCGACTCGAGCAGATAAATAATTAACC
AATATTGGAATGG
pACYC177 cloning primer
GrvA-268/XhoI CCGACTCGAGGGAGGATGCGTCCCGTTCT
T
pMPM-A2 cloning primer
GrvA+884/BamHI CCGAGGATCCGGCTCAGAATTGCTGCAA
TA
pMPM-A2 cloning primer
GrvA-268/XbaI CCGATCTAGAGGAGGATGCGTCCCGTTCT
T
pUC19 cloning primer
GrvA+810-6xHis CCGAGAATTCTCAGTGGTGGTGGTGGT
GGTG CTCCGCTTTATAATAGAGAGAG
pUC19 cloning primer (6xHIS)
GrvA-365/BtFor CGGATAAAAGACAGTACCGG EMSA primer
GrvA-238/BtRev CGTTATAGGGAAAGAACGGG EMSA primer
GrvA-236/BtFor GGATACGCAGTTTTTATCAG EMSA primer
GrvA-1/BtRev TACATTTTATACCTTAGTTG EMSA primer
a
 Restriction sites indicated by bolded nucleotides
Primers used in this study, continued.
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Chapter 4: A novel promoter drives transcription of the Escherichia coli common pilus in 
the 2006 EHEC O157:H7 spinach outbreak strain TW14359 
4.1 Background 
 Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a virulent pathotype of the 
gram negative commensal bacteria, Escherichia coli. Following host colonization, pathogenesis 
of EHEC is largely attributed to the production of the Shiga-like toxin (Stx), which damages the 
kidney vasculature and can lead to the life-threatening hemolytic uremic syndrome (HUS) (Eaton 
et al., 2008). EHEC adherence to epithelial cells, and subsequent host colonization, is enhanced 
by a common pilus structure observed almost ubiquitously across E. coli strains, the E. coli 
common pilus (ECP) (Rendon et al., 2007). The E. coli common pilus is a chaperone-usher 
fimbrial adhesin, composed of a 21-kDa subunit encoded by the gene ecpA, and its production 
plays a role in early-stage biofilm development for commensal and pathogenic E. coli and 
Klebsiella pneumonia strains (Alcantar-Curiel et al., 2013; Garnett et al., 2012; Lehti et al., 2010; 
Wurpel et al., 2013).  
 The ecp operon contains the gene ecpR, encoding a transcriptional regulator of the 
common pilus operon.  In pathogenic and non-pathogenic E. coli, the regulator EcpR positively 
stimulates ecp transcription through the ecpR promoter, aided by integration host factor (IHF) 
and RcsB to relieve H-NS mediated repression (Lehti et al., 2012b; Martinez-Santos et al., 
2012). Binding of EcpR occurs at a consensus site (TTCCT-N17-TTCCT) located upstream of 
ecpR, and is believed to bind as a homodimer (Martinez-Santos et al., 2012). High levels of 
promoter architecture variation have been described for the ecpR (matA) promoter sequence in E. 
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coli strains and a phylogenetic organizational model has been previously proposed, with EHEC 
strains belonging to group E (Lehti et al., 2013a). Within this model, production of ECP varies 
between groups.  For example, E. coli strain MG1655, while possessing a functional ecp operon, 
is unable to counteract H-NS mediated repression of the ecp promoter and direct production of 
ECP (Lehti et al., 2013a). Detailed sequence analyses have been performed for the ecpR 
promoter in EHEC (Martinez-Santos et al., 2012), however no reports to-date have identified 
promotable elements within the ecpR ORF, upstream of ecpA. Indeed, only the presence of 
putative temperature sensitive regulatory elements downstream of ecpR has been observed from 
the ecpA upstream region (Lehti et al., 2013a).  
 The remaining products of the ecpRABCDE operon include EcpA (the major fimbrial 
subunit), EcpB (a predicted chaperone), EcpC (a putative usher protein), EcpD (the ECP tip 
adhesin), and EcpE (a putative chaperone). In meningitic E. coli (NMEC) and EHEC strain 
EDL933, EcpA (MatA in NMEC) is required for efficient biofilm formation (Garnett et al., 
2012; Lehti et al., 2010), indicating that successful ECP pilus formation is thus required for 
attachment and biofilm production in diverse E. coli pathotypes. While a number of adhesins 
produced by Shiga toxin-producing E. coli have been identified (reviewed in (Farfan and Torres, 
2012)), the specific targets recognized by each adhesin and their contribution to virulence in-vivo 
requires further exploration. ECP production is temperature and oxygen dependent, and 
increased ecp transcription has been observed for cultures grown in DMEM, acetate, and acidic 
conditions (Lehti et al., 2013a; Rendon et al., 2007). Further, for cultures grown DMEM with 5% 
CO2, the addition of ethanolamine was recently shown to significantly increase transcription of 
ecp, and other E. coli fimbrial adhesins, in a EutR dependent manner (Gonyar and Kendall, 
2013). 
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 Among divergent EHEC O157:H7 lineages, strain TW14359 has been previously 
reported as having a robust LEE gene expression and adherence phenotype (Abu-Ali et al., 
2010a; Abu-Ali et al., 2010b), which is dependent on intrinsically up-regulated rcsB 
transcription, and an intact type III secretion system (Morgan et al., 2013). However, factors that 
contribute to increased rcsB transcription have not yet been characterized. In this study, a novel 
promotable element within the ecpR open reading frame was identified that is able to drive 
transcription of ecpA, and is dependent on a polymorphism specific to the EHEC O157:H7 strain 
TW14359. Finally, the ECP directed regulation of type III secretion through the response 
regulator RcsB is explored, and establishes a novel mechanism for co-regulation of adherence 
factors by distinct and distally encoded adherence factors. 
 
4.2 Methods…… 
4.2.1 Bacterial and mammalian tissue culture   
 The strains and plasmids used in this study are listed in Table 7 in the supplemental 
material. Strains were stocked at -80°C in glycerol diluted (15% v/v final) in Lysogeny Broth 
(LB), and were maintained in LB or on LB with 1.5% agar (LBA). Unless otherwise noted, 
overnight (18-20 h) cultures grown in LB were used to inoculate fresh LB or LB buffered with 
sodium bicarbonate (44 mM NaHCO3) or fresh Dulbecco’s Modified Eagle’s Medium (DMEM) 
(4 g/l glucose, 4 mM glutamine, 44 mM NaHCO3, pH 7.4) to a final optical density 600 nm 
(OD600) of 0.05. Cultures were grown at 37°C in a rotary shaker (200 RPM) using a 1:10 media-
to-flask volume. Antibiotics (Sigma-Aldrich, St. Louis, MO) were added to cultures when 
required. 
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 Maintenance and culture of Caco-2 and HT-29 colonic intestinal cells was performed as 
previously described (Morgan et al., 2013). Briefly, Caco-2 or HT-29 cells were grown to 
confluency in multi-well plates at 37°C with 5% CO2. Prior to infection with bacterial strains, 
media was aspirated and each well was washed once and replaced with DMEM without FBS.  
For adherence experiments, bacterial cultures were grown to mid-logarithmic phase (OD600 of 
0.5) in DMEM, and 200 μl of culture was added to each well of a 6-well plate. Following 3 hours 
of incubation, each well was washed four times using sterile PBS to remove non-adherent cells, 
and adherent cells were removed using 500 μl of 0.1% Triton X-100.  Finally, cells were 
enumerated through serial dilution and plating on LBA agar.  Each experiment was performed at 
least 3 times.    
 
4.2.2 Mutagenesis and vector construction   
 Primers used for the genetic manipulation are provided in Table 8. For construction of 
isogenic deletion mutants and chromosomal FLAG-epitope fusion construction, the λ-Red 
assisted one-step inactivation method was used, adapted for enterohemorrhagic Escherichia coli 
(Lippolis et al., 2009), and as described (Mitra et al., 2012; Morgan et al., 2013). A previously 
published approach was used to construct FLAG fusions to ecpA, rcsB, and tir (Morgan et al., 
2013) based on the method of Uzzau et al. (Uzzau et al., 2001). When expressed, the fusion 
protein contains a seven amino acid C-terminal epitope (FLAG) that can be detected by western 
immunoblots using anti-FLAG mAbs (Sigma-Aldrich. St. Louis, MO). Confirmation of genetic 
constructs was done using a combination of BccI (NEB) restriction mapping and DNA 
sequencing (MWG Operon, Huntsville, AL)  
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 Deletion of the ecpR promoter region was performed as described above using primers 
EcpR-388/P2 and EcpR+40/P1.  Complementation of ecpR was performed by cloning a fragment 
containing the entire ecpR open reading frame, and upstream promoter region, into the 
BamHI/XhoI digested low copy vector pMPM-A2 (Mayer, 1995) using primers EcpR-404/XhoI 
and EcpR+637/BamHI. To express ecpR under the control of the inducible pBAD promoter, the 
ecpR ORF was cloned into the pBAD-TOPO (Invitrogen) expression vector using primers EcpR-
1/FpBAD and EcpR+637/RpBAD. A vector expressing the ecpABCDE operon, under the control 
of the TW14359 specific ecpA promoter, was created  by amplifying the ecpABDCE operon 
using primers EcpA-666/SacI and EcpA+6,220/XbaI, followed by SacI/XbaI digestion and 
ligation into the similarly digested vector pUC19. 
  
4.2.3 RNA purification and quantitative real-time PCR (qRT-PCR)   
 Primers for qRT-PCR are provided in Table 8 in supplemental materials. RNA 
purification, cDNA synthesis, qRT-PCR cycling conditions and data analysis followed 
previously described protocols (Riordan et al., 2010). qRT-PCR was performed using a 
Realplex2 Mastercycler (Eppendorf). Cycle threshold (Ct) data were normalized to rrsH (16S 
rRNA gene) and normalized cycle threshold values (ΔCt) were transformed to arbitrary transcript 
expression levels using 2
-ΔCt
 /10
-6
 as described (Livak and Schmittgen, 2001; Riordan et al., 
2010). Expression levels were compared using the appropriate t-test or by Tukey’s HSD 
following a significant F-test (n≥3, α=0.05) (R. ver. 2.13.0).  
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4.2.4 β-galactosidase assays  
 The construction of the ecpRP-lacZ reporter transcriptional fusion followed a previously 
described protocol using vector pRS551 (Morgan et al., 2013). Briefly, a 306-bp fragment, 
containing the ecpR promoter(s), was amplified from TW14359 genomic DNA using primers 
EcpR-496/BamHI and EcpR-21/BamHI, BamHI/EcoRI digested, and cloned into the similarly 
digested pRS551. To create ecpAP-lacZ fusions, fragments for regions of the ecpA promoter were 
amplified with forward primers EcpA-666/EcoRI, EcpA-555/EcoRI, EcpA-496/EcoRI, EcpA-
387/EcoRI, EcpA-270/EcoRI, EcpA-131/EcoRI, and the reverse primer EcpA-1/BamHI from 
TW14359 genomic DNA; amplified ecpA promoter fragments were digested and cloned into 
similarly EcoRI/BamHI digested pRS551. 
 Site directed mutagenesis of the ecpA promoter nucleotide polymorphism specific to 
EHEC strain TW14359 was performed by cloning the ecpA upstream region (-666 and -1 
nucleotides, relative to the ecpA translational start site), using primers EcpA-666/EcoRI and 
EcpA-1/BamHI, into the EcoRI/BamHI digested pUC19. Primers containing the desired C to T 
mutation were designed and used to amplify the entire vector using Phusion© High-Fidelity 
DNA Polymerase (NEB). The correct sequence identity of both the wild type and mutagenized 
promoter fragments was confirmed through sequencing (Eurofins MWG Operon, Huntsville, 
AL).  The resulting fragment was digested, gel-purified, and cloned into the EcoRI/BamHI site 
of pRS551. β-galactosidase activity (Miller Units) was measured as previously described and 
compared between strains using the appropriate t-test or by Tukey’s HSD following a significant 
F-test (n≥3, α=0.05) (R ver. 3.0.1) (Miller, 1972; Mitra et al., 2012).   
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4.2.5 Protein extraction and western blotting 
 Protein extraction, purification and western immunoblots were performed as described 
previously (Mitra et al., 2012). The amount of protein loaded on SDS-PAGE gels for western 
blots was measured by a Bradford protein assay standard curve, and equal loading was validated 
by western blots for GroEL using anti-GroEL mAbs (Bio-Rad, Hercules, CA).  Monoclonal 
antibodies against FLAG (Sigma-Aldrich, St. Louis, MO) were also used.  Each experiment was 
repeated a minimum of three times in independent trials.  Densitometry was used to estimate 
differences in protein levels for select experiments using a ChemiDoc XRS+ Imaging System 
and Image Lab 3.0 (BioRad).  
 
4.2.6 Flow cytometry 
 Experiments for flow cytometry to detect relative ECP production were conducted as 
previously described (Martinez-Santos et al., 2012; Morgan et al., 2013). Briefly, overnight 
DMEM cultures of TW14359 or mutant derivatives co-incubated with confluent monolayers of 
Caco-2 cells for 6 hours.   After incubation, 10
6
 bacteria were formalin fixed for 10 minutes and 
labeled with anti-ECP antibodies overnight at 4°C. After overnight incubation, samples were 
washed and labeled with goat-anti rabbit IgG Alexa Fluor 488 conjugated antibodies for 1 hour 
at 4°C. Bacteria were then labeled with propidium iodide for detection using a 42-nm band pass 
centered at 585 nm. Emission from Alexa Fluor fluorescence 488 was detected at a 30-nm band 
pass filter centered at 530 nm. The samples were analyzed in a Becton Dickinson FACScan and 
50,000 events were measured.   
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4.3 Results….. 
4.3.1 Promoter analysis of the ecpR and ecpA upstream regions in TW14359 identified a 
novel promotable element within the ecpR open reading frame   
 Our previous transcriptional profiling of EHEC strain TW14359 revealed markedly 
higher levels of mapped transcripts for the ecp operon (Fig. 22A) at a region upstream of ecpA, 
but located within the ecpR open reading frame (Fig. 22B) (Morgan et al., 2013). The promoter 
region upstream of ecpR has been well characterized in EHEC strain EDL933, and our initial 
experiments in EHEC strain in TW14359, using promoter lacZ fusions, revealed significantly 
higher levels of promoter activity (p<0.05) in DMEM compared with LB,  in agreement with 
previous reports (Fig. 22C) (Martinez-Santos et al., 2012). However, we sought to further 
explore potential promotable elements capable of driving ecpA transcription, located within the 
ecpR open reading frame. Cloning a fragment 666-bp upstream of the ecpA translational start 
site, lacking any portion of the ecpR upstream region, into pRS551 resulted in measurable β-
galactosidase activity significantly higher (p<0.05) than that of the empty vector. Activity from 
the ecpAP-lacZ reporter was significantly lower than that of the ecpRP-lacZ (p<0.05), though 
promoter activity of both constructs was significantly higher for cultures grown in DMEM 
compared with those in LB (Fig. 22C). Maximal promoter activity of the ecpR and ecpA 
promoter fragments was observed for late-log phase cultures grown in DMEM (p<0.05), and in 
LB for the ecpA promoter fragment, however the ecpR promoter fragment was not altered 
between mid- and late-log phase in LB (Fig. 22C). These experiments indicated that ecp 
transcription in EHEC strain TW14359 could be initiated from one of two promotable elements: 
(1) the promoter(s) upstream of ecpR, and (2) a promoter within the ecpR open reading frame, 
and that activity from these promoters is sensitive to changes in growth phase and media. 
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 To identify important regions within the ecpA promoter, several lacZ fusions were 
created with truncated fragments of the region upstream of the ecpA ORF, and cloned into 
TW14359∆lacZ for β-galactosidase assays (Fig. 22D).  The largest fragment, at 666-bp upstream 
of ecpA, had the highest detectable promoter activity. Loss of the first 100-bp resulted in a 
significant drop in promoter activity (p<0.05), which increased slightly following subsequent 
100-bp truncation. The final fragment, at 131-bp upstream of ecpA, displayed levels which 
remained significantly higher (p<0.05) than that of the empty vector, but were substantially 
lower than that of the largest fragment (Fig. 22E). Collectively, these results support the 
observations of transcriptional activity from an element upstream of ecpA, and reveal a region of 
importance for maximal activity located upstream of the ecpA translational start site, within the 
ecpR open reading frame.  
 
4.3.2 Basal EcpA production independent of the ecpR promoter   
 In the previous experiments, promoter activity was observed for the region upstream of 
ecpA within the ecpR open reading frame. It was thus hypothesized that, while primary ecp 
transcription arises from a promoter upstream of ecpR, basal activity from a promoter located 
within the ecpR ORF promoter would be sufficient to detect cytosolic EcpA production. To test 
this, a strain with a chromosomally FLAG tagged ecpA gene was created.  A kanamycin drug 
cassette was then inserted into the region just upstream of the ecpR translational start site, 
replacing the entire ecpR promoter region. Importantly, the kan cassette was inserted in a reverse 
orientation from the ecp operon to prevent polar transcription from the kan promoter. For 
cultures grown to mid-logarithmic phase in DMEM, EcpA was observed in the wild type strain 
with an intact ecpR promoter, and EcpA production was substantially increased by  
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Figure 22 – The transcriptional regulation of ecpR and ecpA 
(A) The ecp operon organization with the respective location of the promoter upstream of ecpR, and the 
described or predicted function of each gene.  (B) Transcriptome profiling for the ecp operon. Mapped 
transcripts are indicated in green (forward orientation) and red (reverse orientation).  (C) β-galactosidase 
activity in Miller units of ecpRP496-lacZ and ecpAP666-lacZ measured during mid log (OD600 of 0.5), late 
log (OD600 of 1.0), and stationary (OD600 of 2.5) growth phases. Asterisks denote significance by a 
Student’s t-test (p<0.05, n≥3). (D) Diagram indicating the relative location of ecpR and ecpA promoter 
fragments for lacZ transcriptional fusions cloned into pRS551, with the ecpR and predicted ecpA 
promoters denoted by a solid or hatched arrow, respectively.  (E) β-galactosidase activity in Miller units 
of each ecpAP-lacZ promoter fragment tested, including the empty vector (pRS551) control, in strain 
TW14359∆lacZ.  Plots which differ by lower case letter, differ significantly by Tukey’s HSD following a 
significant F-test (p<0.05; n≥3).  Error bars indicate standard deviation for all panels. 
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Figure 23 - Western blot analysis of EcpA-FLAG in TW14359 
Western blot for EcpA-FLAG, from cultures grown in DMEM or LB during exponential growth (OD600 
of 0.5), for strains TW14359 and TW14359∆ecpRP::kan. GroEL was included as a control for equal 
loading.   
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ectopically expressing EcpR from its native promoter on a multi-copy vector (Fig. 23). 
Following deletion of the ecpR promoter region, detectable cytosolic EcpA was similar to that of 
the un-induced wild type strain, though activation of EcpA production by EcpR overproduction 
was completely abrogated.  This observation is in-line with the current model of EcpR mediated 
transcriptional activation of ecpR, at the EcpR binding sites upstream of the ecpR promoter, and 
corroborates basal production of EcpA in EHEC strain TW14359 directed through an additional 
promoter within the ecpR open reading frame. 
 
4.3.3 A single nucleotide polymorphism within the TW14359 ecpR open reading frame is 
required for maximal ecpA promoter activity   
 An alignment of a region 666-bp upstream of the ecpA ORF from several pathogenic and 
non-pathogenic E. coli strains revealed substantial sequence diversity (Fig. 24). Fragments from 
several strains, representing a spectrum of sequence variation, were examined using promoter 
lacZ fusions in TW14359∆lacZ.  Surprisingly, only the ecpA upstream fragment from EHEC 
strain TW14359 displayed β-galactosidase activity above that of the empty vector control (Fig. 
25A). Further analysis of the ecpA upstream region, compared with other E. coli strains, 
identified a polymorphism unique to TW14359. The most closely related sequence was that of 
EHEC strain Sakai, which contained a single nucleotide difference within a region predicted, 
through in-silico analysis, to contain a sigma-70 promoter. To explore the significance of this 
polymorphism, the 666-bp fragment upstream of ecpA, from strain TW14395, was cloned into 
vector pUC19 and the nucleotide thymine was changed to a cytosine using site-directed 
mutagenesis. The resulting fragment was subsequently cloned into pRS551 assayed for promoter 
activity. As expected, the T to C mutation resulted in significantly decreased promoter activity  
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Figure 24 - Alignment of the ecpA upstream region from select E. coli strains 
Alignment for multiple E. coli strains for the region upstream of ecpA, but not including the ecpR 
upstream region.  The predicted ecpA promoter is indicated with bold letters, and an asterisk indicates the 
nucleotide polymorphism unique to EHEC strain TW14359. 
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Figure 25 - Characterizing the TW14359 ecpA specific promoter polymorphism 
(A) β-galactosidase activity in Miller units of ecpAP666-lacZ for different E. coli strains. (B)  β-
galactosidase activity in Miller units for the ecpA promoter of TW14359, Sakai, E2348/69 (EPEC 
O127:H6), the TW14359 ecpA promoter with a site-directed mutation, and the E2348/69 ecpA promoter 
with a site-directed mutation. All experiments were performed using strain TW14359∆lacZ, and the 
empty vector (pRS551) was included as a negative control. Asterisks denote significance by a Student’s t-
test (p<0.05; n≥3). Error bars denote standard deviation for all panels. 
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(p<0.05), comparable to that of strain Sakai (Fig. 25B). Collectively these experiments reveal a 
promotable region located upstream of the ecpA ORF, in EHEC strain TW14359, that is 
dependent on a single nucleotide polymorphism within a predicted sigma-70 promoter region. 
However, alteration of the same nucleotide from the EPEC O127:H6 ecpA upstream region did 
not yield detectable promoter activity, suggesting that one or more additional nucleotide 
differences contribute to ecpA promoter function. 
 Activity from the TW14359 ecpA promoter was observed to be weaker than that of the 
ecpR promoter (Fig. 22C). Since direct binding of H-NS to the ecpR open reading frame has 
been previously described, and has been shown to play an important role in regulation of ecp 
transcription (Lehti et al., 2013a; Martinez-Santos et al., 2012), it was of interest to examine 
whether the ecpA promoter activity observed for TW14359 was under the control of H-NS. 
Indeed, mutation of hns significantly increased activity (p<0.05) from the TW14359 ecpA 
promoter fragment, while only slightly increasing promoter activity from the Sakai ecpA 
promoter fragment (Fig. 26). Though activation of the Sakai derived ecpA promoter was 
marginal in the absence of H-NS, activity was significantly higher (p<0.05) than that of the 
empty vector alone, suggesting that the fragment contains a very weak promoter which is 
effectively silenced by H-NS. Taken together, this data suggests that H-NS binding actively 
represses transcription of the ecpR and ecpA promoters in TW14359.   
 
4.3.4 Adherence to epithelial cells mediated by ECP in the absence of the ecpR promoter  
 The positive role of the E. coli common pilus in adherence to cultured epithelial cells has 
been previously described (Rendon et al., 2007; Saldana et al., 2009a). Therefore, we sought to 
explore the contribution of the TW14359 specific ecpA promoter in ECP production 
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Figure 26 - Regulation of the TW14359 ecpA promoter by H-NS 
β-galactosidase activity in Miller units of ecpAP666-lacZ (source of cloned promoter fragment in 
parentheses, strain TW14359 or Sakai) in wild type TW14359∆lacZ or TW14359∆lacZ∆hns::kan from 
cultures grown to mid-exponential phase (OD600 of 0.5) in LB; The empty vector (pRS551) was included 
as a negative control.  Plots which differ by lower case letter, differ significantly by Tukey’s HSD 
following a significant F-test (p<0.05; n≥3).  Error bars indicate standard deviation for all panels.  
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Figure 27 - ECP directed adherence and production of ECP by the ecpR and ecpA promoters 
(left) Box plots for the level of ECP production determined by flow cytometry, in bacteria adhering to 
Caco-2 cultured epithelial cells, for strains TW14359, TW14359∆ecpA::kan, and TW14359∆ecpRP::kan 
with or without pecpR.  (top right) CFU/ml of EHEC strain TW14359 recovered following incubation 
with Caco-2 cells in different ecp mutant strains. Asterisks denote significance by a Student’s t-test (**, 
p<0.01; ***, p<0.001; n≥3). Plots which differ by lower case letter, differ significantly by Tukey’s HSD 
following a significant F-test (p<0.05, n≥3). (bottom right)  CFU/ml of MG1655 containing pecpABCDE 
or the empty vector pUC19.  Asterisks denote significance by a Student’s t-test (*, p<0.05; n≥3). Error 
bars indicate standard deviation for all panels.   
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and adherence. As expected, overproduction of EcpR led to significantly elevated ECP 
production (p<0.01), compared with wild type, and mutation of ecpA resulted in minimal 
detection of ECP production (Fig. 27A). Importantly, while mutation of the ecpR promoter 
region led to a substantial reduction in ECP production, detectable ECP levels were roughly 4.7-
fold higher than the ecpA mutant, revealing that basal activity from the remaining ecpA promoter 
was able to produce low levels of ECP. In agreement with western blots for EcpA, 
overproduction of EcpR did not affect basal production of ECP in strain TW14359∆ecpRP::kan. 
 Adherence to Caco-2 cells was observed to significantly increase following 
overexpression of ecpR in wild type TW14359 (p<0.05), as expected from previous reports 
(Rendon et al., 2007) and our own observations (Fig. 27B). However, adherence experiments 
comparing strains TW14359∆ecpA and TW14359∆ecpRP::kan, or their respective ecpR 
overexpression strains, were not significantly different from one another, suggesting that 
transcription from the TW14359 specific ecpA promoter alone is not sufficient to alter 
adherence, at least in the conditions tested in this study. While the preceding experiments were 
unable to detect noticeable contributions to adherence from the TW14359 specific ecpA 
promoter, it was hypothesized that this might be due to its low level of promoter activity, and 
subsequent ecp transcription, compared with that of the fully activated ecpR promoter. To 
address this, the ecpABCDE operon, excluding the entire ecpR upstream promoter region, was 
cloned into a high copy vector under the control of the TW14359 ecpA promoter. Because the 
ecp operon is not actively transcribed in E. coli strain MG1655, due to mutations inactivating the 
ecpR promoter (Lehti et al., 2010), it was used in adherence experiments with HT-29 human 
colonic epithelial cells. Indeed, expression of the ecpABCDE operon resulted in significantly 
increased adherence (p<0.05), compared to MG1655 containing the empty vector alone (Fig. 
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27C). Collectively, these experiments suggest that, while low levels of ECP production from the 
native ecpA promoter was not able to detectably alter adherence in EHEC strain TW14359, ecp 
transcription arising solely from the TW14359 ecpA promoter is able to increase adherence when 
expressed from a high copy vector. 
 
4.3.5 Overproduction of EcpR increases cytosolic RcsB and Tir protein levels   
 Transcription of ecpR (matA) in meningitic E. coli has been shown to require the 
response regulator RcsB (Lehti et al., 2012b).   However, in EHEC, the rcsB consensus binding 
site was shown to be dispensable for transcription of ecpR in a study using a multi-copy reporter 
system (Martinez-Santos et al., 2012). In this study, overexpression of ecpR led to significantly 
higher ecpA transcription compared with wild-type (P<0.001), but did not alter transcription of 
ecpA in TW14359∆rcsB or TW14359∆ecpRP::kan, in agreement with previous accounts of RcsB 
and EcpR dependent ecp transcriptional (Fig. 28A) (Lehti et al., 2012b; Martinez-Santos et al., 
2012).   
 In EHEC strain TW14359, rcsB transcription is intrinsically up-regulated when compared 
with EHEC strain Sakai (Morgan et al., 2013). However, the specific factors that contribute to 
this phenotype have not yet been identified. It was therefore of interest to determine whether 
increased ECP production had a role in transcriptional regulation of rcsB. To further explore the 
potential co-regulation of EcpR and RcsB in EHEC strain TW14359, ecpR was cloned into a 
multi-copy vector and expressed from either an arabinose inducible promoter or from the native  
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Figure 28 - qRT-PCR and Western blot analysis of rcsB, ecp, and LEE gene targets 
(A) Transcript levels for espA, tir, rcsB, and ecpA in wild type and derivative TW14359 strains 
expressing ecpR on a multi-copy plasmid (pecpR) from its native promoter. Asterisks denote significance 
by a Student’s t-test (*, p<0.05; **, p<0.01; ***, p<0.001; n≥3). Error bars indicate standard deviation for 
all panels.  (B and C) Representative western blots for RcsB-FLAG or (D) Tir-FLAG for cultures grown 
to mid-exponential phase (OD600 of 0.5) in LB or DMEM, with or without vector pBAD-ecpR, pecpR, or 
prcsDB. 
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ecpR promoter. Overproduction of ecpR was observed to slightly but significantly (p<0.05) 
increase transcription of rcsB compared with wild-type TW14359, which was dependent upon an 
intact ecpR promoter (Fig. 28A). Indeed, overproduction of EcpR, under the control of an 
arabinose inducible promoter (pBAD-ecpR), or its native promoter (pecpR), resulted in visibly 
increased cytosolic RcsB for cultures grown in LB, with a slight increase for cultures grown in 
DMEM (Fig. 28B and 28C).     
 In EHEC O157:H7 strains, RcsB overproduction is able to stimulate LEE gene 
transcription and subsequent type III secretion (Tobe et al., 2005). Since increased rcsB 
transcription was observed following ecpR overexpression, it was hypothesized that this may 
have an impact on LEE gene transcription. Therefore, transcription and cytosolic levels of the 
LEE encoded protein Tir was assessed in strains overexpressing ecpR. Analysis of tir 
transcription using qRT-PCR revealed significantly increased levels in TW14359 pecpR 
(p<0.05), but not in TW14359∆ecpRP::kan pecpR or TW14359∆rcsB pecpR (Fig. 28A). Indeed, 
overproduction of ecpR resulted in visibly increased production of cytosolic Tir during growth in 
LB, but not for cultures grown in DMEM (Fig. 28D). As a positive control for LEE activation, 
expression of the rcsDB operon from a multi-copy vector resulted in a similarly increased level 
of cytosolic Tir during growth in LB, with a slight increase observed during growth in DMEM 
(Fig. 28D). These results demonstrate that overproduction of EcpR is able to increase production 
of RcsB and LEE encoded Tir. However, it was not clear whether the regulator EcpR was 
directly influencing their transcription, or whether the effect was indirect.  
 It was thus hypothesized that production of ECP pilus was indirectly influencing 
production of RcsB and Tir, rather than direct activation by EcpR.  To address this, rcsB and tir  
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Figure 29 - qRT-PCR and western blot analysis of rcsB, ecp, and LEE gene targets with 
pecpABCDE 
(A) Representative western blots for RcsB-FLAG for cultures grown to mid-exponential phase (OD600 of 
0.5) in LB or DMEM, with or without vector pecpABCDE. (B) Transcript levels for tir, rcsB, and ecpA in 
wild type and derivative TW14359 strains expressing pecpABCDE on a multi-copy plasmid from the 
TW14359 ecpA promoter (666 bp upstream of the ecpA start codon) for exponential (OD600 of 0.5) phase 
LB cultures. Asterisks denote significance by a Student’s t-test (*, p<0.05; **, p<0.01; ***, p<0.001; 
n≥3). Error bars indicate standard deviation for all panels. 
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transcript levels were determined in TW14359 containing a vector expressing ecpABCDE under 
the control of the TW14359 specific ecpA promoter. In support of this hypothesis, significantly 
higher levels of transcription (p<0.05) were observed for rcsB and tir compared to wild type 
TW14359, with concomitantly elevated RcsB protein in strain TW14359 pecpABCDE (Fig. 29A 
and 29B). And, consistent with the activity of the TW14359 ecpA promoter, loss of the ecpR 
upstream region did not completely abrogate ecpA transcription (Fig. 29B). However, as 
previously observed, TW14359∆ecpRP::kan  and TW14359∆ecpRP::kan pecpABCDE did not 
have significantly different levels of rcsB or tir transcription. Collectively, the results of these 
experiments suggest that transcriptional activation of rcsB and tir transcription by ecpR requires 
an intact ecpR promoter, and confirm that EcpR mediated transcriptional activation of the ecp 
operon, in EHEC strain TW14359, requires an intact rcsB gene. 
 
4.4 Discussion 
A number of chaperone-usher fimbriae are encoded within the E. coli genome (Wurpel et al., 
2013), however their specific contribution to the colonization in the human host, or the specific 
host targets recognized, remains largely unknown. The contribution of the E. coli common pilus 
for adherence to cultured epithelial cells has been previously described (Rendon et al., 2007), 
and a report using the commensal E. coli strain Nissile 1917 identified ecpA as being required for 
colonization in an infant mouse model (Lasaro et al., 2009); more recently, virulence attenuation 
was observed for avian pathogenic E. coli (APEC) following mutation of the ECP tip adhesin 
gene, ecpD (Stacy et al., 2014). Though, the contribution of ECP to host colonization and 
virulence for EHEC strains has yet to be definitively shown. Among pathogenic and non-
pathogenic E. coli strains the ecp operon structure is highly conserved; however, a phylogenetic 
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grouping has been defined based on promoter architecture of ecpR (matA), and the diverse 
regulatory patterns of the ecp operon among strains are at least in part a direct result of this 
promoter sequence variation (Lehti et al., 2013a). For example, transcription and production of 
ECP during growth at physiological temperatures is observed for EHEC strains, but not for 
NMEC (Lehti et al., 2013a). The results presented in this study identify a regulatory feature of 
the ecp operon that is unique to EHEC strain TW14359, and reveal novel a pathway for ECP 
mediated rcsB transcriptional activation and LEE gene regulation. 
 Using the mapped transcripts from previous RNA sequencing experiments (Morgan et. 
al., 2014), the transcriptional profile of the ecp operon was examined. In agreement with 
previous reports (Lehti et al., 2013a), transcription of the ecp operon appears to be under the 
control of a transcriptional terminator (d'Aubenton Carafa et al., 1990), with levels of mapped 
transcript reduced substantially near the location of the mapped terminator sequence within the 
ecpA-ecpB intergenic region. Indeed, modulation of mRNA production through transcriptional 
termination has been previously described in other pilus and fimbrial operons, and was proposed 
to regulate stoichiometric levels of adhesin assembly machinery (He et al., 2004; Jordi et al., 
1993; Kram et al., 2008). More importantly, while the entire operon was mapped, the highest 
level of mapped transcript was located within and immediately upstream of ecpA. This finding 
suggested that, though the promoter(s) upstream of ecpR can drive production of ECP, another 
previously cryptic element within the ecpA ORF was capable of promoting transcription. In this 
study, a TW14359 specific polymorphism was characterized within the ecpR ORF that is 
required for ecpRP-independent ecpA transcription. While the region upstream of ecpA in is 
largely transcriptionally silent in E. coli strains, in EHEC strain TW14359 the promoter activity 
was detectable. This promoter activity required a single polymorphism located near a predicted 
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sigma-70 promoter region, and was negatively repressed by H-NS. One possibility is that the 
polymorphism present in TW14359 alters the binding affinity of some unknown factor required 
for efficient transcription from the ecpA promoter. Alternatively, it may more directly influence 
the architecture of the promoter itself. A sequence analysis revealed a predicted sigma-70 
promoter immediately upstream of polymorphism, and this difference might disrupt or inhibit 
RNA polymerase binding. Repression by H-NS was present in EHEC strain Sakai, but promoter 
activity was significantly lower than strain TW14359. It is then possible that the promoter for 
ecpA transcription exists in the other strains assayed, but is cryptic in function. Future work is 
aimed at determining the specific ecpA promoter sequence, and at identifying potential 
regulatory elements present in TW14359 which may contribute to its distinct regulation when 
compared with other E. coli strains. The results of this study thus show that, even without 
repression by H-NS, ecpA promoter activity from other E. coli strains is significantly weaker 
than that of TW14359.   
 While EcpR directly regulates transcription from the EcpR promoter, and has been shown 
to weakly bind to the ecpA upstream region (Lehti et al., 2013a), loss of ecpR or its 
overproduction had no effect on transcription from the ecpA promoter.  This is consistent with 
the fact that sequence analysis of the ecpA upstream region did not reveal any EcpR binding 
consensus sites (TTCCT-N17-TTCCT) (Martinez-Santos et al., 2012) within the region 666-bp 
upstream of ecpA.  Overall, this data is consistent with the observation of high levels of mapped 
transcripts within the ecpA ORF, and the presence of a predicted sigma-70 promoter (Huerta and 
Collado-Vides, 2003). Future experiments are aimed at identifying potential factors or conditions 
which act through the ecpA promoter to direct ECP production independent of primary 
transcription from the promoter(s) upstream of ecpR.   
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 Further, this study has corroborated the contribution of ECP pilus production to cultured 
epithelial cells (Garnett et al., 2012; Rendon et al., 2007), specifically to Caco-2 and HT-29 
epithelial cells.  E. coli strains have been shown to produce an expansive repertoire of adhesins 
contributing to adherence, including intimin, curli, hemorrhagic coli pili (HCP), long polar 
fimbriae (Lpf), the acid inducible YadK, and others (Avelino et al., 2010; Chingcuanco et al., 
2012; DeVinney et al., 1999; Elliott et al., 2000; Erdem et al., 2007; Fordtran and Locklear, 
1966; Garnett et al., 2012; Giron et al., 2002; Gonyar and Kendall, 2013; Hernandes et al., 2013; 
Hernandes et al., 2011; Kenny et al., 1997b; Saldana et al., 2009b; Torres et al., 2002; 
Xicohtencatl-Cortes et al., 2007). It is therefore not difficult to rationalize the variation observed 
in promoter architecture for different E. coli pathotypes, and even further promoter sequence 
refinement within hemorrhagic E. coli strains, where each pathotype alters the expression of 
surface expressed adhesins to suit its unique biological niche or preferred site of colonization.  
This is important particularly in light of the co-regulatory nature of different EHEC adhesins, 
such as Ler (LEE1 encoded, transcriptional activator of the LEE) mediated activation of Lpf 
transcription (Elliott et al., 2000; Sperandio et al., 2000; Torres et al., 2007). This dynamic 
extends beyond just regulation, as the localized adherence pattern of enteropathogenic 
Escherichia coli was shown to be dependent on bundle-forming pili (BFP), the T3SS and ECP 
working synergistically with other adhesins to coordinate adherence to host epithelial cells 
(Saldana et al., 2009a). Conversely, a recent study identified factors involved in the formation 
and microanatomy of E. coli strain W3110 macrocolonies, and showed that type I fimbriae and 
ECP were dispensable, while flagella production played a significant role in macrocolony 
morphology (Serra et al., 2013). However, for different non-pathogenic E. coli strains, such as 
MG1655 and W3110, the promoter upstream of ecpR has undergone mutational attrition and is 
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no longer able to facilitate active ecpR transcription (Lehti et al., 2013a). It is therefore 
interesting to speculate on the potential contribution of ECP to the formation of the distinct 
macrocolony structure in ECP strains producing biofilms.  
   Expression of ecpR from a multi-copy vector resulted in substantially increased ecpA 
transcription, but was completely dependent on an intact rcsB gene. However, a previous report 
using EHEC strain EDL933 found that the RcsB consensus site was dispensable for ecpR 
promoter activity (Martinez-Santos et al., 2012). The reason for this disparity might be due to the 
nature of the expression analysis performed, wherein the authors utilized a multi-copy vector for 
their expression experiments, which might have masked subtle regulatory interactions between 
RcsB and EcpR at the ecpR promoter. However, this study has corroborated the RcsB dependent 
regulatory pathway for ecp transcriptional activation, through the ecpR promoter(s), at least in 
EHEC strain TW14359.   
 Strain TW14359 has been previously shown to possess intrinsically upregulated rcsB 
transcription, which was shown to be required for its increased adherence phenotype compared 
with EHEC strain Sakai (Abu-Ali et al., 2010b; Morgan et al., 2013). However, the specific 
factors which contribute to increased rcsB transcription remained elusive. Since transcription of 
matA (ecpR) was shown to be dependent on RcsB (Lehti et al., 2012b), and our own analysis 
validated this finding in EHEC strain TW14359, the potential contribution of increased ECP 
biogenesis on RcsB production was explored. Where previous reports aimed at examining the 
contribution of EcpR (MatA) to the transcriptional regulation of rcsB did not identify a 
significant increase in rcsB transcript (Lehti et al., 2012b), this study revealed a slight but 
significant increase in strain TW14359. Differences in the two strains examined, as well as the 
specific growth conditions, might account for the disparity in the studies. Furthermore, and in 
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agreement with RcsB regulation of type III secretion (Tobe et al., 2005), increased tir mRNA 
and cytosolic Tir was detected following overproduction of ECP, specifically following 
overexpression of ecpR. It is important to note that, while overproduction of EcpR did increase 
cytosolic levels of RcsB, a similar increase was also observed following overexpression of the 
ecp operon alone without ecpR. Therefore, one intriguing possibility is that activation of rcsB 
transcription is a result of increased ECP pilus production, rather than a result of direct or 
indirect activation by EcpR, such as is the case with EcpR mediated repression of motility 
through the flhDC promoter (Lehti et al., 2012a).  Bacterial sensing of pilus production has been 
previously reported during overproduction of the type IV bundle-forming pilus, resulting in 
activation of the Cpx envelope stress response system (Nevesinjac and Raivio, 2005). And, more 
recently, loss of ecpD (encoding the ECP tip adhesin) was shown to decrease motility in APEC 
(Stacy et al., 2014). Collectively, these findings indicate that increased production of the ECP 
pilus is able to modulate transcription of rcsB, and thus indirectly effect the production of 
additional, distally encoded, adherence factors in EHEC strain TW14359.  As ECP production 
has been found to play a critical role in E. coli biofilm formation (Lehti et al., 2010; Rendon et 
al., 2007; Stacy et al., 2014), it is possible that biogenesis of the E. coli common pilus may 
directly or indirectly activate the Rcs phosphorelay and transcription of genes involved in 
biofilm formation. 
 To conclude, in EHEC strain TW14359 it was shown that transcription of ecpA is under 
the control of a promoter that is repressed by H-NS. The promoter activity in TW14359 was 
further shown to be dependent on a strain specific polymorphism, and that mutation of the SNP 
to that of the closely related Sakai sequence reverted promoter activity to the low level observed 
for other E. coli strains. Furthermore, overproduction of ECP stimulated production of RcsB and 
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the LEE encoded Tir. And finally, ecp transcription, driven by the promoter upstream of ecpA, 
was able to positively affect adherence to cultured epithelial cells.   
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Table 8 - Strains and plasmids used in Chapter 4 
  
  
      
Strain/plasmid Relevant characteristics Reference 
Strain name:     
DH5α Vector propagation, recA1 endA1   
MG1655 F-, lambda-, rph-1    
E2348/69 Escherichia coli O127:H6; (typical EPEC) Iguchi, 2009 
3256-97 Escherichia coli O55:H7; (atypical EPEC) Zhou, 2010 
TW14359 WT 2006 outbreak, western U.S.A. (EHEC) Manning, 2008 
Sakai WT 1996 outbreak, Osaka, Japan (EHEC) Michino, 1998 
CFT073 Escherichia coli O6:K2:H1 CFT073 (UPEC) Welch, 2002 
EAEC O42 
Wild-type Peruvian Escherichia coli O44:H18 
(EAEC) Nataro, 1985 
UTI89 Escherichia coli O18 K1 H7 UTI89 (UPEC) Chen, 2006 
EcRJM-6 TW14359∆rcsB Morgan, 2013 
EcRJM-10 TW14359rcsB-FLAG Morgan, 2013 
EcRJM-13 TW14359tir-FLAG Morgan, 2013 
EcRJM-73 TW14359∆lacZ Morgan, 2014 
EcRJM-86 TW14359 rcsDB-luxE Morgan, 2014 
EcRJM-113 TW14359∆ecpRp::kan  This study 
EcRJM-114 TW14359∆ecpA::kan This study 
EcRJM-115 TW14359 ecpA-FLAG This study 
EcRJM-116 TW14359∆ecpRp::kan ecpA-FLAG This study 
EcRJM-117 TW14359∆lacZ∆hns::kan  This study 
      
Plasmid name:     
pACYC177 Low copy cloning vector, Amp
R
 Kan
R 
P15A Chang, 1978 
pBAD-TOPO Ara inducible expression vector, pBR322 Invitrogen 
pMPM-K3 Low copy cloning vector, Kan
R
 p15A/f1  Mayer, 1995 
pUC19 High copy cloning vector, Amp
R 
pMB1 Yanisch-Perron, 1985 
pRS551 lac fusion vector, Amp
R
 Kan
R
 lacZ
+
 ColE1 Simons, 1987 
pCP20 Flp recombinase expression vector Datsenko, 2000 
pKD4 Template plasmid for Kan cassette Datsenko, 2000 
pKM208 Red-recombinase expression vector Datsenko, 2000 
pSU312 FLAG epitope template, Amp
R
, Kan
R
, R6K Uzzau, 2001 
placlux8 placlux8 Shimizu, 2011 
pLuxCDAB3 pLuxCDAB3 Shimizu, 2011 
pRJM-34 
pecpR, ecpR ORF and promoter in vector pMPM-
K3 This study 
pRJM-35 pBAD-ecpR, ecpR ORF in pBAD-TOPO vector This study 
pRJM-36 
pMPMBAD-ecpR, ecpR ORF and pBAD promoter 
cloned from pRJM-35 in pMPM-K3 This study 
pRJM-37 pecpABCDE, ecpABCDE operon cloned into pUC19 This study 
pRJM-38 pRS551-ecpR (-496,-1), from TW14359 This study 
pRJM-39 pRS551-ecpA (-666,-1), from TW14359 This study 
      
a
 Nucleotide positions based on the published TW14359 (NC_013008) genome sequences 
(NCBI) 
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Table 7 
Strains and plasmids used in Chapter 3, 
continued.   
      
Strain/plasmid Relevant characteristics Reference 
Plasmid name:     
pRJM-40 pRS551-ecpA (-555,-1), from TW14359 This study 
pRJM-41 pRS551-ecpA (-496,-1), from TW14359 This study 
pRJM-42 pRS551-ecpA (-387,-1), from TW14359 This study 
pRJM-43 pRS551-ecpA (-270,-1), from TW14359 This study 
pRJM-44 pRS551-ecpA (-131,-1), from TW14359 This study 
pRJM-45 pRS551-ecpA (-666,-1), from Sakai This study 
pRJM-46 pRS551-ecpA (-666,-1), from UTI89 This study 
pRJM-47 pRS551-ecpA (-666,-1), from CFT073 This study 
pRJM-48 pRS551-ecpA (-666,-1), from O55:H7 This study 
pRJM-49 pRS551-ecpA (-666,-1), from O127:H6 This study 
pRJM-50 pRS551-ecpA (-666,-1), from MG1655 This study 
pRJM-51 
pRS551-ecpA (-666,-1), from TW14359 (T to C 
directed mutation) This study 
pRJM-52 
pRS551-ecpA (-666,-1), from O127:H6 (C to T 
directed mutation) This study 
pRJM-53 pUC19-ecpAP (-666,-1), from TW14359 This study 
pRJM-54 
pUC19-ecpAP (-666,-1), from TW14359 (T to C 
directed mutation) This study 
pRJM-55 pUC19-ecpAP (-666,-1), from O127:H6 This study 
pRJM-56 
pUC19-ecpAP (-666,-1), from O127:H6 (C to T 
directed mutation) This study 
pRJM-21 pMPM-K3-rcsDB Morgan 2014 
      
a
 Nucleotide positions based on the published TW14359 (NC_013008) genome sequences 
(NCBI) 
 
 
 
 
 
 
 
 
 
142 
 
 
Table 9 - Primers used in Chapter 4 
Primer name Sequence (5'→ 3')a,b Function/Reference
FLAG-F gactacaaagatgacgacga Uzzau, 2001
P1 gtgtaggctggagctgcttc Datsenko, 2000
P2 catatgaatatcctccttag Datsenko, 2000
Tir+664 ACTTCCAGCCTTCGTTCAGA qRT-PCR Primer/Mitra, 2012
Tir+869 TTCTGGAACGCTTCTTTCGT qRT-PCR Primer/Mitra, 2012
EspA+128 AGGCTGCGATTCTCATGTTT qRT-PCR Primer/Mitra, 2012
EspA+310 GAAGTTTGGCTTTCGCATTC qRT-PCR Primer/Mitra, 2012
RcsB+300 TCTGGATATCGAAGGGATCG qRT-PCR Primer/Morgan, 2013
RcsB+485 AACAGGCGCAGAACTTCACT qRT-PCR Primer/Morgan, 2013
EcpA+208 CTATTTGACGTGGCTATCG qRT-PCR Primer
EcpA+291 CTGGGTTAATGTGTTGGTG qRT-PCR Primer
Hns-41/P1 CCTCAACAAACCACCCCAATATAAGTTT
GAGATTACTACAGTGTAGGCTGGAGCTGC
TTC
Deletion Primer
Hns+455/P2 CGCCGATGGCGGGATTTTAAGCAAGTGCA
ATCTACAAAAGCATATGAATATCCTCCT
TAG
Deletion Primer
Hns-83/FVal CTGAATTTAAGGCTCTATTA Deletion Validation
Hns+482/RVal TGTCTTAAACCGGACAATAA Deletion Validation
EcpR-388/P2 CTTATCATTTAGACTTGTTTTTTTACTAG
TCCATTACACACATATGAATATCCTCCT
TAG 
Deletion Primer
EcpR+40/P1 CAACCTCATAGTCCCTGCTGTAATCATTT
TGCCATGTCACGTGTAGGCTGGAGCTGCT
TC 
Deletion Primer
EcpR-496 GGGATGAACACCCATAACCA Deletion Validation
EcpR+70 CAGAACGGTTTTGACATTCC Deletion Validation
EcpA-41/P1 TGGGACATCACGTCCTCAATTCAACTCGG
GAAGAAATACAGTGTAGGCTGGAGCTGC
TTC
Deletion Primer
EcpR-496 GGGATGAACACCCATAACCA Deletion Validation
EcpR+70 CAGAACGGTTTTGACATTCC Deletion Validation
EcpA-41/P1 TGGGACATCACGTCCTCAATTCAACTCGG
GAAGAAATACAGTGTAGGCTGGAGCTGC
TTC
Deletion Primer
EcpA+610/P2 CCCTGCTGGTACATCAGAGAGATTAACT
GGTCCAGGTCGCCATATGAATATCCTCCT
TAG
Deletion Primer
a
 Restriction sites indicated by bolded and underlined nucleotides
b
 Nucleotides changed through site-directed mutagenesis are indicated by bold nucleotides.
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Table 8
Primer name Sequence (5'→ 3')a,b Function/Reference
EcpA+546/Flag-F CGGCGACGTTAGCGTACAGTTCGACGCGA
CCTGGACCAGTGACTACAAAGATGACGA
CGA
FLAG Tagging Primer
EcpA+658/P2 GGTGCTTTTTCATAACAATTCCGTCCAGG
AATAAAGCTGGCATATGAATATCCTCCT
TAG
FLAG Tagging Primer
EcpA+524 CTCTACCGGAAGGCATCTGG FLAG Validation Primer
EcpA+676 GCAGAGCGAGAAGCAGAAGG FLAG Validation Primer
EcpR-496/BamHI CGGGATCCGGGATGAACACCCATAACCA Fragment for pRS551
EcpR-21/BamHI CGGGATCCTACTTTCCAAACCTGTAATT Fragment for pRS551
EcpA-666/EcoRI (1) CGCGGAATTCGTGACATGGCAAAATGAT
TAC 
Fragment for pRS551
EcpA-555/EcoRI CGCGGAATTCGGACTATCTGAACTGATTG
T
Fragment for pRS551
EcpA-496/EcoRI CGCGGAATTCCAGAAAAGATTTCGTGTT
TA 
Fragment for pRS551
EcpA-387/EcoRI CGCGGAATTCGCGGCCAGAAAGTCAGAA
GC 
Fragment for pRS551
EcpA-270/EcoRI CGCGGAATTCGGCAGGTTCCTGAGAAAA
GA 
Fragment for pRS551
EcpA-131/EcoRI CGCGGAATTCATCGGCGTAATGCAGAGGC
C 
Fragment for pRS551
EcpA-1/BamHI (1) CGCGGGATCCTGTATTTCTTCCCGAGTTG
AA 
Fragment for pRS551
EcpA-666/EcoRI (2) CGCGGAATTCGTGACATGGCAAAGTGAT
TAC 
Fragment for pRS551
EcpA-1/BamHI (2) CGCGGGATCCTGCTTTTCTTCCCGAGTTG
AA 
Fragment for pRS551
EcpA-1/BamHI (3) CGCGGGATCCTGCATTTCTTCCCGAGTTG
AA 
Fragment for pRS551
ecpAp/SDMForward AGTGTATACCC ATCGGCGTAA Site-Directed Mutagenesis
ecpAp/SDMReverse TTACGCCGATG GGTATACACT Site-Directed Mutagenesis
ecpAp/SDMForward 
(O127)
AGTGTATACCT ATCGGCGGAA Site-Directed Mutagenesis
ecpAp/SDMReverse 
(O127)
TTCCGCCGATA GGTATACACT Site-Directed Mutagenesis
a
 Restriction sites indicated by bolded and underlined nucleotides
b
 Nucleotides changed through site-directed mutagenesis are indicated by bold nucleotides.
Primers used in Chapter 4, continued.
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Chapter 5: Conclusions and Future Directions 
 The 2006 EHEC O157:H7 outbreak strain TW14359 is characterized by increased 
virulence and an increased adherence phenotype when compared with distantly related EHEC 
strains (Abu-Ali et al., 2010a). Increased virulence is associated with increased LEE and stx2 
gene transcription, with concomitantly increased adherence and Stx2 production compared with 
the less virulent Sakai outbreak strain (Abu-Ali et al., 2010b). However, no specific factors had 
been identified which could account for increased virulence gene expression in TW14359 
hitherto. Here, the proteome and transcriptome of EHEC strain TW14359 was explored to 
determine specific factors which contribute to increased virulence gene expression and 
adherence. Our proteomic analysis identified the Rcs response regulator RcsB as being more 
abundant in TW14359 when compared with EHEC strain Sakai.  Indeed, loss of rcsB collapsed 
the differences in LEE gene expression and adherence between Sakai and TW14359, suggesting 
that it plays a role in the enhanced virulence phenotype.  
 The previous finding suggested that one or more factors, acting at one of the rcsB 
promoters, direct hypervirulence in TW14359. It is possible that some factor is directly binding 
to the rcsB promoter to influence transcriptional activation of the response regulator. Our 
analysis has only shown increased rcsB and LEE gene transcription during exponential phase in 
DMEM, a condition which is known to stimulate LEE gene transcription. Thus, it is possible that 
the effect is specific to those conditions which mimic the host environment and promote 
colonization. The production of other colonization factors, such as the E. coli common pilus 
(ECP), are stimulated during growth in DMEM for EHEC (Rendon et al., 2007; Torres et al., 
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2002; Torres et al., 2007). While no additional rcsB regulators have been identified in this study, 
a few specific regulators have been previously shown to influence rcsB transcription, including 
QseE and LexA (Gervais et al., 1992; Reading et al., 2010). However, neither regulator was 
identified as being increased in either previous transcriptional profiles or comparative proteomic 
analyses herein. It is therefore possible that another unknown factor contributes directly or 
indirectly to increased rcsB transcription in EHEC strain TW14359. One additional possibility is 
that RcsB is directly regulating its own transcriptional activation through the phosphorelay itself. 
For example, in Salmonella the rcsDB operon is negatively regulated by RcsB through direct 
binding at the rcsDB promoter upstream of rcsD (Pescaretti Mde et al., 2009). This is 
particularly salient as it suggests RcsB may directly regulate its own transcription to some 
degree. However, no such regulatory pathway to-date has been identified in E. coli.   Moreover, 
the predicted RcsB binding site upstream of rcsD present in Salmonella bears little homology to 
the same site in E. coli, opening the possibility for differences in auto-regulation. 
 Because RcsB is more abundant in TW14359, a strain which has high levels of LEE gene 
transcription, it was of interest to determine if overproduction of the LEE had a role in 
transcriptional activation of rcsB. While no specific activation of rcsB was observed following 
overproduction of GrlA, elevated RcsB was seen. This finding was particularly interesting since 
GrlA is known to repress motility in E. coli, and this study has shown RcsB is required for GrlA 
mediated repression of motility.  Although increased RcsB was observed in GrlA overexpression 
strains, rcsB transcriptional activation was not. This data suggests some post-translational 
regulation of RcsB, either direct or indirect, by GrlA. As GrlA has been shown to interact 
directly with GrlR (Padavannil et al., 2013),  it is possible that GrlA interacts with RcsB in some 
way to promote its stability. Alternatively, GrlA may affect some other factor that is able to post-
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translationally modulate cytosolic RcsB levels. To determine potential interactions between GrlA 
and RcsB, it would be of interest to perform protein-protein interaction analyses using purified 
tagged variants of both GrlA and RcsB in pull-down studies. Alternatively, a co-
immunoprecipitation experiment could be performed with purified GrlA and RcsB to determine 
specific protein-protein interactions. These experiments would begin to clearly determine if the 
regulatory effect of GrlA on RcsB abundance is direct, or whether it is through some other 
factor. In light of the latter findings, it is important to note that a previous study on 
transcriptional differences between EHEC strains Sakai and TW14359 revealed differences in 
LEE gene transcription, but also identified decreased transcription in genes associated with 
motility (Abu-Ali et al., 2010b). This finding was of particular interest as GrlA overexpression 
was also shown to negatively affect motility through the flhDC promoter, though direct 
interaction has not yet been shown (Iyoda et al., 2006). The results of this study have shown that 
GrlA mediated repression of motility requires an intact rcsB gene. As heterodimerization of 
RcsB with a number of transcriptional regulators has been previously described (Krin et al., 
2010; Torres-Cabassa and Gottesman, 1987; Venkatesh et al., 2010), one possibility is that GrlA 
and RcsB interact directly to regulate flhDC promoter activity. While a specific RcsAB binding 
consensus site was identified in E. coli (Francez-Charlot et al., 2003), no current GrlA consensus 
sequence has been described. Alternatively, the regulatory effects on motility by GrlA and RcsB 
could be simply due to the downstream affects of increased RcsB protein levels alone. 
 As a positive LEE gene expression control, sodium bicarbonate was added to the growth 
media to stimulate LEE gene transcription. Surprisingly, addition of bicarbonate led to 
substantially increased cytosolic RcsB protein level (Fig. 31), which were elevated above that 
observed following GrlA overproduction.  It was further shown that bicarbonate mediated 
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transcriptional activation of the ler promoter required an intact Rcs phosphorelay, and that full 
stimulation was also dependent on the EHEC specific regulator GrvA (Morgan et al., 2013; Tobe 
et al., 2005).  To date, numerous studies have shown that LEE gene expression is maximal 
during active growth, but also in conditions which are similar to the predicted host physiology. 
These include, but are not limited to, pH, osmolarity, and the availability of different nutrients 
and host derived signals (Alam et al., 2010; Kendall et al., 2012; Kenny et al., 1997a; Kenny and 
Finlay, 1995; Pacheco et al., 2012; Sperandio et al., 2002). While this work has demonstrated 
RcsB dependent bicarbonate induction of the LEE, the method of RcsB activation by bicarbonate 
remains to be determined. Experiments aimed at elucidating this mechanism could explore 
factors which are dependent on the bicarbonate ion for function in E. coli that might activate the 
Rcs phosphorelay. For example, the cyclopropane fatty acid synthase (Cfa) is an enzyme which 
catalyzes the formation of cyclopropane groups in the non-polar region of phospholipids, a 
process that has a significant role in moderate acid resistance during stationary growth (Brown et 
al., 1997; Chang and Cronan, 1999). Recent studies have identified a bicarbonate molecule 
within the Cfa active site, and have further shown that enzyme activity can be inhibited 
following the addition of the Cfa active site competitor, borate, with a similar planar trigonal 
structure (Courtois and Ploux, 2005; Iwig et al., 2005). Thus, it is possible that bicarbonate 
increases enzymatic activity of the Cfa enzyme during exponential growth, when cfa 
transcription is typically lower (Rosenthal et al., 2008), and promotes the addition of 
cyclopropane groups to the cell membrane. Such a membrane alteration could conceivably 
activate the Rcs phosphorelay and promote downstream LEE gene transcription. Initial 
experiments aimed at exploring this hypothesis would be aimed at mutational analysis of cfa and 
the contribution to LEE gene transcription during growth with and without bicarbonate. 
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Preliminary data (not shown) has shown that addition of borate is able to quench bicarbonate 
mediated rcsDB promoter activation. However, the chemical nature of this is not yet clear as 
potential chemical reactions with bicarbonate and borate were not fully determined. As an 
alternative to Cfa, the aminopeptidase A (PepA) catalytic domain utilizes a bicarbonate ion, 
though it does not require bicarbonate for function (Strater et al., 1999). The PepA 
aminipeptidase was implicated in bicarbonate mediated virulence gene regulation in Vibrio 
cholera (Abuaita and Withey, 2009), though no study to-date has fully addressed the hypothesis.    
 Increased transcription of rcsB was observed in EHEC, and the effect was hypothesized 
to be due to some factor specific to TW14359. A comparative analysis of the TW14359 genome 
with other EHEC strains was performed (Kulasekara et al., 2009), and identified an insertion in 
the tolA gene which was initially hypothesized to contribute to rcsB dysregulation, which would 
make sense in light of the role for TolA in membrane integrity and subsequent Rcs phosphorelay 
activation (Clavel et al., 1996; Levengood et al., 1991) (Fig. 30). However, while loss of tolA in 
both TW14359 and Sakai EHEC strains did indeed elevate rcsB transcription, it was still 
proportionally higher in TW14359. Although data towards understanding the role for the 
TW14359 specific insertion in tolA did not support the initial hypothesis, further analysis into its 
role in potential physiological stress response differences in TW14359 is warranted. Specifically, 
variation in the E. coli tolA membrane spanning repeat domain length has recently been shown to 
affect stress tolerance to 4% sodium dodecyl sulfate (SDS) (Zhou et al., 2012).  Furthermore, 
differences in the TolA transmembrane domain length contribute to distinct stress resistance 
differences observed for Salmonella enterica subsp. enterica serovars Typhi and Typhimurium 
(Lahiri et al., 2011). Thus, further examination into the direct role of TolA in EHEC virulence 
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Figure 30 - Schematic model for TolQRA and the Rcs phosphorelay 
The TolQRA complex is in E. coli facilitates maintenance of outer membrane integrity and has a role in 
division (Lloubes et al., 2001).  The TolR and TolQ proteins energize TolA by coupling the proton 
motive force of the periplasmic space (Cascales et al., 2000).  TolA is anchored to the inner membrane 
and has an extended alpha helical which connects the terminal domain that interacts with OmpF and Pal.  
Loss of TolA leads to outer membrane perturbation and strongly promotes signal transduction between 
RcsF and RcsC through some unknown mechanism (Clavel et al., 1996).  Activation of the Rcs 
phosphorelay thus leads to transcriptional activation of capsular polysaccharide genes (cps) and is 
predicted to increase LEE gene transcription through the RcsB-GrvA pathway. 
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could include exploring its specific role in virulence, as observed in Salmonella (Paterson et al., 
2009), and the mechanism by which tolA mutation communicates membrane perturbation to the 
inner-membrane lipoprotein RcsF (Clavel et al., 1996). As increased rcsB transcription was 
observed in both Sakai and TW14359 following mutation of tolA, it is possible that potential 
auto-activation of RcsB through the Rcs phosphorelay is a contributing factor. Finally, virulence 
assays for tolA mutant EHEC strains could be performed to explore the significance of the 
membrane spanning protein in pathogenesis and growth fitness in both bovine and mouse models 
of colonization. The contribution to adherence could be ascertained through adherence assays for 
EHEC on cultured epithelial cells, with either visual microcolony counts or fluorescent 
microscopy with antibodies for actin to determine pedestal formation under adherent EHEC 
cells. The experiment latter would permit detection of type III secretion mediated actin 
accumulation, and could help to discriminate between adherent cells utilizing other important 
EHEC adhesins, such as Lpf or HCP.   
 To identify additional factors unique to EHEC strain TW14359, a further sequence 
analysis of the TW14359 genome for other factors which might directly affect rcsB transcription 
was performed. Subsequent analysis of nucleotide polymorphisms specific to TW14359 revealed 
a SNP located upstream of the ecp operon encoded gene ecpA. This gene, encoding the major 
fimbrial subunit of the E. coli common pilus (ECP), was of particular interest as a regulatory 
dynamic between RcsB and the major ecp promoter had been previously established (Lehti et al., 
2012b). A detailed mapping of the promoter, and further site-directed mutagenesis of specific 
nucleotide polymorphisms, revealed that promoter activity upstream of ecpA was significantly 
higher than all other E. coli ecpA promoters tested. And, perhaps more importantly, promoter 
activity was significantly higher than that of EHEC strain Sakai. This finding was particularly 
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salient as the only difference between the two promoters was the polymorphism identified. The 
regulatory region 270-bp upstream of ecpA identified had been previously tested for promoter 
activity (Martinez-Santos et al., 2012), but was performed on a strain lacking the polymorphism 
unique to TW14359. Likewise, another study has explored transcriptional regulation of the ecpR 
promoter and the region upstream of ecpA, specifically mediated by H-NS, and suggested that 
the sequence located within the ecpR open-reading frame may contain an 'upstream regulatory 
element' (Lehti et al., 2013b). This finding was congruent with our observation of H-NS control 
over the TW14359 specific ecpA promoter, where mutation of hns resulted in substantially 
higher ecpA promoter activity. A slight but significant increase was also seen for the promoter 
fragment derived from EHEC strain Sakai, supporting a model of H-NS regulation through the 
ecpA promoter in E. coli strains regardless of the promoter activity strength. Future 
investigations into the regulation of the ecpA promoter could include a more detailed analysis of 
the sequence differences between TW14359 and more distantly related strains, such as 
enteropathogenic E. coli O127:H6 strain E2348/69. Our initial findings revealed that the 
TW14359 specific SNP alone was not enough to activate transcription in E2348/69, and that one 
or more of the other nucleotide sequence differences might be responsible for promoter activity 
below that of strain TW14359. Identification of factors which directly regulate transcription from 
the ecpA promoter, in TW14359 and other E. coli strains, would provide insight into how ECP 
production is controlled in different nutritional conditions and growth phases, and provide 
insight into the contribution of unique nucleotide polymorphisms found among divergent E. coli 
strains.  
 Promoter variation for the primary ecp operon promoter, upstream of the ecp encoded 
ECP regulator EcpR, has been previously explored (Lehti et al., 2013b). The latter study 
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identified phylogenetic group specific variation in transcription that is associated with 
differences in promoter architecture, and suggests that it may contribute to adaptation among E. 
coli strains in response to different environments and growth conditions. Such a model for 
promoter adaptation would make sense, in an evolutionary sense, as production of ECP in EHEC 
has been associated with adherence to both mammalian and plant tissue, specifically to cultured 
epithelial cells and spinach leaves, respectively (Rendon et al., 2007; Saldana et al., 2011). It is 
thus possible that enhanced promoter activity of the ecpA pilin gene in EHEC strain TW14359 
could provide a competitive advantage during colonization of a human or bovine host, or in 
adherence to spinach leaves. The latter food matrix is particularly interesting as the 2006 EHEC 
outbreak to which TW14359 was involved occurred largely through contaminated pre-packaged 
spinach (Wendel et al., 2009). Whether increased ecpA promoter activity in TW14359 has a role 
in adherence to mammalian or plant tissue has yet to be determined, however our analysis of 
ECP production has shown that ECP is produced in TW14359 in the absence of a functional 
ecpR promoter. Future analyses of TW14359 ECP production could involve experiments for 
competitive mammalian and plant tissue colonization with strains lacking other major adhesins, 
such as the type III secretion system, and in strains with distinct ECP expression patterns. 
 The primary ecp promoter upstream of ecpR is directly regulated by RcsB, as previously 
observed for neuromeningitic E. coli (NMEC) (Lehti et al., 2012b) and herein observed for 
EHEC. However, overproduction of EcpR in NMEC only slightly increased rcsB promoter 
activity, while in EHEC strain TW14359 our experiments have shown that a significant increase 
in mRNA and cytosolic RcsB is observed following expression of ecpR. This finding was quite 
intriguing as it suggests the former observation of increased ecpA promoter activity in EHEC 
strain TW14359 may have a role in dysregulation of rcsB when compared with other EHEC 
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strains (Morgan et al., 2013). As the regulator of the ecp operon, EcpR overproduction increases 
total ECP production. Thus, it is possible that increased rcsB transcription could be as a result of 
significantly increased ECP protuberance. Increased fimbriae production has been observed to 
activate the Cpx response in E. coli (Hung et al., 2001), in accordance with the proposed model. 
The ecp operon contains all of the factors required for ECP production. Specifically, following 
the chaperone-usher model of pilus biogenesis in E. coli (Thanassi et al., 1998; Waksman and 
Hultgren, 2009), ECP pili require the insertion of an usher protein (EcpC) into the outer-
membrane through which the pilus is assembled (Volkan et al., 2013a).  For ECP pili, two 
predicted ecp encoded chaperones (EcpB/EcpE) direct the assembly of both the ECP tip adhesin 
(EcpD) and the major ECP subunit (EcpA) (Garnett et al., 2012; Sauer et al., 1999). Since 
expression of the ecp operon, excluding ecpR, resulted in a similarly increased level of rcsB 
transcription, biogenesis of ECP is at least partly able to stimulate rcsB transcription (Fig. 31). 
However, as EcpR has been shown to directly regulate additional genes outside of the ecp 
operon, specifically flhDC (Lehti et al., 2012a), it remains a possibility that EcpR is able to 
regulate rcsB production in a manner independent of the pilus. How exactly assembly of ECP is 
capable of activation rcsB transcription is still unknown, however a recent study demonstrated 
that loss of the ECP tip adhesin EcpD, but not the major fimbrial subunit EcpA, significantly 
reduced motility in avian pathogenic E. coli (APEC) (Stacy et al., 2014). One possible 
explanation for this could be that loss of the ECP tip adhesin results in either mis-assembly or 
excess accumulation of EcpA in the periplasmic space, where chaperone binding capacity is 
exceeded. Indeed, previous reports on the basis of pilus biogenesis indicate that pilin subunits in 
the periplasm can be either chaperone-bound and awaiting assembly through the outer- 
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Figure 31 - Model for ECP biogenesis and predicted stimulation of the Rcs phosphorelay 
The E. coli common pilus is assembled through the chaperon-usher model of pilus biogenesis (Volkan et 
al., 2013b; Wurpel et al., 2013). The ecp operon is regulated by both the ecp encoded EcpR and the 
response regulator RcsB.  Though two ecp promoters have been identified in TW14359, only the ecpR 
promoter is directly regulated by EcpR and RcsB. ECP pilus components localize to the periplasmic space 
where the EcpD and EcpE chaperones guide the major pilin subunit (EcpA) and the tip adhesin (EcpD) to 
the usher protein (EcpC) for assembly. In this model, accumulation of EcpA could stimulate the Rcs 
phosphorelay through RcsF, or another unknown mechanism, to promote transcription and production of 
both RcsB and the LEE. 
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membrane usher, or alternatively involved OFF-pathway interactions leading to stress pathway 
activation (Hung et al., 1999; Hung et al., 2001). The outer-membrane lipoprotein RcsF has been 
shown to sense membrane perturbations and transmit signals to the Rcs sensor kinase (Majdalani 
et al., 2005; Shiba et al., 2012), and could thus effect transcription of the rcsB gene itself.  
Indeed, as previous studies have shown that mutation of tolA results in unambiguous activation 
of the Rcs phosphorelay (Clavel et al., 1996), loss of tolA in TW14359 led to significantly higher 
rcsB transcription (Morgan et al., 2013), in support of the proposed model of RcsB auto-
regulation. However, as noted previously, work remains to be done in elucidating specific auto-
regulation of the rcsDB operon by RcsB. 
 The LEE gene regulatory pathway through RcsB and GrvA had previously only been 
functionally described; indeed, the grvA dependence for LEE gene transcription had only been 
shown during overexpression of RcsB or through intrinsic activation of the Rcs phosphorelay 
through expression of a hyper-phosphorylating variant of RcsC (Tobe et al., 2005). However, the 
specific regulatory dynamic between RcsB and the grvA gene and downstream LEE gene 
regulation by GrvA remained unknown. Since our work has shown that RcsB binds directly to 
the grvA promoter, direct regulation through phosphorylated RcsB likely occurs at one or both of 
the tandem RcsB consensus sequences located proximal to the predicted grvA sigma-70 
promoter. Interestingly, the grvA promoter appears to be under tight regulation during all post-
lag growth phases, suggesting that some other factor may be involved in transcriptionally 
regulating its activity. Even during growth in DMEM, a condition which significantly increase 
rcsB transcription, grvA promoter activity eventually collapsed following transition to 
exponential growth.  One such possible regulator includes the capsule synthesis regulator RcsA, 
which is typically under tight proteolytic degradation during growth at physiological 
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temperatures (Torres-Cabassa and Gottesman, 1987). If RcsA is able to accumulate during 
stationary phase, transition to growth could ultimately leave a population of the regulator able to 
act of RcsA/RcsB promoters prior to its eventual degradation. In support of this, the RcsB 
binding sites upstream of the grvA promoter bear high sequence similarity to that of the RcsAB 
box identified upstream of flhDC (Francez-Charlot et al., 2003), a promoter which is actively 
repressed during RcsA accumulation. To determine whether RcsA is indeed a bona-fide grvA 
regulator, direct interaction could be determined through electrophoretic mobility shift assays or 
through co-immuno precipitation with epitope tagged RcsA.   
 While the direct regulation of grvA by RcsB was identified, the specific role for GrvA in 
the regulation of LEE gene transcription had not been shown. RNA sequencing was employed to 
explore the transcriptional differences in wild type compared with grvA and rcsB mutant strains.  
This aim of this approach was to determine the pathway, direct or indirect, through which GrvA 
transcriptionally regulates the LEE1 promoter, and downstream type III secretion. However, 
between the grvA isogenic mutant strain and the rcsB and grvA double mutant, only increased 
transcription of the GAD acid fitness island (AFI) could account for decreased LEE gene 
transcription. The AFI encoded transcriptional regulator GadE is a known direct repressor of 
LEE gene transcription, and is under complex regulation at 3 independent promoters located 
within a 750-bp sensory region upstream of the gadE ORF (Kailasan Vanaja et al., 2009; Sayed 
and Foster, 2009; Tree et al., 2011). Only the gadEP3 promoter was consistently up-regulated in 
the grvA mutant strain and up-regulation required an additional AFI encoded regulator, GadW 
(Fig. 32).  This regulatory dynamic is of particular interest as attempts to identify GrvA 
interaction at the gadEP3 promoter, while unsuccessful, revealed an additional unexpected shift 
with purified membrane fractions independent of GrvA. Thus, the GAD acid fitness island may 
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Figure 32 - Schematic model for RcsB-GrvA regulation of the LEE 
Bicarbonate is predicted to be a signal of at least RcsC, and its activation results in phosphotransfer to 
RcsD and thus RcsB. The grvA promoter is activated through direct transcriptional activation by RcsB 
and, through an as of yet unknown mechanism, is predicted to represses production of the gadE positive 
regulator GadW. Ultimately, de-repression of gadW leads to increased GadE production through the 
gadEP3 promoter, and results in both exponential acid resistance and LEE1 promoter repression.  
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interact with the inner membrane through direct binding of some factor at the gadE P3 promoter. 
In this model, GrvA bound to the inner membrane could more easily interact with the AFI 
encoded gadW promoter region. This mechanism of transcriptional regulation has been 
extensively described for the Vibrio cholerae toxin regulator ToxR (Kolmar et al., 1995).  
However, it has not been investigated whether GrvA directly binds to either of the mapped gadW 
promoters, or whether its regulatory role is indirect. Although preliminary evidence does suggest 
GrvA is localized to the inner membrane (unpublished data), in accordance with the location of 
its predicted transmembrane domain and high amino acid homology with ToxR.    
  To conclude, the results presented herein have demonstrated that differences in 
transcriptional regulation between two genetically distant EHEC strains is as a result of 
dysregulation of the capsule synthesis regulator RcsB. In the course of experimentation, a 
reciprocating regulatory loop between the LEE encoded regulator GrlA and RcsB was identified, 
and bicarbonate mediated virulence gene activation in EHEC was shown to be dependent on an 
intact Rcs phosphorelay. Further investigations into the genetic differences between EHEC 
strains Sakai and TW14359 revealed a polymorphism upstream of the ECP major fimbrial 
subunit gene encoding EcpA, and was subsequently shown to be unique to the 2006 O157:H7 
EHEC spinach outbreak strain TW14359. Although increased ECP production results in rcsB 
transcriptional activation, it remains a possibility that other factors contribute to intrinsic 
dysregulation of the rcsB in TW14359. Finally, the RcsB-GrvA pathway was explored using 
comparative RNA sequencing to elucidate the specific mechanism through which GrvA effects 
LEE gene transcription, and a pathway wherein GadE, stimulated by GadW, was identified. 
Taken together, the results presented significantly expand the role for RcsB in virulence gene 
159 
 
regulation for EHEC, identify a novel pathway for ECP stimulated LEE gene activation, and 
characterize the specific pathway for GrvA regulation of type III secretion. 
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